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Longevity is an important trait in animal production systems because long-lived animals
reduce the requirement to carry non-productive replacement livestock. Many factors affect
animal longevity including animal fecundity and performance for whichever trait, or traits, is
valuable in that production system. Longevity is therefore an economically important trait and
should be a consideration in any breeding programme.
Little research has been undertaken on longevity in sheep. So-called “longevity genes”
in other animal species have not been identified in sheep and/or effort has been primarily put
into improving other sheep production traits. In this study, the aim was to identify sheep
homologues for some putative longevity genes, including IGF1R, FOXO3, CAST and TLR4,
to assess the extent of variation in these genes, and to ascertain whether variation in these
genes is associated with longevity.
IGF1R is structurally conserved across species and its product is an evolutionarily
conserved regulator of the insulin-like growth factor (IGF) signalling pathway from lower
animals to mammals. Variation in IGF1R has been described in many species and associated
with variation in longevity. In this study, a fragment of intron 2 and exon 3 of ovine IGF1R
that encompasses the α subunits of the ligand-binding region, was screened for genetic
variation. Three novel sequences (named A, B and C) were identified in this region of the
gene. The three sequences were subsequently used to investigate associations with longevity.
FOXO3, a subgroup member of the Forkhead transcription factor family, plays an
important role in mediating the effects of insulin and other growth factors on metabolism.
Genetic variation in FOXO3 has been associated with longevity in a number of species. In this
study, the coding regions (two exons) of ovine FOXO3 were firstly sequenced and identified.
The entire exon 2 of ovine FOXO3 was 1422 bp long and encompasses the C-terminus of the
DNA-binding domain and a transcription activation domain. These are key regulators of
transcription activity in the target genes that FOXO3 binds. Seven haplotypes with 10
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nucleotide substitutions were identified across the 1422-bp exon 2 fragment. One of these
substitutions was predicted to produce an amino acid change (p.M201V). The effect of the
seven haplotypes (A to G) on sheep longevity was investigated.
CAST plays a role in protein-turnover and appears to be implicated in a range of
phenotypes such as exercise-induced muscle injury, diabetes and degenerative neural diseases
in humans. It has post-mortem effects on meat quality traits in livestock species and body
weight traits in sheep. Recently, genetic variation in a non-coding region of CAST has been
linked to longevity and fertility in dairy cattle, suggesting that this gene might play the same
role in sheep. In this study, two highly polymorphic regions of ovine CAST were investigated
revealing five sequences for exon 6 (A to E) and four sequences (A to D) for part of intron 12,
respectively. Extended haplotype variation across the two regions was also investigated to
better understand genetic diversity in ovine CAST. Nine haplotypes were defined across this
extended region and four haplotypes were identified that suggested historical recombination
events occurred within this gene. This intragenic recombination may make the discovery of
phenotypic associations more challenging. Therefore, the five sequences (A to E) defined in
the exon 6 of ovine CAST were further investigated in the context of sheep longevity.
TLR4 is a receptor for lipopolysaccharide (LPS) found on Gram-negative bacteria as
well as a number of other endogenous ligands that drive immune responses to pathogens. In
mammals, an optimized immune system plays an important role in good health and longevity.
Variation in TLR4 has been shown to be associated with various infectious and age-related
diseases. In this study, seven sequences (A to G) were identified for exon 3 of ovine TLR4
which encodes an important ligand-binding site, and these sequences were investigated and
assessed for their effect on longevity.
Using the PCR-SSCP method, 1826 sheep, from six different breeds and 36 different
stud breeding flocks, were genotyped for the variation described above in IGF1R, FOXO3,
CAST and TLR4. The age of these sheep varied from 2 to 16 years old and fecundity data (the
number of lambs raised per each year of their productive life) was collected for many of the
ewes to investigate the relationship between longevity and fecundity. A general linear mixed
model (GLMM) in SPSS version 17 (SPSS Science Inc., Chicago, IL, USA) was used to
assess the effects of the variation in IGF1R, FOXO3, CAST and TLR4.
Genetic association study has revealed that genetic variation in both IGF1R and FOXO3
had a significant association with sheep longevity, but genetic variation in CAST and TLR4
had no significant effect on sheep longevity across breeds and flocks. Ovine IGF1R C was a
significantly associated with an increase in age of about half a year (breed correction, P =
0.009 and flock correction, P = 0.024), while the D haplotype of FOXO3, which carries the
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amino acid substitution p.M201V, was associated with a decrease in age of about five months
(breed correction, P = 0.006 and flock correction, P = 0.034). The presence of TLR4 A and
TLR4 C was associated or was trending to an association with fecundity when the model was
corrected for ‘breed’ (1.64 ± 0.03, P = 0.004) and ‘flock’ (1.75 ± 0.02, P = 0.066),
respectively. The Spearman’s correlation coefficient between longevity and fecundity in the
sheep studied was -0.248 (P<0.001), suggesting a weak negative interaction between these
traits.
Keywords: Longevity, fecundity, insulin-like growth factor 1 (IGF1R), forkhead box class O
3 (FOXO3), calpastatin (CAST), toll-like receptor 4 (TLR4), sheep, genetic selection
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1Chapter 1
Literature review
1.1 Introduction
Productive longevity in sheep is normally defined as the length of their productive life,
or the amount of time that sheep spends producing (VanRaden & Klaaskate, 1993). In ewe
flocks, it can reflect the ability of an individual ewe to delay being culled for having low
productivity or succumbing to illness. Maintaining un-productive or under-productive ewes is
economically inefficient; hence longevity plays a major role in the economics of sheep
production. With increased longevity in a flock, it is possible to increase the life-time number
of lambs born per ewe, thus making more lambs available for sale and without the need to
retain juvenile stock to ultimately replace that ewe. Increased longevity in a flock also has
another positive economic impact. Long-lived ewes do not need to be culled if meat prices are
low and can instead be retained until the market situation improves and a higher value for
them can be realised.
Despite the value of longevity in animal production system, there has been little
research into identifying longevity genes in livestock. What is more, longevity studies in other
species reveal that it is a complicated trait and potentially controlled by a large number of
different and complex mechanisms. It is however heritable (Ricklefs & Cadena, 2008) and
while several longevity genes have been described in other mammals (Rattan, 2006),
investigation has been limited in the livestock industries. This is typically because effort has
been primarily put into improving other production traits.
The viability of New Zealand’s sheep industry is dependent on maintaining, if not
enhancing its productivity. This can in part be achieved through the selective breeding of
livestock to produce animals that are optimised for productivity in the system. To assist in
animal breeding, Estimated Breeding Values (EBV’s) have been calculated for many
economically valuable traits and these are then used in breeding programs to improve the
accuracy of animal evaluation (Van der Werf, 2007).
There are several limitations to this method as estimated breeding values cannot be
easily calculated for some traits, especially those that are hard to measure. Among these
“difficult to measure” traits is longevity, because it is impossible to measure on young
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animals and therefore it cannot be bred for directly, or rapidly. Typically multiple generations
of progeny have been produced before the trait becomes obvious in the older individuals.
Recent, advances in molecular genetics and statistical methodology have contributed to
the identification of key genes in livestock and estimation of their effects on animal
physiology. Knowledge of the action of these genes is now being applied to improving animal
production (Williams, 2005).
If genetic selection by either method (EBVs or molecular genetics) is well managed, it
is a cost-effective way of improving productivity and in a way that is both cumulative and
permanent. As an example, the use of a quantitative genetic approach to breeding in the New
Zealand dairy industry has resulted in a considerable improvement in key milk production
traits (Harris, 2005; Harris & Kolver, 2001), while in the New Zealand sheep industry there is
now widespread use of genetic selection for various traits using the services of Sheep
Improvement Limited (SIL), including the calculation of EBV’s for the number of lambs
born, growth rate and carcass characteristics (Blair & Garrick, 2007).
In cattle production, there has been some progress in increasing longevity by means of
genetic selection based on the use of EBV’s. In addition, it was recently reported that there
was an association between genetic variation in the bovine calpastatin gene (CAST) and
longevity and fertility in dairy cattle (Garcia et al., 2006).
Given the genetic similarity between cattle and sheep and the conservation of many
metabolic systems across the animal kingdom, it may therefore be possible to identify specific
longevity genes in sheep and genes that could ultimately be used to improve productivity.
There are also emerging examples of the use of molecular genetics in improving
production and disease resistance traits in livestock (see Appendix A). Molecular genetics has
allowed us to identify genes that are associated with reproductive traits in cattle, goats, pigs
and sheep (see Appendix B). To date emphasis has primarily been on the identification of
SNPs that mark production traits, or on nucleotide changes in coding regions, but there is
increasing evidence that non-coding regions of genes also explain variation in some
production traits (e.g., 3’UTR variation in myostatin).
While improving longevity is desirable, the relationship between longevity and fertility
is both intriguing and worthy of investigation in livestock. This relationship has been studied
in various organisms and in general, longevity or life-span reflects good health, which also
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positively influences both fertility and consequently fecundity (Ducrocq & Sölkner, 1998).
Although there is less information on whether the relationship between life-time reproductive
success and longevity is passed down through generations, longevity exhibits such a strong
correlation with life-time performance that there is a strong potential for the inheritance of
genetic factors that affect life-span.
However, one theory, called the “trade-off theory” (Holliday, 2006) suggests there is a
negative relationship between longevity and fertility. According to this theory enhanced
longevity comes at the expense of reduced fertility. Thus, fertility may be negatively
influenced by potential longevity genes and vice versa. In this respect it is notable that in
some livestock industries, there have been reports of declining fertility with age (Dobson et
al., 2007), especially as these industries have focused on selection for increasing production
traits. While improving longevity is desirable, the relationship between longevity and fertility
is potentially antagonistic and both are accordingly worthy of investigation in livestock.
Studies in model organisms such as the flat worm Caenorhabditis elegans (C. elegans)
(Kenyon, 2011), the fruit fly Drosophila melanogaster (D. melanogaster) (Clancy et al.,
2001; Giannakou & Partridge, 2007) and the Ames and Snell dwarf mice (Bartke & Brown-
Borg, 2004), have implicated, genes that affect metabolism, energy homeostasis, stress
responses, and cell maintenance and repair in the regulation of longevity. The underlying
processes appear to have been conserved through evolution and several biological pathways
that affect aging and longevity in model organisms, also appear to affect longevity in other
species.
In this study, a number of genes that have been described in other species as affecting
longevity were identified in sheep and the relationship between variation in those genes and
variation in both longevity and fecundity was investigated in a large population. The genes
studied were the Insulin-like Growth Factor 1 Receptor gene (IGF1R), Forkhead box class O3
gene (FOXO3), Calpastatin gene (CAST) and Toll-Like Receptor 4 gene (TLR4).
1.2 Sheep production
Sheep are multi-purpose animals and provide meat, wool, milk and skin. Almost all
sheep can be classified based on their ability to produce a particular product, or a combination
of these products. The relative economic importance of these products varies from country to
country. In the hotter parts of the Middle East, and generally in tropical climates, hair as
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opposed to wool sheep predominate. This is understandable, as a heavy wool fleece is a
handicap in very high temperatures. On the other hand, wool producing sheep are favoured in
temperate and cold regions, where wool not only has a protective function, but also a
considerable commercial value.
Sheep meat can be produced from both milk and wool types of sheep. Table 1.1
summarises world sheep meat production with Asia and Africa producing 67% of world
sheep meat by volume. However, the average per capita production and consumption of sheep
meat is highest in Oceania and countries in this region underpin the international trade in
sheep meat (Table 1.1). In this region, New Zealand and Australia are major sheep meat
exporting countries, accounting for over 90% of world export trade (source: major exporting
countries of sheep meat in 2009, United Nations). Together they provide large quantities of
sheep meat for consumption in the European Union (EU) and South West Asia.
Historically the sheep meat industry was developed as a by-product of the wool
industry. For example in New Zealand the early 1900’s, the majority of income from sheep
was from the sale of wool. Since then changes in the wool industry have heavily influenced
the direction of sheep production with the main productive value in New Zealand now being
the sale of lamb. Wool production has been in a very deep economic crisis since the end of
World War II, in part because of the reduction in wool use for military uniforms (Jones,
2004). In addition, by the mid-1960s, synthetic fibres were less expensive than wool, and
synthetic/natural fibres blends were more attractive to consumers. Wool is however still
economically important to many sheep farmers, textile manufacturers, retailers and the
garment/fashion industry.
Internationally, Australia is the largest supplier of apparel wool, with two-thirds of the
wool sold on the world market originating from that country (source from ABARE report).
Major markets for Australian wool include China, Italy, India, Taiwan, the Czech Republic,
the Slovak Republic, France and Germany.
New Zealand is the world’s second-largest wool producer and exporter (MAF
SONZAF report). More than 90% of the wool production is exported as fibre. New Zealand is
the leading producer of coarser or strong wool, which is used primarily for interior textiles
such as carpets, blankets, upholstery and yarn. China accounts for about 25% of New
Zealand’s wool exports. Other export markets include the United Kingdom, India, Italy and
Australia.
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Table 1.1. World sheep meat, milk, wool and skin production in 2009.
Continent Sheep Meat
Tonne, (%)
Sheep Milk
Tonne, (%)
Greasy Wool
Tonne, (%)
Sheepskin
Tonne, (%)
Asia
(China)
4294 (52%)
(2090)
4074 (44%)
(1150)
851 (41%)
(364)
1026 (53%)
(326)
Africa 1260 (15%) 1988 (21.5%) 222 (11%) 213 (11%)
America
(South America)
411 (5%)
(247)
38 (0.5%)
(38)
165 (8%)
(147)
92 (5%)
(72)
Oceania
(Australia)
(New Zealand)
1136 (14%)
(658)
(478)
– 550 (27%)
(371)
(179)
285 (15%)
(144)
(140)
Europe
(UK)
(Greece)
(France)
(Turkey)
(Iran)
1138 (14%)
(302)
(89)
(83)
(262)
(350)
3145 (34%)
-
(780)
(253)
(734)
(577)
257 (13%)
(65)
(7)
(8)
(40)
(74)
304 (16%)
(68)
(18)
(11)
(46)
(58)
Total 8240 (100%) 9245 (100%) 2045 (100%) 1920 (100%)
Sources: FAOSTAT (Food and Agriculture Organization of the United Nations)
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Figure 1.1. World sheep population.
Sources: FAOSTAT (Food and Agriculture Organization of the United Nations)
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Sheep milk contains almost twice the concentration of solids when compared to cow or
goats milk. The production of this milk, which is mainly used for cheese, is an important
consideration in a number of countries (e.g., Turkey, France and Iran). Asia and Europe
together produce 78% of the total milk production from sheep, but on a per capita basis, milk
production in Europe exceeds that of any other continent (Table 1.1).
Sheepskin is usually a by-product of meat production and reflects the number of
animals slaughtered for meat production in the various areas of the world. It is used for
making sheepskin leather products and soft wool-lined clothing or coverings, including
gloves, automobile seat covers and childcare applications such as cot, pram, and child car seat
covers. Sheepskins are mainly produced in Asia and Africa. These two continents together
produce 63% of the total world production (Table 1.1). For some sheep breeds, such as the
Karakul, skin production is the primary product and these sheep are often bred for this
purpose (Pascal, 2011). By-product sheepskins constitute an important source of export
income in Oceania and South America.
Dual-purpose sheep have been developed for both meat and wool production with the
capacity for high levels of production under appropriate environmental and management
systems. In New Zealand, dual-purpose types of sheep such as the NZ Romney, Coopworth
and Perendale are common and the production of both meat and wool is a major industry.
Although sheep numbers continue to fall in NZ (Figure 1.1), it remains the world’s largest
exporter of sheep meat and cross-bred (strong) wool (http://www.stats.govt.nz).
There are a number of challenges facing the New Zealand sheep farmer, such as
changing land-use patterns, climate change and the desire for greenhouse gas mitigation, and
all of which will potentially impact on future sheep farming profitability. The cost of sheep
management has increased, including the cost of disease control, labour and other input costs,
while the income from meat and wool especially, has decreased in the last two decades. This
has had a strong negative influence on sheep numbers in New Zealand.
World demand is now directed towards producing meat alone and less so wool in many
places. This has caused the structure of the sheep industry to change. To overcome these
changes in the market for sheep products and to overcome other challenges, the New Zealand
sheep industry needs to transform itself into a more efficient and competitive entity.
Variation in sheep productivity can be due to both genetic and environmental
influences. Genetic improvement in sheep productivity is founded in understanding the
biology of adaptation and its relationship with productivity. This requires good estimates of
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both the genetic and phenotypic characteristics of production. The effective selection of more
productive sheep using genetic approaches will assist ensure continued high quality outputs
are produced.
The New Zealand sheep industry has already shown a great improvement in sheep
productivity, but new genetic approaches to improving sheep productivity may provide new
opportunity for the industry.
1.2.1 The effect of life-span on sheep production systems
Longevity in livestock is typically a desirable trait and for several reasons. It reflects
many things including ongoing good health and prolonged fertility. These characteristics are
rewarded when selecting stock, as farmers require replacements that are at least as productive
as the stock they are replacing.
Sheep are however susceptible to many diseases and parasites, and losses to death are
high relative to other livestock. As a result, sheep farming requires more careful selection for
breeding stock than other livestock production system.
Young sheep or lambs have a high mortality that is both variable and can range up to
80% of individuals dying. It averages 5 to 30% in New Zealand (MAF biosecurity & animal
welfare NZ). After 2 years of age, mortality reduces and in general, sheep can live to over 10
years of age with individual ewes living up to 19 years of age. Rams typically survive to 14
years of age (Simmons & Ekarius, 2001).
Attainment of these ages in typical production systems is however rare. Typically, ewe
longevity is reduced by the decisions made by farmers as they select animals to be culled
based on their health, productivity and reproductive performance. Accordingly, the average
life-span of a ewe in a commercial sheep flock is six to seven years before she is replaced. If
the productive life of a ewe could however be increased to 10 years, then the life-time earning
capacity of that ewe would increase and the cost of replacing her would decrease.
As the cost of replacing ewes is related to the cost of producing feeding and managing
the replacements, the effect of having longer-lived ewes would be to reduce the number of
replacements required. This could improve the efficiency of sheep production. This concept is
illustrated in Figure 1.2.
Since the phenotype of longevity can be measured, albeit only after the fact, and given
that the trait is under genetic control and hence is heritable, then it should therefore be
possible to breed more long-lived sheep. That stated, it is unlikely the improvement will be
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that spectacular, as the trait is both complex and affected strongly by environmental factors
such as disease. What is more, a conventional approach to breeding through selecting long-
lived animals will be manifestly slow, as longevity by its very nature, takes a lot of time to
manifest.
Figure 1.2. The value of longevity in sheep.
1.2.2 Measurements of longevity and reasons for culling sheep in production
systems
Ducrocq & Sölkner (1998) defined two types of production longevity in livestock:
“real” longevity and “functional" longevity. Real longevity is independent of productivity and
is related to natural survival. However, functional longevity is related to an animal’s
productivity and depends on the ability of the animal to avoid culling for reasons such as low-
fertility and disease susceptibility. According to this definition, functional rather than real
longevity is the trait which should be selected for in a production system.
To maintain functional longevity in a productive ewe flock, sheep need to be replaced
every year to maintain numbers. This is because ewes die of both natural and unexplained
causes. They are also culled for various reasons including; udder health, tooth wear and loss,
and because of the presence of disease (See table 1.2 for more detail on culling) (Nugent &
Jenkins, 1992). In general, in New Zealand, 15-20% of a flock will be replaced or culled
annually (MAF biosecurity & animal welfare NZ, 2010). Functional longevity is therefore
composed of several components.
Long-lived sheep  
 Decreased number of ewe 
replacements needed annually 
Increased number of lambs  
per breeding ewe    
Decreased ewe culling from 
the flock 
Decreased ewe replacement cost 
across a flock 
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Sheep culling can be for two general reasons. Voluntary culling is usually for low
performance (e.g., poor producer), and these animals may also accrue expenditure on animal
health, whereas involuntary culling results from death, often due to misadventure or other
environmental challenge. Losses from both can be a major financial cost to sheep production.
With voluntary culling the decision to replace any given ewe is mainly based on
economic considerations (e.g., the breeder expects a greater profit from replacing the ewe
than by keeping her in the flock). Whether to cull or not to cull a ewe depends not only on
individual factors (e.g., health, fecundity), but also on flock factors (e.g., variation in flock
size, availability of replacements, lamb and adult sheep meat markets, etc.). If an
improvement in longevity was achievable it may allow the manager or farmer to place greater
emphasis on culling sheep for low productivity.
Table 1.2. Reasons for culling sheep. Sheep farmers can improve their stock by making
sound culling decisions. A reasonable culling decision should focus on traits that will
maximise sheep production. As longevity reflects overall performance and good health, a
longevity trait would be a useful addition to making effective selection decisions
Reason for culling Manifestation or trait of importance
Poor reproduction Lambing rate (singles/twins/triplets)
Litter size and weight, occurrence of infertility, reduced
fecundity or birth problems
Poor lamb birth weight, weaning weights, poor ewe milk
production,
Udder soundness, uterine prolapse
Poor production Carcass yield and quality, growth rate
Wool traits such as staple length, fleece weight, fineness
Diseases susceptibility Scrapie, footrot, internal parasites, infectious disease
Physical problem Tooth wear/loss, lack of physical soundness, poor eyesight,
lameness, body condition
To obtain genetic
improvement
Genetic progress in meat and wool production traits
Other economic factors Feeding cost, health care costs, sheep market price
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1.3 The biology of aging and longevity
Aging in animal species appears to be influenced by several evolutionarily conserved
metabolic signalling pathways and environmental factors such as nutrient availability and
temperature. Growth and reproduction are also metabolically expensive and they create
additional “costs” that contribute to aging (Brown-Borg, 2007). Most animals have the
capacity to balance energy between growth, reproduction and the maintenance of somatic
tissue (Takahashi et al., 2000). This maximises the likelihood of survival for the offspring
when born.
Aging is associated with a decline in metabolic factors and this contributes to the
accumulation of deleterious changes (Rattan, 2004). For example, metabolic factors from
various biological signalling pathways and other regulatory proteins affect maintenance and
repair mechanisms, and hence unbalanced control in these pathways can lead to the
accumulation of damaged macromolecules (Breusing & Grune, 2008). Such molecular
damage can appear as oxidized, misfolded, cross-linked or aggregated macromolecules, which
are structurally abnormal and therefore cannot function properly. These ultimately affect other
biological activities.
There are also several mechanisms that are considered to underlie the primary aging
process and may contribute to age-related changes in adaptive responses. These mechanisms
are involved in cellular aging (Miller, 2009), oxidative stress (Kregel & Zhang, 2007),
mitochondrial energy production (Lenaz et al., 2000) and DNA damage in stem cell activity
(Shenghui et al., 2009; Slijepcevic, 2008). All of these things can interact to influence the
aging of an entire organism.
In many organisms from yeast to humans, the molecular, cellular and physiological
aspects of aging are regulated by genetic factors (Finch & Ruvkun, 2001). Research has
revealed conserved genetic systems associated with metabolism (Puca et al., 2008), protein
regulation (Rattan, 2010) and immunity (Ostan et al., 2008), and that these can regulate the
aging process in a variety of species primarily through genetically-derived in the various
pathways involved (Glotov & Baranov, 2007).
For example, in the nematode C. elegans, aging-regulating genes have been identified
and these can have both pro- and anti-aging effects (Antebi, 2007; Kenyon, 2005). Genes
involved in the insulin-like growth factor 1 (IGF1) pathway and protein synthesis promote the
aging process, while genes associated with cellular degradative pathways such as proteolytic
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enzyme systems, slow the aging process. These pro- and anti-aging genes also significantly
affect life-span in response to biological and environmental conditions, including caloric
restriction and oxidative stress stimuli (Figure 1.3). The biological aging process therefore
could be caused by a combination of several factors, including accumulation of cellular
damage, environmental factors, and pro- and anti-aging factors (Figure 1.3).
Figure 1.3. Regulation of the biological aging process. During aging, there is an
accumulation of damaged macromolecules, including DNA and proteins. Although aging is a
multi-factorial process, it is apparent that different factors activate some common, highly
conserved molecular pathways which limit stem cell function, organ maintenance and
regeneration. The pro-aging factors (green) accelerate the aging progress while the anti-aging
factors (red) delay the aging process. The molecular mechanisms for maintenance and repair
are also of crucial importance, and damage to these maintenance and repair pathways can
increase the aging process. Adapted from Vellai (2009)
The aging process is biologically complex. A variety of experimental procedures have
been used to examine changes in the cells, tissues or organs during the aging of various
animal species (Balcombe & Sinclair, 2001). This has led to the proposition at a variety of
theories of aging, and these are based on different aspects of biology at the cellular, systemic
and molecular levels.
Pro-aging factors Anti-aging factors
The aging process
TGF-β signalling
Insulin/IGF1
signaling
Mitochondrial
respiration
Protein synthesis
Temperature
Caloric restriction
FOXO, FOXA
Cellular degradative
pathways
p53
Other chemical
Sirtuins
Variation in
Life-span
Environmental
factors Genetic factors
Intracellular accumulation
of cellular damage
(including damaged macromolecules
such as DNA and protein)
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There are two basic types of aging theory that can be described broadly as the
“programmed” and “error” theories (Platt, 1979). According to the programmed theories,
aging depends on biological clocks regulating the timetable of the life-span through the stages
of growth, development, maturity and old age. Programmed regulation would depend on
genes sequentially switching on and off signals to the nervous, endocrine and immune
systems. These systems are ultimately responsible for the maintenance of homeostasis and for
activation of defense responses. In contrast, the error theories identify environmental insults
to living organisms that induce progressive damage at various levels such as mitochondrial
DNA damage, oxygen free-radical accumulation and the inappropriate cross-linking of
proteins. While this basic classification is useful, it can be further refined into more precise
groupings based on mechanism.
Table 1.3 summarises a classification system for the main mechanisms of aging,
including evolutionary mechanisms (e.g., mutation accumulation, somatic cell maintenance),
molecular mechanisms (e.g., variation in the expression of genes), cellular mechanisms (e.g.,
accumulated oxidative damage) and systemic mechanisms (e.g., endocrine shifts) (Weinert &
Timiras, 2003). These mechanisms overlap at various levels, such as when molecular events
lead to cellular alterations, which then contribute to organ and systemic failure. If these affect
reproduction they may have evolutionary implications. Each of these mechanisms will be
described below in more detail to reveal common aspects of the underlying biology.
Table 1.3. Classification of biological mechanisms thought to be associated with aging.
Mechanism Description
Evolutionary
Mutation accumulation • The accumulation of somatic mutation arising from
genome instability in a single generation
Disposable soma • Somatic cells are maintained only to ensure continued
reproductive success
Antagonistic pleiotropy • Genes beneficial at younger age become deleterious at
older ages
Cellular
Replicative senescence • An increase in the frequency of senescent cells, resulting
from loss of telomeres
Mitochondrial dysfunction • Oxidative metabolism produces highly reactive free
radicals that subsequently damage lipids, proteins and
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DNA
Wear-and-tear • Accumulation of injuries and tissue/organ damage
Apoptosis • Programmed cell death from genetic events
System
Neuroendocrine • Alteration in neuroendocrine control by glucose
homeostasis
Immunological • Decline of immune function with aging, results in
increased incidence of infectious and inflammatory
diseases
Molecular
Gene regulation • Aging is caused by changes in the expression of genes that
regulate both development and aging
Somatic mutation • Accumulation of molecular damage, primarily to
DNA/genetic material
1.3.1 Evolutionary mechanisms of aging
The evolutionary theories of aging provide an explanation for aging based on natural
selection, as opposed to describing metabolic mechanisms per se. They were first formulated
in the 1940s based on the observation of patients with Huntington disease, a genetic disorder
of the central nervous system (Haldane, 1941). It was noted that the disease remained in the
population even though it should be selected against. Its ongoing presence was explained by
the late age of onset (30-40 years), which allowed a disease carrier to reproduce before dying,
and thus pass on the faulty gene. There was therefore a lack of natural selection against the
disease.
This observation inspired the mutation accumulation theory of aging, which suggests
that mutations may accumulate in the population if they have little or no effect prior to
reproduction, but that these mutations could ultimately lead to disease and death.
The concept of an evolutionary “trade-off” was proposed to explain the balance between
maintaining somatic cells and facilitating reproduction (Holliday, 2006). The balance between
somatic maintenance and reproduction would depend on the life strategy and ecological niche
of any given species. Somatic maintenance or longevity would therefore have a cost and the
balance of resources invested in longevity versus reproductive fitness would determine life-
span.
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While it might be possible to select for an increased total intake of energy, this does not
avoid the problem of how best to divide the resources available between longevity and
reproduction. The problem of the optimal allocation of resources becomes a central issue in
life-history and particular attention has to be paid to the at times high cost of reproduction, as
may be the case for those animals that breed rarely, or have few offspring.
This “trade-off” theory underpins both the “disposable soma theory” and the
“antagonistic pleiotropy theory” (Weinert & Timiras, 2003). The “disposable soma theory” of
aging suggests that the somatic organism is effectively maintained only for reproductive
success and after that it is disposable, while the “antagonistic pleiotropy theory” suggests that
genes that improve the likelihood of reproductive success, may ultimately be a cost post-
reproductively to the aging organism.
The antagonism between reproduction and longevity explained by “the trade-off” theory
is supported by experiments in which the limitation of reproduction by the destruction of
germ line cells, can extend life-span in both Drosophila melanogaster (Sgrò & Partridge,
1999) and Caenorhabditis elegans (Arantes-Oliveira et al., 2002). This suggests that animals
cannot have both higher rates of reproductive success and an extended life-span.
1.3.2 The cellular mechanisms of aging
Cellular aging occurs within cells and it is explained by replicative senescence,
mitochondrial dysfunction, “wear and tear” and apoptosis. When cells accumulate damage at
the cellular level they can stop functioning properly. This could damage their chromosomes,
affect gene expression and hence, cellular aging could ultimately affect longevity.
Replicative senescence is a specific type of cellular aging that is associated with the loss
of telomeres (Shawi & Autexier, 2008). The telomeres are repetitive DNA elements at the end
of chromosomes and appear to protect the chromosomal DNA every time a cell divides. With
each cell division, the very end of a chromosome cannot be copied as there is no DNA to act
as a template for a primer to initiate replication of the lagging strand. When the telomere
becomes too short, essential parts of the chromosomal DNA might not be replicated and this
may contribute to cellular death. Although there is considerable variation in telomere length
between individual animals within a species, shortened telomeres are nevertheless associated
with cell age.
Mitochondria act as the “power-house” of a cell. The electron transport chain occurs in
mitochondria and in this process electrons are passed between different molecules, with each
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translation producing chemical energy (Lenaz et al., 2000). Oxygen is involved in the final
position of the electron transport chain and occasionally electrons in the chain interact
incorrectly with oxygen and produce oxygen in free radical forms. These free radicals are
very reactive, and if cells continuously produce free radicals, then this can damage and
eventually kill the cell.
With aging, the efficiency of mitochondrial function and energy production declines.
This can lead to further mitochondrial dysfunction, disruption of cellular energy production
and accelerated cellular aging (Trifunovic & Larsson, 2008). Evidence is accumulating that
mitochondrial dysfunction underlies many common age-related disease, including Parkinson
disease, Alzheimer disease, heart disease, and numerous genetic conditions (Simon & Johns,
1999; Trifunovic & Larsson, 2008)
The “Wear and Tear” theory, developed by August Weismann (1834-1914) is a cellular
theory. It states that toxins in our environment and diet; such as excess sugar, caffeine and
alcohol, and physical and emotional stresses cause damage of the cells, tissues and organs.
The damage begins at the level of molecules within a cell. Eventually, the cells in the organs,
such as the liver, stomach, kidney and skin are worn down by the progressively accumulated
damage. Once they wear down, they cannot function correctly and that results in aging.
Apoptosis is a type of death for a cell in the body. It is a programmed cell death,
meaning that when a cell gets old, weak or unneeded, it is deliberately disposed of. Apoptosis
happens continuously in a variety of organisms, as the cells are deliberately killed and
replaced. Normally, apoptosis is a natural and necessary process for the body. However, if
apoptosis happens too often, or not often enough, then this causes problems. Some aging
studies in human have shown that with age, a significant amount of apoptosis occurs, causing
damage to skeletal (Pollack et al., 2002; Sandri & Carraro, 1999) and cardiac cells (Pollack et
al., 2002) and that this is directly related to conditions such as osteoporosis and chronic heart
failure.
The cell-cycle is tightly regulated, only a few tissue types have cells that are constantly
dividing (e.g., skin, mucosa), whereas other cells enter a state of senescence, whereby they no
longer grow and divide. Normally, in adult tissue however, there is a delicate balance
between apoptosis and cell-cycle turnover, producing a steady state (Medema & Macurek,
2011). During the progression through the phases of the cell-cycle: G1, S (DNA synthesis),
G2, and M (mitosis), DNA is duplicated and the chromosomes are distributed evenly between
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the two daughter cells. To maintain the integrity of cell-cycle progression, cells proceed
through several pauses, or “checkpoints”(Vermeulen et al., 2003). At one checkpoint, late in
G1, the cell either enters a quiescent phase (called G0), or commits to DNA synthesis and the
rest of the cycle. A second checkpoint is located at the end of G2 phase, triggering the start of
the M phase (Mitosis). DNA damage checkpoints occur at the G1/S and G2/M boundaries.
After DNA damage, the cell-cycle checkpoints are activated. Activated checkpoints
pause the cell-cycle and give the cell time to repair the damage before continuing to divide.
They are controlled by two master kinases, ATM (ataxia telangiectasia mutated kinase) and
ATR (ataxia telangiectasia and Rad3-related kinase) (Vermeulen et al., 2003). ATM and ATR
phosphorylate several substrates, such as p53, the checkpoint kinases (Chk1 and Chk2) and
regulate checkpoint signalling. ATM responds to DNA double-strand breaks and disruptions
in chromatin structure (Bakkenist & Kastan, 2003), whereas ATR primarily responds to
stalled replication forks.
If the DNA damage is irreparable, or too severe, activation of p53 may not only arrest
the cell-cycle, but also initiate the process of apoptosis, which eliminates a cell whose DNA
alterations could not be repaired (Reinhardt & Schumacher, 2012). Therefore, failure of DNA
repair or checkpoint controls can lead to an accumulation of mutations and genomic
instability, which in turn may lead to development of cancer (B. B. Zhou & Elledge, 2000).
Cells enter “senescence”, a state of stable proliferative arrest, in response to variety of
cellular stresses, including telomere dysfunction, aberrant oncogenic activation, DNA damage
and oxidative stress (Bree et al., 2002; Hornsby, 2011). These stresses have a significant
effect on cellular senescence. Such senescence cells are often dysregulated in cell-cycle
checkpoints and apoptosis, resulting in premature aging, increased sensitivity to carcinogens
and a correspondingly increased cancer risk.
1.3.3 System mechanisms of aging
In mammals, the neuroendocrine and immune systems play a key role in the response to
external and internal stimuli, and are essential for the control and maintenance of the organ
systems (Knight, 2000). In the system theories of aging, the aging process is related to the
decline of the organ systems, and through failure of the regulatory system to maintain
structure and function. When demand exceeds the capacity of the organ or organism to
respond, pathology ensues.
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The neuroendocrine theory proposes that aging is due to changes in neural and
endocrine functions that are crucial for maintaining an optimal functional state for
reproduction and survival, while also maintaining a response to environmental demands
(Kirkwood, 2011). The primary hormone involved in the neuroendocrine system is insulin-
like growth factor 1 (IGF1). IGF1 has an important role in both tissue maintenance and
developmental processes (Martinelli et al., 2008). With increasing age there is a decline in
IGF1 production in the liver and other tissues and the loss of IGF1 contributes to the general
decline in protein synthesis, skeletal muscle mass, immune function, and cognitive ability in
rodents, nonhuman primates and humans (Berryman et al., 2008).
In C. elegans, the IGF1 pathway constitutes a primordial neuroendocrine system, which
integrates information from environmental stressors (Gerisch et al., 2001). The resulting
integrated response plays an important role in monitoring metabolic and reproductive status
and permits appropriate energy adjustments and ultimately, extend life-span. Thus, it may be
assumed that this primitive neuroendocrine system has the capacity to coordinate various
metabolic activities that affect longevity.
The immune system controls and eliminates foreign organisms and substances in the
host body (Butcher & Lord, 2004). It has been suggested that maintaining effective immune
function is important to having a long life (Pawelec, 2003). Immunity in the elderly is a
crucial determinant of life-span, because without effective immunity susceptibility to disease
including age-related diseases increases, and thus survival can be compromised.
The rate of aging is largely controlled by having an optimal immune system. Aging of
the immune system (immunosenescence), is associated with decreased immunity or having a
less functional immune system that leads to chronic inflammation (De Martinis et al., 2005).
While, inflammation is a normal reaction to physiological and nonphysiological stressors such
as infection, irritation and injury in young animals, immune cells can also be stimulated by
age-related stressors and this can result in chronic stimulation. This can lead an expansion of
memory cell numbers, a decrease in the number of naïve cells, and shrinkage of the reactive
T-cell repertoire (Ginaldi et al., 2005). The decreased number of naïve cells may reduce the
function of the immune system, resulting in an increase in the incidence of tumours and
greater susceptibility to infection.
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1.3.4 Molecular mechanisms of aging
Molecular mechanisms of aging explain that aging is primarily associated with
differences in the genetic constitution of species (Teixeira & Guariento, 2010). Genes
predetermine the maximum age by controlling the development of the organism, which
controls the maximum life-span in that species. In these aging theories, genetic alterations
such as changes in gene regulation and somatic mutation can accelerate the aging process.
Longevity studies have found that disruption of gene regulation mechanisms involved in
stress-responses, metabolism and reproduction are significantly associated with the aging
process in many species. The insulin-like growth 1 (IGF1) signalling genes are instrumental
in this process and have been revealed to be important in regulating life-span in species as
diverse as C. elegans (Golden & Melove, 2007), D. melanogaster (Paaby & Schmidt, 2009)
and M. musculus (Liang et al., 2003). This suggests that the genetic control of life-span was
already developed in the common ancestor of modern animals and that the subsequent
evolution of life-span variation is underpinned by quantitative changes in the control of
metabolism through IGF1 signalling.
Somatic mutation explains aging in terms of accumulation of mutations in the genome
of somatic cells, that leads to cell senescence, cell death (apoptosis) or transformation, and
loss of processes (Weinert & Timiras, 2003). Many of the mechanisms implicated in somatic
mutation are shared with mechanisms involved in cellular aging.
1.3.5 Summary
Aging is considered a multifactorial process with interactions of genetics, chemistry,
physiology and environment. As described above in any mechanisms have been proposed to
explain the aging process in a variety of species. The most widely accepted theories describe
the major causes of aging as mechanisms that operate at the evolutionary, cellular, systemic
and molecular levels. The various theories explain what aging is, and why and how it
happens. Typically, they describe the fundamental variability in longevity in different species.
The various theories provide a framework for understanding mammalian aging, including
aging in sheep.
Some of these theories of aging are linked, as the aging process entails a variety of
phenomena within a complexity network. For example, there is a clear interrelationship
between evolutionary theories and systemic theories. The evolutionary theories of aging are
fundamental to the understanding of life-span by describing the balance between survival and
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reproduction, and the metabolic processes that underpin them. However, given that metabolic
performance is coordinated by systemic regulatory mechanisms, such as the endocrine and
immune systems in organisms (Harman, 2004), then systemic effects must also be considered.
There may also be genetically determined evolutionally trade-offs between benefits to
young organisms and their viability at older ages, suggesting that molecular theories of aging
can be explained from an evolutionary view point. The molecular theories of aging are also
inter-related to cellular theories of aging, as cells can age through the accumulation of DNA
damage.
These overlapping theories of aging suggest that the emergence of a unified theory is
still some time off.
1.4 The relationship between longevity and fertility
Metabolic rate is thought to be inversely proportional to maximum life-span
(Demetrius, 2004) and it has been acknowledged for some time that a primary determinant of
how long species live is the relative speed of their resting metabolism. Typically species that
“live fast” will die young, while species with a slower metabolic rate live “slower” and
longer. This notion was historically incorporated in to the rate of living theory (Pearl, 1928);
in which it was proposed that “the duration of life” varies inversely as the rate of energy
expenditure during its continuance. Based on “the duration of life” theory, the disposable
soma theory was introduced, and this better explains the importance of balancing the cost of
reproduction against the need to maintain the soma or organism as a whole. It suggests that
maximum life-span is the result of optimisation of the metabolic trade-off between longevity
and fertility (Kirkwood, 1977).
Nutrition, reproduction and life-span are closely interlinked in the trade-off theory.
Specifically, in times when food is scarce, re-allocation of resources away from current
reproduction to somatic maintenance might increase survival (Kirkwood & Holliday, 1979).
This increase in survival would facilitate on increased likelihood of enduring to plentiful
times, when increased reproduction is more profitable.
According to the disposable soma theory, trade-off is driven by the conflicting
requirements for resources (Kirkwood & Holliday, 1979). Costly processes such as
reproduction, somatic maintenance and repair, growth and movement compete for resources
and it is impossible to maximize allocation to them all. “Trade-offs” must therefore be made.
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Resources that are diverted into reproduction cannot also be used for somatic repair and
maintenance, and a high reproduction rate will accordingly shorten life-span. According to
this theory, there would be a negative relationship between longevity and fertility in any given
species.
Caloric restriction (CR) has been associated with the trade-off theory. When nutrient
intake is restricted, a reallocation of resources occurs from reproduction capacity into somatic
protection. CR extends life-span and reduces fecundity in model organisms such as yeasts
(Oliveira et al., 2008), nematodes (G. Walker et al., 2005), fruit flies (Partridge et al., 2005),
rodents (Merry, 2005) and even humans (Everitt & Le Couteur, 2007).
Functionally, CR may promote longevity by a metabolic reprogramming which results
in a transcriptional shift towards reduced energy metabolism and increased biosynthesis and
turnover of proteins (R. M. Anderson & Weindruch, 2007). Some of the common and
consistent effects of CR in rodents and humans (Weindruch, 1996) include lower fat mass,
particularly visceral fat, lower circulating insulin and IGF1 concentrations, increased insulin
sensitivity, lower mean body temperature, lower fat-free mass, lower sedentary energy
expenditure (adjusted for fat-free mass), decreased levels of thyroid hormones and decreased
oxidative stress (Pamplona & Barja, 2006).
The effect of CR on longevity is believed to be mediated by regulation of the IGF1
pathway. The IGF1 pathway is responsive to nutrients, growth factors, and the energy balance
of an organism and regulates many metabolic mechanisms that modulate longevity and
reproduction (Partridge & Gems, 2002). Mutations or treatments that decrease the levels, or
effectiveness of IGF1, often result in an increase in longevity. Likewise, the IGF1 pathway
increases life-span through the readjustment of the metabolic trade-off with reproduction.
Overall the aging process might therefore be the result of the failure of maintenance
mechanisms balancing reproduction and life-span via metabolic regulation.
1.5 Genetic control of longevity
Molecular and evolutionary theories suggest that a strong genetic component impacts on
survival to an advanced age. The molecular theories suggest that genes that control the level
of DNA damage and repair mechanisms regulate longevity (Hsieh & Yamane, 2008), while
the evolutionary theories suggest that reproductive cost is traded off against the cost of
longevity. There is also evidence that genes have evolved to detect and respond to changes in
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the environment (e.g., food supply), suggesting biological evolution contributes to longevity
(Ljubuncic & Reznick, 2009).
The evolutionary theories of aging suggest that animals maintain themselves using a
wide range of mechanisms and that these consume a considerable proportion of their total
metabolic activity (Ricklefs, 1998). These biological pathways include nutrient metabolism
pathways, cell maintenance mechanisms and differentiation pathways. All of these
mechanisms are regulated by gene-encoded proteins, making longevity potentially heritable
(Browner et al., 2004; Kirkwood, 2002).
There are several direct pieces of evidence that longevity is controlled by genetic
factors. Variation in the life-span both within and between species strongly supports the
concept that, to a large extent, the rate of aging is under genetic control. For example, in mice,
there are significant differences in life-span between different inbred strains of laboratory
mice, and even when these strains are in an identical environment (Ferguson et al., 2008). In
humans, the life-span of monozygotic twins is statistically closer than life-span in dizygotic
twins (Hjelmborg et al., 2006).
Studies have also revealed an association between genes and longevity in model
organisms such as C. elegans, D. melanogaster, S. cerevisiae and M. musculus (Kennedy,
2008). These organisms provide many advantages for studying longevity, most notably
because of their relatively short life-spans, rapid reproduction, well-characterised biology and
completely sequenced genomes. These organisms have allowed rapid progress in the
discovery of genetic factors and pathways that affect aging.
The first pathway of this kind that was identified was the evolutionarily conserved
insulin/IGF1 signal-transduction pathway. In C. elegans, mutations in the daf-2 and age-1 
genes, which are related to the mammalian insulin-like growth factor 1 receptor (IGF1R) and
to the catalytic subunit of phosphatidylinositol-3-kinase (PI3 kinase) respectively, both lead to
increased life-span (Friedman & Johnson, 1988; Kenyon et al., 1993; Larsen et al., 1995;
Morris et al., 1996). In subsequent studies, similar effects were observed for other genes in the
IGF1 pathway, and in other pathways involved in metabolism and physiological processes
that regulate stress resistance, fertility and genomic maintenance (Christensen et al., 2006;
Vijg & Suh, 2004).
Collectively, these studies in lower organisms suggest that specific genes may also
affect the rate of aging in higher organisms, including mammals.
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1.5.1 Genes implicated in longevity
The identification and characterisation of the genes involved in various biological
processes is important in the study of longevity. Genes that potentially affect longevity are
found associated with metabolism, mitochondrial function, immune response, heat-shock
responses and others physiological responses. In mammals, several studies have reported that
single nucleotide polymorphisms (SNPs) in a variety of genes, have an association with
longevity (Guarente & Kenyon, 2000; Perls, 2002; Tatar et al., 2003).
Analysis of the literature that describes specific longevity genes reveals that they are
involved in a range of biochemical pathways and act as kinases, kinase receptors,
transcription factors, DNA helicases, membrane glucosidases, GTP-binding protein–coupled
receptors and chaperones. Some are involved in cell-cycle checkpoint pathways. All of these
activities contribute to maintaining the biological mechanisms of normal aging in mammals,
including sheep.
There is a challenge in classifying the various genes that have been associated with
longevity. This is not least because so many genes have been linked to the trait. The most
prominent longevity genes include Angiotension 1-Converting Enzyme (ACE) (Rahmutula et
al., 2002), Angiotensinogen (AGT) (Tan et al., 2001), Apolipoprotein A (APOA) (Garasto et
al., 2003), Apolipoprotein E (APOE) (Atzmon et al., 2006), Calpastatin (CAST) (Barendse et
al., 2007), Carboxypeptidase B2 (CPB2) (Reiner et al., 2005), Cholesteryl Ester Transfer
Protein (CETP) (Barzilai et al., 2003), Coagulation Factor VII (F7) (Tan et al., 2001),
Forkhead Box O3 (FOXO3) (Flachsbart et al., 2009), Growth Hormone 1 (GH1) (Van Heemst
et al., 2005), Glutathione S-Transferase Theta (GSTT1) (Taioli et al., 2001), Human
Leukocyte Antigen (HLA) (Akisaka et al., 1997), Heme Oxygenase (HMOX1) (Yamaya et al.,
2003), Heat Shock 70kDa Protein 1A (HSPA1A) (Altomare et al., 2003), Interferon Gamma
(IFNG) (Lio et al., 2002a), Insulin-like Growth Factor 1 Receptor (IGF1R) (Bonafè et al.,
2003), Interleukin 6 (IL 6) (Bonafè et al., 2001), Insulin Receptor (INSR) (Kojima et al.,
2004), Integrin Beta 3 (ITGB3) (Hessner et al., 2001), Klotho (KL) (Arking et al., 2002),
Major Histocompatibility Complex (MHC) (Lio et al., 2002b), 5-Methyetrahydrofolate-
Homocysteine Methyltransferase (MTR) (Linnebank et al., 2005), Transforming Growth
Factor, Beta 1 (TGFB1) (Carrieri et al., 2004), Toll-Like Receptor 4 (TLR 4) (Candore et al.,
2006a) and Tumour Necrosis Factor (TNF) (Soto-Vega et al., 2005).
It is likely that many more genes associated with aging have yet to be discovered,
further complicating the challenge of classification. Up until now, there appears to be no
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widely accepted classification system for the various longevity genes, as longevity is a
complex trait and the various genes interact with other genes and the environment. However,
there are suggested classifications, including the various categories of genes that are outlined
below (Browner et al., 2004):
 Genes involved in the regulation of DNA repair and nuclear structure and
function: Genes associated with Werner syndrome (WRN) and Lamin A (LMNA).
When mutated these genes cause progeroid syndromes.
 Genes involved in the regulation of telomere length: Shorter telomeres have been
associated with shorter survival. Genes associated with Human Telomerase RNA
(hTR), Dyskeratosis Congenital 1 (DKC1).
 Genes that affect stress resistance and oxidative damage: Longevity and stress
resistance are closely linked. Oxidative stress actually constitutes a defined hypothesis
of aging in that macromolecule oxidative damage accumulates with age and tends to
be associated with longevity. Genes associated with Superoxide Dismutases (SOD),
Insulin Receptor (IR), Insulin-like Growth Factor1 Receptor (IGF1R).
 Genes encoded by mitochondrial DNA, reactive oxygen species: Mitochondria are
the major source of reactive oxygen species, also known as free radicals, within a cell.
Mutations in mitochondrial DNA reduce production of ATP and lead to cell death and
aging.
 Genes that mediate the effects of caloric restriction: The responses to caloric
restriction and other forms of cellular stress trigger various mechanisms, which
increase life-span, including activation of the sirtuin pathways. Sirtuins are
deacetylase enzymes that regulate gene expression. Genes associated with Silent
Mating Type Information Regulator1 (SIRT1).
 Genes that regulate signalling by insulin and insulin-like growth factor-1 (IGF1) -
like molecules: The best studied longevity pathway involves insulin/IGF1 signalling.
Reduced activity in this pathway is associated with prolonged life-span in several
species. Genes associated with IGF1 signalling such as Insulin Receptor (IR), Insulin-
like Growth Factor 1 Receptor (IGF1R), Forkhead Box O3 (FOXO3).
 Genes involved in inflammation: Genes that increase the inflammatory response to
infectious organisms are associated with harmful effects, such as atherosclerosis. A
common SNP (Asp299Gly) in Toll-like Receptor 4 (TLR4), which reduces the
inflammatory response to bacterial infection, is associated with longevity. Other genes
related to longevity are Interleukin 6 (IL6), C-Reactive Protein (CRP).
 Genes that control protein degradation: Age-related changes in protein-turnover
show that especially intracellular protein degradation decreases with the aging process.
Calpastatin (CAST) is one of the proteolytic systems which control protein
degradation.  
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Choosing candidate genes that control longevity for study in sheep, is therefore
potentially very challenging, especially as considerably less is known about the sheep genome
than the genome of humans, mice and other well studied species.
However, most genes in the above categories have been conserved through evolution
and have homologues with apparently similar functions across species. In this thesis, I have
chosen to study genes that are both characterised to some extent in sheep and that are
representative of at least some of the above groupings, and investigated as many longevity
genes as possible. These genes are IGF1R, FOXO3, CAST and TLR4. While IGF1R and
FOXO3 are well known among the identified longevity genes, CAST and TLR4 have
relatively received little attention from researchers studying longevity.
1.5.1.1 The Insulin-like Growth Factor Receptor 1 gene (IGF1R)
The endocrine system is a complex system of glands that produce hormones that
influence almost every cell, organ, and function of the body. Among the many processes and
activities regulated by hormones and hormone receptors, it has been demonstrated that they
may affect both life-span and reproduction (Piper et al., 2008; Russell & Kahn, 2007; Taguchi
& White, 2008; Tatar et al., 2003)
IGF1R is a hormone receptor and it is expressed by most organs and tissues. This
receptor mediates the effects of IGF1, which is a polypeptide protein hormone similar in
molecular structure to insulin. IGF1 plays an important role in carbohydrate and lipid
metabolism, growth, survival and fertility in a variety of species. Studies of various animal
models suggest that life-span may be affected by IGF1R (Barbieri et al., 2003).
Pioneering work by Kenyon et al. (1993) showed that genes in the IGF pathways are
important in determining nematode life-span (Cynthia, 2001). This knowledge allowed
subsequent research to target homologous genes in more complex model organisms like the
fruit fly and mouse. The latter was the first mammalian model system. Principal IGF pathway
components and their role in mammalian life-span regulation are now under wide-spread
study, including IGF1R, which has become the focus of much attention.
IGF1R is originally known for its prominent role in the promotion of somatic growth
and development in mammals and other vertebrates (Dupont & Holzenberger, 2003). Two
different IGF1R mouse models (Baker et al., 1993; J. P. Liu et al., 1993; Selman & Withers,
2011) have shown IGF1R is required for normal growth and survival. These mice have either
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introduced IGF1R mutations (Baker et al., 1993), or homozygous IGF1R null mutations (J. P.
Liu et al., 1993). The former mice have increased neonatal death rates and reduced postnatal
growth rates if they survive. They have smaller birth weights, at about 60% of normal
controls and suffer from severe developmental delays. The latter mice die at birth from
respiratory failure (Baker et al., 1993; J. P. Liu et al., 1993; Selman & Withers, 2011).
In contrast, a study by Holzenberger et al. (2001) has indicated that mice with partial
IGF1R’s are viable, but have postnatal growth retardation. It appears that as long as the
IGF1R inactivation does not exceed 50%, then the effects on somatic growth remain subtle
and the mice are healthy despite their mutation.
The control of cell growth and metabolism is critically important to survival. Studies in
mice have shown that IGF1R is not only regulating growth, but also survival. In a recent
longevity study using heterozygous knockout mice (IGF1R+/– mutants: mice with 50% of
wild-type receptor levels); because null mutants are not viable, Holzenberger et al. (2003)
have shown that heterozygous mice live on average 26% longer than their wild-type
littermates. When the sexes are evaluated separately, heterozygous females live on average
33% longer than wild-type females, whereas male mutants live on average 16% longer.
Heterozygous mice appear to have normal energy metabolism, nutrient uptakes, and levels of
physical activity that are identical to that of their wild-type controls. Moreover, no change is
observed in male and female fertility and reproduction. This finding supports the contention
that IGF1R affects mammalian longevity.
1.5.1.2 The Forkhead box class O3 gene (FOXO3)
Mammalian FOXO3 regulates the transcription of target genes that act in the
insulin/IGF1 pathway (Kloet & Burgering, 2011). It contains a highly conserved central DNA
binding domain (the Forkhead Box) that binds the target genes via their FOXO response
element, located in their promoters. FOXO3 binding not only results in increased transcription
of the majority of the target genes, but it also can serve as a transcriptional repressor (Calnan
& Brunet, 2008; van der Vos & Coffer, 2008).
FOXO3 functions as a key link in the IGF1 signalling pathway and is thought to
influence both aging and longevity. The initial evidence that FOXO3 might be a key
downstream effecter of the PI3K-AKT pathway was derived from genetic studies in C. 
elegans (Mukhopadhyay et al., 2006). Inactivating mutations in the C. elegans insulin
receptor (daf-2) or PI3K (age-1), resulted in up to 3-fold extended longevity. Importantly, this
Chapter 1: Literature review
26
life-span extension was reverted when the C. elegans daf-16 was mutated. These genetic
studies confirmed that the IGF1 signalling pathway is a major determinant of life-span, and
mutation in FOXO3 may therefore have negative effects on IGF1 signalling, as it controls
gene expression of the pathway through direct binding to target DNA sites. This suggests that
FOXO3 may be an important candidate for genetic longevity studies in mammals.
Recent studies have indicated that polymorphism in the human FOXO3 gene can
influence longevity (Flachsbart et al., 2009; Willcox et al., 2008). This would suggest that the
role of FOXO3 in longevity is evolutionarily conserved, and hence that FOXO3 may
influence longevity in sheep.
FOXO3 also controls various biological functions, including cell-cycle progression
(Medema et al., 2000; Tran et al., 2002), detoxification of reactive oxygen species (ROS)
(Kops et al., 2002), repair of damaged DNA (Tran et al., 2002), apoptosis (Brunet et al., 1999;
Dijkers et al., 2000), cell differentiation and glucose metabolism (Kashii et al., 2000) through
activating or suppressing gene transcription. The ability to detoxify ROS and to repair damage
is correlated with increased organismal longevity in many species (Kirkwood & Austad,
2000), and these additional functions of FOXO3 may be relevant to FOXO3’s ability to
control longevity.
FOXO3 has also been shown to play role in mammalian reproduction. An increasing
number of studies has provided evidence that FOXO3 controls crucial steps in embryogenesis
and is important for the development of ovarian follicles and reproductive organs (John et al.,
2007). A recent study by Castrillon et al. (2003) has now confirmed a function for FOXO3 in
the control of follicular development. In this work, FOXO3-null mice show abnormal ovary
development, and are sterile.
Although FOXO3 acts as a key nuclear target of activation of IGF1 signalling
pathways in a variety of species, no study focused on FOXO3 has been undertaken in relation
to longevity in any livestock species. In this thesis, FOXO3 will also be investigated for its
association with longevity and fecundity
1.5.1.3 The Calpastatin gene (CAST)
The proper functioning of a cell requires structural proteins, enzymes, and regulatory
proteins to be synthesised, used and degraded at appropriate times. The concentration of
individual cellular proteins is determined by a balance between the rate of synthesis and rate
of degradation (also called protein-turnover) (Cuervo & Dice, 1998), which in turn is
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controlled by a series of regulated biochemical mechanisms (Hebert & Molinari, 2007).
Protein-turnover is believed to decrease with aging in all organisms.
There is also an age-related increase in the concentration of abnormal proteins, and this
is a common feature of aged cells (Rosenberger, 1991). The generation of abnormal proteins
may be due to genetic mutation, failure of the protein to properly fold, or denaturation of the
protein induced by various environmental stresses such as heat, oxidation, the present of
heavy metals, and the effect of ultraviolet light exposure. Unfolded proteins are structurally
unstable, and they may aggregate and precipitate (Glabe, 2008; Ono et al., 2009). If these
abnormal proteins accumulate in the cells and tissues, they may interfere with intracellular
transport mechanisms, hence disrupting normal cellular processes. The control of protein-
turnover is therefore essential to cellular well-being.
Abnormal proteins, including excessive levels of particular proteins are normally
broken down by the proteolytic degradation systems. Proteolytic systems are responsible for
most intracellular protein-turnover and they are essential to ensure homeostasis and the
controlled degradation of regulatory proteins that are necessary for cellular activities. Four
proteolytic systems have been identified in eukaryotic cells: the ubiqutin-proteasome system,
the calpain-calpastatin system, the lysosomal compartment, and the mitochondrial proteases
(Liton et al., 2009). Impairment of these proteolytic systems is associated with several age-
related neurodegenerative diseases (Alzheimer, Parkinson and Huntington diseases), cancer
(Attaix et al., 1999) and autoimmune diseases (Martinez-Vicente et al., 2005; J. P. Taylor et
al., 2002).
The calpain-calpastatin system is a major cellular proteolysis system and has been
implicated in the aging process (Nixon et al., 1994). In general, this system regulates muscle
growth by altering the relationship between protein-synthesis and protein-degradation,
indicating once again its importance in the important regulation of protein-turnover (Hayashi
et al., 1985; Klasing et al., 1987). Calpains also undertake specific proteolytic cleavages of
several tissue-specific proteins, and therefore modify and control the function of these
proteins (Goll et al., 2003).
Calpain activity is regulated by the specific endogenous inhibitor, calpastatin (CAST)
(Goll et al., 2003). The calpain-calpastatin system is also modulated by intracellular calcium
concentrations. Once calpains are activated, they are likely to play a role in degradation of
certain membrane and cytoskeletal proteins (Figure 1.4) (Cuervo & Dice, 1998). However,
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the calpains are usually present in an inactive form associated with CAST, suggesting that
calpain activity is primarily regulated by CAST activity.
Figure 1.4. Protein degradation by the calpain-calpastatin system. Calpains are usually
present in an inactive form associated with calpastatin, an intracellular inhibitor. After
translocation to the cell membrane and limited autolysis, calpains are activated
Studies of CAST have revealed its role in various physiological and pathological
functions such as differentiation of myoblasts (Dedieu et al., 2003) and adipocytes (Patel &
Lane, 1999; Yajima et al., 2006), actin reorganization (Dedieu et al., 2004), apoptosis
(Harwood et al., 2005) and cataract formation (Biswas et al., 2005).
In recent studies, CAST function has been reported to be importance in the aging
process and age-related diseases including Alzheimer disease, diabetes, atherosclerosis and
ischaemia (Ibrahim et al., 1994). These diseases are caused by the accumulation of certain
peptides in the brain, pancreas and blood vessels. These studies suggest that CAST is likely to
be linked to the aging process and probably by regulating calpain proteolytic activity (Baudry
et al., 1986).
CAST may also regulate calpain activity in mammalian reproductive tissues and cells,
as it is ubiquitously present in placenta (Takano et al., 2011), oocytes (Malcov et al., 1997),
and testis (Li & Goldberg, 2000; Ravulapalli et al., 2009). A recent study in rat has suggested
that CAST mediates rat oocyte activation and embryo development through the calpain-
specific breakdown of α–spectrin, a cytoskeletal protein (Haim et al., 2006; Malcov et al.,
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1997). This effect of the calpain-calpastatin system has also been observed in human oocytes
(Ben-Aharon et al., 2005), placenta (Thompson et al., 2002) and testis (Rojas et al., 1999),
suggesting that CAST activity plays a pivotal role in reproduction in mammals.
In livestock, CAST is known to be a regulator of post-mortem beef tenderisation and
muscle proteolysis, and genetic variation in CAST is now used as a gene-marker for meat
tenderness in cattle (Casas et al., 2006; Schenkel et al., 2006) and pigs (Ciobanu et al., 2004;
Koćwin-Podsiadła et al., 2003). Although all these outcomes are of value to the livestock
industries in improving meat quality, very little work has been done in examining the effects
of CAST on longevity and fertility. A recent study reported that polymorphic variants of this
gene are associated with longevity and fertility in dairy cattle (Garcia et al., 2006), further
supporting the contention that this gene is associated with variation in both longevity and
fertility.
1.5.1.4 The Toll-Like Receptor 4 gene (TLR4)
The major function of the immune system is to recognise foreign biological entities
(antigens) and destroy or inactivate them either directly killing them, or by tagging them with
very specific antibodies. The effectiveness of the immune system in most animals declines
with age (Pawelec, 2003). Age-related loss of immune function, also called
‘immunosenescence’, is of importance, not only in terms of protection against infectious
diseases (Hazlett & Wu, 2011), but also in several age-related chronic diseases such as
Alzheimer disease, atherosclerosis, diabetes, cancer and some autoimmune diseases (Pawelec,
2003).
Studies in elderly humans and “old” mice have demonstrated that the innate immune
system has a profound influence on immunosenescence (Gomez et al., 2005). Innate
immunity is the first line of defense against pathogens as it activates immediately after the
body encounters a pathogen. It includes the activity of neutrophils, dendritic cells (DCs),
macrophages, natural killer (NK) cells and the complement system.
By comparison adaptive or acquired immunity involves the activation and expansion of
lymphocytes populations. The adaptive immune response is antigen-specific and requires the
recognition of specific non-self antigens during antigen presentation. The two parts of the
immune system (innate and adaptive) are not independent, but are closely interlinked.
Activated innate immunity not only mediates adaptive immunity, but also maintains acute and
chronic inflammatory responses by controlling the level of inflammatory conditions (Larbi et
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al., 2008; Pawelec, 2003) (Figure 1.5). Chronic inflammation is caused by elevated systemic
inflammatory responses, and is a major driving force of age-related diseases (Vasto et al.,
2007). It can be referred to as “inflamm-aging” (Franceschi et al., 2000).
The acute inflammatory response is a primary defense and protects an animals’ body
against bacteria, viruses, parasites and other invading organisms by releasing immune cells
and chemical mediators, that maintain homeostasis in response to injury or infection (Libby,
2007). This inflammatory response should eradicate the infection and then subside to allow
normal tissue to be rebuilt. However, if the acute inflammatory response persists for a
prolonged period of time due to over-activation, (e.g., an increased sensitivity of
inflammatory response or dysfunction of the innate immune system in the distinguishing
between self and non-self in autoimmune disorders) (Gomez-Mejiba et al., 2009), the
inflammatory response may become a chronic inflammatory response.
Figure 1.5. The effect of the aging process on the innate immune system. Adapted from
Larbi et al. (2008)
The toll-like receptors (TLRs) are major constituents of innate immunity and play an
essential role in inflammatory responses. TLRs recognise pathogen-associated molecular
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patterns (PAMPs) on microorganisms. The PAMPs are unique to the microorganisms and not
to the hosts and this allows discrimination between self and non-self. There are various
groups of PAMPs and these include a wide variety of bacterial components such as lipids,
carbohydrates, peptides and nucleic-acids (Kumar et al., 2009). Recognition of PAMPs by
TLRs leads to a series of signalling pathways, resulting in innate immune responses and
inflammation (Bauer et al., 2009).
Mammalian TLRs are classified into groups based on the types of PAMPs they
recognise. To date, 13 TLRs have been described in mice and 11 in humans (Trinchieri &
Sher, 2007). Of the known TLRs, Toll-like Receptor 4 (TLR4) recognises not only the
lipopolysaccharides (LPS) of Gram-negative bacteria, but also other viral PAMPs and
endogenous molecules, including the heat-shock proteins HSP60, HSP70 and GP96 (Beg,
2002; Beutler, 2000).
Excessive exposure to the PAMPs can cause antigenic overload and this can affect the
innate immune system throughout life, leading to progressive activation of innate immunity
and generation of inflammatory responses.
Most of the parameters influencing immunosenescence appear to be under genetic
control (Candore et al., 2006) and it fits with the basic concepts of aging whereby what may
be valuable in a younger organism, may become a cost in that organism as it ages.
Accordingly, the innate immune system may be beneficial for reproduction and parenting by
neutralizing infection agents, but it can be detrimental later in life by under-pinning chronic
inflammation.
Single nucleotide polymorphisms (SNPs) in TLR4 have been described to be related to
the incidence or progression of human inflammation-related diseases, such as asthma,
atherosclerosis and rheumatoid arthritis, and also to cancer in humans (Achyut et al., 2007;
Balistreri et al., 2009; L. C. Chen et al., 2007) and in mice (Pasterkamp et al., 2004). For
example, human TLR4 SNP +896A/G has been revealed to have an association with the
development of cardiovascular disease.
Despite the recognition of a role for TLR4 variation in controlling longevity, little or no
effort has been made to determine if TLR4 variation will occur in sheep, or whether that
impacts on their longevity.
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1.6 Aim of this thesis
Sheep are expected to live up to 20 years and the average life-span of sheep outside of
commercial flocks is 10 to 12 years (Simmons & Ekarius, 2001). In sheep production
systems, the length of a sheep’s productive life-time tends to be much less. This is because a
ewe’s productivity is usually highest between 3 and 6 years of age and begins to decline after
the age 7. As a result, survival and longevity in commercial adult sheep typically depends on
a farmer’s culling decisions, and is based primarily on measures of health and production
performance.
The replacement of breeding ewes poses a large cost to the New Zealand sheep
industry, and inevitable wastage, as ewe replacements that do not “make the grade”, need to
be culled. This is often when their meat value has declined relative to the cost of feeding and
maintaining those replacements. Having longer-lived sheep would reduce the requirement to
carry non-productive replacements.
As described above longevity in animals is controlled by a large number of different
biological pathways and it is a heritable trait. It can be influenced by many factors both
environmental and genetic. From simple yeast to humans, genes have been identified that are
implicated in determining longevity. These genes have many activities including being
involved in hormone signaling pathways, metabolic pathways, proteolytic systems and
immune responsiveness. Variation in these genes has also been shown to affect longevity in a
variety of animal species, with both positive and negative impacts recorded. The gene
associated with variation in longevity often share common functions across different animal
species and thus they have the potential to provide insight into longevity in those species.
Longevity in animals can be influenced by many factors, both environmental and
genetic. There will be genetic diversity within breeds and between breeds that might be
important as regards their longevity. Therefore, sample collection is the first and the most
important step in planning a study of sheep longevity. The main breeds chosen for study in
this thesis were Coopworth and NZ Romney. However, those two breeds were not considered
sufficiently diverse to be able to reliably describe diversity. Accordingly, a large number of
ewes from many different flocks spread all over New Zealand were used. This not only
creates genetic diversity but also allows variation in environmental factors to be better
accommodated.
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Methodologically, the single-stranded conformational polymorphism (SSCP) technique
was used to determine genetic diversity in the sheep studied. This technique is ideal for
studying a large number of genetic samples and at a low cost. SSCP enables large numbers of
sheep to be rapidly screened for genetic diversity over larger regions of a gene. It does this
more effectively than PCR- restriction fragment length polymorphism (RELP) or single
nucleotide polymorphism (SNP) analysis and it can be done prior to the cost of cloning and
sequencing amplicons to reveal nucleotide differences. Microsatellites analysis while useful
for revealing regions of large variability and those regions that are useful for association
analysis, can be less effective at finding functional gene variation especially if the
microsatellites fall outside of the gene region and these are only in linkage disequilibrium
with the functional in the gene.
Using the PCR-SSCP method, the aim of this thesis was to identify sheep homologous
for the putative longevity genes IGF1R, FOXO3, CAST and TLR4, ascertain the nature and
extent of variation in these genes and investigate what role they may have in controlling sheep
longevity and fertility. If any genetic variation in these candidate genes is found to be
significantly associated with sheep longevity, then it would provide options for further study
and with a longer-term aim of developing gene-markers for longevity.
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Chapter 2
The relationship between longevity and fecundity in sheep
2.1 Introduction
While improving longevity may be desirable in sheep, the potential for a relationship to
exist between longevity and fecundity is worthy of investigation. This relationship has been
studied in a variety of organisms and in general, longevity or life-span reflects good health
which positively influences both fertility and fecundity (Ducrocq et al., 1988). However, it
has been suggested that there is possibly a “trade-off”, whereby an organism may have a
limited amount of resources available for investment in reproduction, maintenance and
somatic growth (Holliday, 2006) and this the cost of reproduction may negatively influence
longevity and vice versa.
Recently, a relationship between longevity and fertility has been observed in the
experimental nematode organism C. elegans (Kirkwood, 2005) and the fruit fly D.
melanogaster (Schnebel & Grossfield, 1988). In both species, the germ cells (that give rise to
sperm and oocytes) influence the aging of the whole animal (Flatt et al., 2008; Hsin &
Kenyon, 1999). If the germline precursor cells are removed in either the nematode (Hsin &
Kenyon, 1999) or the fruit fly (Flatt et al., 2008), life-span is extended by 40-60%. These
germline deleted organisms not only live longer than normal, but they also remain youthful
and active for longer, suggesting that loss of the germline precursor cells extends life-span by
slowing the animals’ rate of aging.
Interestingly, removing the entire reproductive system of C. elegans does not extend
life-span (Hsin & Kenyon, 1999), which argues against there being a simple reproductive
trade-off. This suggests that a specific signal from the germ cells allows the animal to
coordinate its rate of aging with the timing of reproduction.
Since reproduction is costly, but essential, it makes the task of surviving even more
challenging, and primarily because of the energetic and nutritional requirements of pregnancy,
lactation and parenthood. Pregnancy and lactation take energy and nutrients away from other
processes including other physiological and metabolic functions. Accordingly, if a female has
a higher number of offspring, this may negatively affect her health, especially at older ages,
and ultimately reduce her longevity.
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The idea, that there is a “cost of reproduction,” has been put forward as an example of
an evolutionary constraint, but this doesn’t mean that there must always be a trade-off
between reproduction and longevity. For example in some species, individuals die soon after
mating or have shorter life-spans as a consequence of mating. In contrast, many examples of
life-span extension with little or no inhibition of reproduction have also been confirmed
(Kenyon, 2005). This illustrates the plasticity of aging and reproductive fitness in different
species.
In humans, Westendrop & Kirkwood (1998) investigated pre-modern British aristocracy
and reported a negative correlation between the number of progeny and female longevity,
which they concluded, provided evidence that human life histories involve the “trade-off”
between longevity and reproduction. However, a positive relationship between human
fecundity and longevity has also been reported (Borgerhoj Mulder, 1988; Voland & Engel,
1989). It would appear that the “trade-off” is only for women who have considerably more
than average number of children (Voland & Engel, 1989) and that modern medicine may have
now affected the apparent trade-off.
In livestock production systems, the longevity of individuals within a herd or flock
becomes a critical issue. For example, the fitness and longevity of dairy cows in herds has an
impact on profitability (Coelho & Barbosa, 2006; Essl, 1998; Sewalem et al., 2006). There is
also evidence that selection exclusively for production traits such as milk yield and fertility,
may cause a correlated reduction in longevity (Essl, 1998; Wall et al., 2006). If the trade-off
such as this exists in dairy cattle, it is therefore appropriate to investigate the relationship
between longevity and fecundity in sheep.
Given the apparent potential for a trade-off between reproductive performance and
longevity to exist in sheep, it is necessary to investigate the relationship between longevity
and fecundity prior to investigating whether the former is under genetic control. If there is no
negative relationship found between them, then long-lived ewes might provide both
production quality and reproductive performance. This may enable genetic selection for
improved longevity, without any loss of performance.
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2.2 Materials and Methods
2.2.1 Details of the sheep to be studied
For the sheep longevity study, blood samples were collected over the years 2007-2009.
Forty stud farms from all over New Zealand provided blood samples from ewes. These stud
farms were chosen specifically because breeding sheep are frequently retained longer in studs
than commercial sheep.
Farmers were asked supply the oldest ewes possible to assist in finding the genes that
may affect longevity. For each sample the current age of the sheep in years was recorded. To
compare between older and younger sheep, blood samples were also collected from two-tooth
(two year old) replacement ewes on each farm. The geographical locations of the farms are
shown in Table 2.1.
Table 2.1. Geographical region of the 40 farms studied.
No. of Farms Region
8 Southland
9 Otago
6 Canterbury
4 Wanganui/Rangitikei/Manawatu
3 Central North Island
3 Waikato
2 East Coast
2 Wairarapa
1 Hawke’s Bay
1 Auckland
1 Northland
Total 40
The recording of lambing data was undertaken by the farmers and in the study group
lambing occurred from late August to October. For each ewe a record was kept of how many
lambs were raised to weaning each year.
Blood from a total of 1826 ewes was collected on FTA cards (Whatman BioScience,
Middlesex, U.K.). Blood drops on FTA card were sampled from the ear of the sheep using
electrical side-cutters. Details on sampling can be found in appendix C.
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This study did not require ethical approval as ear-clipping is considered a standard
sheep management practice. The blood was obtained from sheep of the Coopworth,
Corriedale, NZ Romney, Merino, Polwarth, Hampshire, Texel and Kelso breeds. The main
breeds were the Coopworth and NZ Romney. Farmers were willing to provide these different
breeds for this study. The Coopworth breed was specially provided through collaboration with
the Coopworth Sheep Society, hence why it is the main breed in this study. This breed is an
internationally unique and a valuable genetic resource for finding genetic effects, because it is
outbred.
A total of 40 farms were used to investigate the relationship between longevity and
fecundity in this chapter, but some farms were excluded from the subsequent longevity and
fecundity analyses for assessing genetic variation in the potential longevity genes (IGF1R,
FOXO3, CAST and TLR4). These farms had small numbers of Hampshire and Texel sheep
and this may have biased the analyses because of the potentially confounding effect of breed,
sire, environment and management.
2.2.2 Sheep investigated to define variation in the potential longevity genes
The Gene-Marker Laboratory in Lincoln University provided a collection of blood
samples to enable the development of the tests to screen for the identification of genetic
variation in the IGF1R, FOXO3, CAST and TLR4 genes. These samples were randomly
selected from wool and meat research projects and where of a variety of breeds, both gender
and of variable age (see details in materials and methods section of chapter 3, 4, 5 and 6). As
a consequence of the samples for longevity analysis having to be used at least four times with
genotyping for the four different longevity genes, some of the samples were not enough to use
screen for variation in the four genes. The longevity samples were collected over a two year
period, which is another reason why samples from the Gene-Marker Laboratory were used for
initially identifying genetic variation before all the longevity blood samples were collected.
2.2.3 Statistical analysis
Frequency data and basic descriptive statistics were calculated using SPSS version 17
(SPSS Science Inc., Chicago, IL, USA) with a two-tailed significance level of α = 0.05. To
investigate the relationship between longevity and fecundity, Pearson Correlation and Scatter
plot analyses were performed.
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2.3 Results
2.3.1 Study population in young and old NZ sheep breeds
A total of 1826 blood samples from 40 flocks were collected for the longevity study.
These comprised 1018 older ewes (from 3 to 16 years of age) and 808 younger ewes (two-
tooth replacement ewes).
The data shown in table 2.1 compares the mean age in the younger and older groups.
The average age of the ewes was 5.35 years (ranged from 2 to 16 years). While the young
population had all 2 years old, the old population had age ranges from 3 to 16 years. The
oldest sheep was 16 years old in this study.
In table 2.2, the number of sheep of each age in years and the proportion of the total is
reported. The majority of sheep in the older group were between 7 and 9 years old.
Table 2.2. Young and old age groups of sheep used in this study.
Category Age Number (n) Percentage (%)
Young 2 808 44.2
Old
Mean
(8.1 years)
3
4
5
6
7
8
9
10
11
12
13
14
16
1
26
62
103
175
288
181
105
57
17
1
1
1
0.1
1.4
3.4
5.6
9.6
15.8
9.9
5.7
3.1
0.9
0.1
0.1
0.1
Total 1826 100
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2.3.2 Average number of lambs raised for the different age groups
Six hundred and ninety eight of the older ewes had records of their lambing
performance over their life-time made available. An average per annum lambing performance
was calculated as an indication of fecundity. This ranged from an average 1.40 to 2.27 lambs
per year, with a mean of 1.79 lambs per year.
Table 2.3 shows that the average number of lambs raised per ewe, per year, decreased
gradually with increasing age.
Table 2.3. Average number of lambs rasied for different age groups.
Age group
(Year)
n Percentage
(%)
Average lambs
raised/year
3-4
5
6
7
8
9
10
11
12
13-16
24
58
63
148
156
127
65
42
12
3
3.4
8.3
9.1
21.2
22.3
18.2
9.3
6.1
1.7
0.4
2.27
1.95
2.01
1.79
1.76
1.62
1.73
1.76
1.66
1.40
Total 698 100 1.79
2.3.3 Average number of lambs raised for the different NZ sheep breeds
The main breeds selected in this study were the Coopworth, Corriedale, NZ Romney
and Merino. The NZ Romney is the most common breed in New Zealand and makes up about
41% of the national flock in 2007 (Meat & Wool New Zealand, 2007), but in this study
Coopworth was the dominant breed, as the research was supported by the Coopworth Society
of New Zealand.
Table 2.4 shows the averages of age and number of lambs raised in the different breeds.
Among the breeds, the average lambing rate per year was highest in the Texel breed and
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lowest in the Merino. However, this table was not analysed for further tends as it is unlikely
that the selected sheep were representative of the whole breed and hence, these average
cannot be interpreted as being breed-specific or typical.
Table 2.4. Average number of lambs raised for different breeds.
2.3.4 The relationship between longevity and fecundity
Data from the ages of sheep and the average lamb per year were used to explore the
relationship between longevity and fecundity.
A weak negative Pearson correlation between longevity and fecundity (measured as
number of lambs raised) was observed (r = -0.248, P < 0.001).
The correlation between longevity and fecundity traits is illustrated in Figure 2.1. Age
only accounts for 6% (R2 = 0.059) of the variation in fecundity. This suggests that although
older ewes do tend to have fewer lambs, other characteristics may be better predictors of
fecundity than age, at least over the range of ages studied.
Breed Number
of farms
n Average lambs
raised per ewe
per year
Average ewe
age
Coopworth
Romney
Merino
Corriedale
Polwarth
Texel
Hampshire
Kelso
Total
9
8
8
8
2
2
2
1
40
439
340
326
318
129
60
40
174
1826
2.11 ± 0.03
1.91 ± 0.03
1.28 ± 0.03
1.65 ± 0.04
1.65 ± 0.05
2.32 ± 0.08
2.06 ± 0.08
NA
6.4 ± 0.10
8.6 ± 0.11
8.7 ± 0.12
8.4 ± 0.12
7.9 ± 0.19
7.1 ± 0.23
5.6 ± 0.33
8.6 ± 0.11
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Figure 2.1. A correlation between longevity and fecundity in sheep.
2.4 Discussion
The effect of aging on survival and reproductive success are key elements of the trade-
off theory, which suggests that reproductive costs could affect longevity in mammals. This is
also known as reproductive senescence.
In the sheep industry, profitability in part depends on the number of lambs born for
meat production per ewe, and over that ewe’s life-time. Longer-lived ewes, provided they
remain reproductively active throughout their lives, are effectively more efficient to farm as
fewer replacements are needed. However, in studying sheep longevity it is necessary to
investigate whether increasing their life-span is associated with a decrease in fertility as would
be suggested by the trade-off theory.
Reproductive senescence has been shown in both short-lived mammals (Hoogland,
1995; Wauters & Dhondt, 1989) and long-lived mammals (Green, 1990). In many long-lived
mammals and birds, longevity and reproduction patterns tend to follow a bell-shaped curve
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(Jorgenson et al., 1997; Newton & Rothery, 1997), whereby reproductive ability increases
after sexual maturity, becomes stabilized and then at some stage decreases until death.
Reproductive senescence in mammals does not usually begin at sexual maturity or with the
first reproduction (Gaillard et al., 1994), but at some time after these events.
In livestock, most measures of reproductive performance (including litter size, birth
weight, and neonatal survival) usually remain approximately constant, only declining near the
end of the animal’s life-span. However, the life-span of livestock often depends on the ability
to avoid culling (Ducrocq et al., 1988) and natural longevity is therefore masked behind a
management practice that prematurely abbreviates life-span.
A recent study has investigated reproductive senescence in bighorn sheep (Ovis 
canadensis) (Festa–Bianchet & King, 2007). According to this research, reproductive
senescence in bighorn sheep begins 6-7 years after the onset of survival senescence. The study
confirmed the existence of reproductive senescence, but established no negative relationship
between early and late reproductive success, or between early reproductive success and
longevity. The study also confirmed that only ewes of higher phenotypic quality survived
long enough to reach reproductive senescence. This suggests that bighorn ewe longevity had a
positive influence on life-time reproductive success. Whether this is the case in domestic
sheep (Ovis aries) is unknown.
In this thesis, the level of reproductive senescence was very similar to that reported for
other female ungulates (Loison et al., 1999) including the bighorn sheep (Festa–Bianchet &
King, 2007), with declining at the end of the ewes life. However, the relationship between
longevity and fecundity in these NZ sheep was weak and negative. This suggests that
although older ewes do tend to have fewer lambs, other factors such as farm management
practices and availability of quality nutrition may be better predictors of fecundity, than age.
The investigation of the relationship between longevity and fecundity revealed in this
study may have been affected by a number of things. Firstly, farmers were asked for number
of lambs that survived to weaning, but they may have accidentally included lambs that were
born, but died at birth, or between birth and weaning. This would affect the assessment of ewe
fecundity and also possibly any decision to cull them.
For lamb survival, the first 48 hours after birth are critical time (Kerslake et al., 2005).
Around 70% of lamb mortality occurs between birth and weaning and lamb mortality is
generally associated with a lower birth weight (Brien et al., 2010; Scales et al., 1986).
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Although ewes can be highly fecund, producing multiples lambs (twins and triplets), the
multiple lambs have a lower average birth weight and are therefore more likely die between
birth and weaning compared to single-born lambs (Everett-Hincks & Dodds, 2008; Kerslake
et al., 2005). Being excessively fecund may therefore pose a productive cost.
Secondly, ewe culling decisions are based on production performance (wool and meat
production and reproductive performance), animal health (structural unsoundness and
temperament), management considerations and varying market opportunities. As ewe culling
criteria may vary widely from farm to farm and season to season, the decision to replace ewes
may reflect things other than just their reproductive performance, and this might affect their
ability to realise their full reproductive potential.
This thesis has revealed that longevity and fecundity appeared to vary among the eight
breeds studied. The Texel had the highest fecundity and Merino had the lowest. Different
sheep breeds are characterised by different physical, productive and reproductive features. In
this thesis, eight breeds were investigated from 40 different flocks. These flocks were subject
to different management regimes, hence differences between flocks may affect either
variation in longevity and fecundity within a breed or variation in flock management. In
addition, the Coopworth and Romney breeds are dual purpose and suited for meat and wool
production. Selection for two separate production systems in these breeds may also affect
both their fecundity and longevity. For example, when these sheep are selected primarily for
meat production, reproductive performance is the most important factor contributing to the
efficiency of meat production, but this is less important for wool as the value is derived
primarily from the ewe and not how many lambs she has.
An understanding of the factors governing reproductive success has fundamental
implications for this study. From a trade-off point of view, artificial selection for production
traits should theoretically lead to a deterioration of longevity. This has certainly been
demonstrated in dairy cattle where selection for reproductive success and production traits
including increased milk yield, reduced live weight and increased growth rate has resulted in
negative correlated responses in fitness or longevity (Essl, 1998; Wall et al., 2006). On the
other hand, studies of undomesticated species of sheep suggest that individuals with high life-
time reproductive performance have greater longevity (Clutton-Brock et al., 1996; Hamel et
al., 2009). Although a correlation between longevity and fertility/fecundity has been reported
for many species, few studies have explored this in domestic sheep. In this thesis, there was a
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negative correlation between longevity and fecundity, but it was weak, suggesting that
selection for increased longevity is unlikely to adversely affect ewe fecundity.
In conclusion, reproductive success remains fairly steady until the end of the life-span,
and some ewes remain reproductive beyond 12 years of age. Therefore, it would seem
plausible to be able to select for long-lived ewe without having a major effect on their ability
to produce lambs. The long-lived ewes would bring more reproductive opportunities, that are
lost if they need to be regularly replaced. However, if ewes are kept longer, then there may be
other costs to productively, including a reduced potential for genetic gain as generation time
would increase.
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Chapter 3
An association between longevity and variation in IGF1R
IGF1 signalling is considered to be a key determinant of somatic growth and adult body
size (Rogol et al., 2002). Signalling driven by the binding of IGF1 to the IGF1 receptor
(IGF1R) is a principle mechanism underpinning both metabolism and growth in animals, with
the receptor being widely expressed across many cell types in both foetal and postnatal
tissues.
 A generalised role for IGF1 in growth and metabolism
IGF1 is a small peptide (molecular weight 7,647) with a high sequence and structural
homology to insulin (Kim & Accili, 2002; Laron, 2004). It is an anabolic hormone and found
in almost every cell in the body, including muscle, cartilage, bone, liver, kidney, nerve, skin,
and lung cells.
IGF1 is part of a complex metabolic system, with both GH-like and insulin-like effects
(Laron, 2004). In a primary role, it affects somatic growth and differentiation by inducing a
variety of growth factors, while in a secondary role it operates through insulin-like
mechanisms. The latter play an important role in glucose metabolism by increasing insulin
sensitivity and lowering glucose levels. The activity of IGF1 at the cellular level is largely
mediated by IGF1R, although IGF1 can also bind to the insulin receptor (IR), with a low
affinity.
Early observations revealed that in growing animals IGF levels increase with post-natal
age to puberty (Imran et al., 2010). Serum concentrations in neonatal animals are relatively
low, but gradually increased during maturation. They then gradually decline through
adulthood. Excess IGF1, or a deficiency of it, can cause abnormal growth and other metabolic
disorders. For example, in humans, abnormally high IGF1 levels have been linked to breast
cancer, prostate cancer and certain types of colon cancer (Ouban et al., 2003).
IGF1 has been shown to mediate many growth-promoting effects (Guevara-Aguirre et
al., 1997; J. L. Walker et al., 1992) in experimental animal systems. These effects were
assessed using different doses and different routes of administration of IGF1 (Mauras &
Haymond, 1996). If a low dose of IGF1 is used, it stimulates protein anabolic activity by
selectively increasing whole body protein synthesis without affecting the rate of proteolysis,
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whereas in higher doses IGF1 suppresses proteolysis (Mauras & Beaufrere, 1995; Turkalj et
al., 1992).
The growth-promoting effects of IGF1 have been observed in many tissues, including
bone (J. I. E. Wang et al., 1999), cartilage (Jenniskens et al., 2006), adipose cells (Wright &
Hausman, 1995) and muscle (Barton-Davis et al., 1998) (Figure 3.2). In bone and cartilage,
IGF1 promotes the growth of long bones at the epiphyseal plates, where there are actively
proliferating cartilage cells (Jenniskens et al., 2006). This ‘growth support’ ceases once the
epiphyses of the long bones fuse at the end of adolescence. Excessive GH after this time leads
to progressively dysmorphic growth called acromegaly (a chronic metabolic disorder).
IGF1 also mediates bone turnover and bone mineral density. In adipose cells, IGF1
stimulates lipid synthesis and reduces lipolysis in an opposite fashion to GH (Wright &
Hausman, 1995). In muscle cells, it increases the number of cells (hyperplasia) and the growth
of new muscle fibre (mitogenesis), as well as inducing skeletal muscle hypertrophy. IGF1 is
stimulated by nutrient intake through a complex interaction with GH. GH provides a
mechanism for surviving periods of food deprivation, and hence its major function is
catabolism. GH increases lipolysis to produce energy substrates and inhibits hepatic
gluconeogenesis (Gasco et al., 2010). These effects increase blood glucose levels and reduce
the need for dietary sources of carbohydrate.
IGF1 also has anabolic effects on the body. It stimulates peripheral tissue uptake of
glucose, which lowers blood glucose levels (Berneis & Keller, 1996; Mauras & Haymond,
2005). Thus, during starvation, circulating IGF1 decreases rapidly. Furthermore, it is a major
inhibitor of GH secretion, via a negative feedback control system (Thakore & Dinan, 1994),
and this plays a role in maintaining metabolic balance by controlling whether metabolism will
be anabolic or catabolic.
Circulating (endocrine) IGF plays a major role in glucose homeostasis compared to
locally secreted (paracrine/autocrine/free) IGF1 (Phillips et al., 1990). Several authors have
demonstrated the link between IGF1 and glucose homeostasis (J. L. Liu et al., 2000; Ohlsson
et al., 2000; Sjögren et al., 2001). Liu et al. (2000) generated a mouse that specifically lacked
IGF1 expression in the liver (Liver-specific IGF1 deficient: LID), the primary site of
endocrine IGF1 production. While mice without the IGF1 gene will not generally survive,
LID mice survive with normal growth and no obvious malformation. This suggests that GH
can stimulate IGF1 production in extra-hepatic tissues (paracrine/autocrine production) and
Chapter 3: An association between longevity and variation in IGF1R
47
that this is enough to produce body growth. In these LID mice circulating and serum levels of
IGF1 were decreased by approximately 80%. Liu et al. (2000) also demonstrated the mice had
specifically impaired “insulin sensitivity” in muscle and compensated for their low total IGF1
levels with hyperinsulinemia. This hyperinsulinemia was an attempt to maintain
normoglycemia, as IGF1 administration reduced insulin levels and increased peripheral
insulin sensitivity. This result suggests a direct role for circulating IGF1 in modulating insulin
sensitivity and irrespective of free IGF1 levels. Overall, liver derived IGF1 has been
confirmed as an important factor in maintaining normal carbohydrate metabolism, while
extra-hepatic IGF1 is important in normal growth.
The control of cell growth and metabolism is critically important to survival. IGF1
regulates growth during the prenatal period as well as survival during adulthood. For
example, caloric restricted mice have increased longevity and decreased IGF1 levels without
an apparent effect on body size (Bartke et al., 2008). Indeed, when food is scarce, adult
animals typically enter into a semidormant state allowing them to survive periods of food
deprivation. Studies of GH/IGF1 deficient mice (Ames dwarf and GHRKO (growth hormone
knockout)) have also revealed that they have increased longevity (Al-Regaiey et al., 2005;
Bartke et al., 2008). These results support the idea that the IGF1 signalling pathway and its
control of metabolic activity are likely to be a general regulator of the rate of aging and
primarily through the control of metabolism and growth.
 Knockout mouse models (IGFs and IGF1R)
The central role of the IGF axis in regulation of pre- and post-natal growth has been
confirmed in gene-knockout mouse models (Baker et al., 1993; J. P. Liu et al., 1993). The GH
and GH receptor gene-knockouts have normal birth weight, confirming that GH is not an
important regulator of pre-natal growth. However, elimination of IGF1 and IGF1R by
homologous gene recombination has demonstrated that IGF1 is important for pre-natal tissue
development and growth. IGF1 gene-knockout mice had a birth weight of 60% of normal and
subsequently severe postnatal growth failure (Baker et al., 1993; J. P. Liu et al., 1993).
IGF2 null mice are equally growth retarded at birth (60% of normal size), but grow
normally in the postnatal period, suggesting that IGF2 is primarily responsible for pre-natal
growth (Baker et al., 1993; J. P. Liu et al., 1993). The synergistic effect of IGF1 and IGF2 on
pre-natal growth has been confirmed by the observation that mice with deleted IGF1 and
IGF2 genes have a birth weight of only 30% of normal.
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While IGF1R is important in mediating both IGF1’s and IGF2’s actions, IGF1R
knockout mice are affected more profoundly and die of postnatal respiratory failure due to
poor development of the respiratory muscles (J. P. Liu et al., 1993). This suggests IGF1R is
pivotal in IGF1 and IGF2 mediated activity.
IGF2R is also called “the mannose-6 phosphate receptor” and binds IGF2 alone. The
receptor inactivates IGF2 and makes less IGF2 available for binding with IGF1R (Taguchi &
White, 2008). This function of IGF2R is well supported by knockout mouse models, as mice
lacking functional IGF2R (KO-IGF2R) are overgrown by up to 30% relative to their wild-
type littermates (Ludwig et al., 1996). Collectively these studies demonstrate that the IGF axis
is critical for regulating body growth and tissue development, and is therefore also of potential
importance in determining life-span.
 The structure of the IGF1 receptor
The human complementary DNA (cDNA) of IGF1R was first cloned and sequenced in
1986 (Yamashita & Melmed, 1986). It consisted of 4989 nucleotides and encoded a 1367-
animo acid precursor. The dimeric IGF1R protein contains two extracellular α subunits (~135
kDa each) and two transmembrane spanning β subunits (95 kDa each), which are joined by
disulfide bridges to form a heterotetrameric receptor complex (a β-α-α-β arrangement, Figure
3.1). The α and β subunits are derived from different sub-regions of the IGF1R cDNA.
Mammalian IGF1R genes typically contain between 19 and 22 exons, 11 that produce
the α subunit and 9 to 11 that produce the β subunit. These exons span approximately 100 kb
of genomic DNA.
The α subunit can be subdivided into six distinct protein domains as follows: an N-
terminal receptor L domain (L1), a cysteine-rich repeat (CRR) domain, a second receptor L
domain (L2), and three type III fibronectin domains. The β subunit contains a tyrosine kinase
catalytic domain (Adams et al., 2000).
The first three α domains (L1-cys-rich-L2) of the IGF1R are important for IGF1
binding. Of these, the cysteine-rich domain of IGF1R is critically important, as it has a high-
affinity binding activity. Mutations or variation in the α subunits of IGF1R can affect IGF1
binding and this may have a significant effect on the physiology of the IGF1 axis.
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Following ligand (IGF) binding to IGF1R, its tyrosine kinase activity is activated, and
this stimulates signalling through intracellular networks that regulate various physiological
mechanisms including cell proliferation and cell survival.
Figure 3.1. The structure of IGF1R.
 IGF1R signalling and cellular metabolism
IGF1R binds both IGF1 and IGF2 with high affinity and the insulin receptor (IR) binds
insulin with high affinity. However, since both receptors share a high degree of structural and
functional homology, IGF1R can also bind insulin and conversely the IR can bind IGF1 with
a low affinity (LeRoith & Yakar, 2007).
The insulin-like growth factor binding protein (IGFBP) family has at least six members,
which serve both as transporter proteins and as storage pools for IGF1 and IGF2. They control
IGF1R action by regulating the bioavailability of IGF1 and IGF2 (Blakesley et al., 1996).
Approximately 98% of IGF1 is bound to one of the six IGFBPs. Of these proteins, IGFBP-3
is present at the highest level in adults and is responsible for carrying IGFs to target tissues
and prolonging it’s half-life in circulation. However, in general, IGFBPs inhibit IGF activity
by making them unable to bind to IGF1R and IGF2R. All six IGFBPs have been shown to
inhibit IGF1 and IGF2 activities, but IGFBP-1, -3, and -5 also stimulate the action of IGF1
and IGF2 (Firth & Baxter, 2002).
1 740 1367
(Exons 1-11) (Exons 12-22)
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Once the IGFs are able to bind their receptors, IGF1R can initiate signalling cascades
via its cytoplasmic domains (Figure 3.2)
Figure 3.2. The physiology of GH and IGFs.
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Downstream IGF1R signalling involves autophosphorylation and subsequent tyrosine-
mediated phosphorylation of the Src-homology collagen protein (Shc) and insulin receptor
substrate (IRS) proteins -1, -2, -3, and -4. The IRSs serves as docking proteins and can
activate two well-characterized IGF1 signalling pathways; the MAPK pathway and the PI3K
pathway (Figure 3.3). Activation of these signalling pathways induces different biological
activities, including metabolism, cell growth, differentiation, migration and survival (Tatar et
al., 2003).
Figure 3.3. IGF1R activation and downstream signalling. Following ligand (IGFs) binding
to IGF1R, tyrosine kinase activity of IGF1R is activated, and this stimulates downstream
networks include the Ras/Raf/MEK/ERK and the PI3K-AKT pathways. The MAPK pathway
is involved in cell survival, differentiation, proliferation, and protection against apoptosis. The
PI3K-AKT pathway is involved in protein translation, cell survival, proliferation, apoptosis,
and glucose metabolism
In the mitogen-activated protein kinase (MAPK) pathway, the proximal substrates for
IGF1R include insulin receptor substrate (IRS) proteins 1 to 4 and the Src-homology collagen
protein (Shc) (Firth & Baxter, 2002). Following activation of IGF1R, Shc and the IRSs bind
to a complex consisting of growth factor receptor bound-2 (Grb2) and Son of sevenless (Sos).
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This complex allows the activation of Ras and its downstream cascade, the Ras/Raf/MEK
(MAPKK: mitogen activated protein kinase kinase) pathway.
Ras is a small guanosine triphosphate protein which is anchored to the inner surface of
the plasma membrane (Figure 3.3). It is able to interact physically with several alternative
downstream signalling partners. The first of the Ras effectors is the Raf kinase. After
activation of Raf by Ras, Raf becomes phosphorylated, acquires active signalling capability
and proceeds to phosphorylate and activate a second kinase known as MEK. MEK can
phosphorylate serine/threonine residues as well as tyrosine residues, which will phosphorylate
two other kinases, the extracellular signal-regulated kinases 1 and 2, commonly referred to as
ERK1 and ERK2 (Boulton et al., 1991; Robbins et al., 1992). Phosphorylated and activated,
each ERK then regulates various cellular processes including cell proliferation,
differentiation, and protection against apoptosis.
In the PI3K pathway, IRS is the first adapter protein that is activated by IGF1R (Figure
3.3). Activated IRS also interacts with the p85 regulatory subunit of PI3K, leading to
activation of catalytic subunit p110 of PI3K. The activation of PI3K leads to an increase in
phosphatidyl inositol 3,4,5 triphosphate (PIP3) levels that induces the recruitment of AKT
(protein kinase B). This allows the constitutively activated 3’-phosphoinositide-dependent
kinase (PDK)-1 and PDK-2 to phosphorylate and activate AKT.
The activation of AKT mediates various cellular processes, including increased protein
synthesis and cell growth by inhibition of the mTORC1 complex (mammalian target of
rapamycin complex 1) (Datta et al., 1999), increased conversion of glucose to glycogen via
inhibition of glycogen synthase kinase-3β (GSK-3β) activity (Asano et al., 2007) and
increased proliferation and survival by activation or inhibition of anti-apoptotic factors such
as BAD (pro-apoptotic protein of the Bcl-2 family), and nuclear factor kappa-B (Guertin &
Sabatini, 2005) (Figure 3.3).
The mammalian Forkhead members of the class O (FOXO) transcription factor family
are well-characterised substrates of AKT. Activated AKT in turn represses the FOXO
transcription activity by direct phosphorylation. Phosphorylated FOXO remains inactive in
the cytoplasm. In the absence of the AKT signal, FOXO becomes dephosphorylated and then
transported into the nucleus, where it modulates the transcriptional activity of its target genes,
which control among other things cell-cycle, cell death, cell metabolism and oxidative stress.
Recent studies in nematodes (Lin et al., 1997) and insects (Hwangbo et al., 2004; Ogg et al.,
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1997) have shown that having consistently activated FOXO as a consequence of insufficient
IGF1 deficient signalling, can extend life-span. Accordingly, one of the main mechanistic
outputs of IGF1 signalling is inhibition of the FOXO family.
 The IGF1R gene and its homology across species
Genes involved in the IGF1 pathway appear to be conserved from lower order species to
complex organisms, reflecting the observation that they share a similar role across species
ranging from C. elegans to humans (Barbieri et al., 2003; Xuan & Zhang, 2005).
Figure 3.4 is a phylogenetic tree constructed based on alignment of the full-length
nucleotide sequence of IGF1R mRNA from various species. In the phylogenetic tree, species
are clustered together according to similarity of their gene sequences. Table 3.1 was also
derived from the same references as mentioned Figure 3.4. Humans, monkeys, cows, pigs,
mice and rats; all mammals are very similar with over 95% nucleotide sequence identity
(Table 3.1). This genetic relatedness of mammals allows us to speculate that the gene
sequences will be similar in other mammalian species, including sheep. Therefore what we
understand about the regulation of longevity in other species (e.g., humans, cows and mice)
could be used to try and understand what is occurring in sheep. In effect, we expect those
genes associated with variation in longevity in mice, humans and other characterised species,
to also be associated with longevity in sheep.
Figure 3.4. Phylogenetic tree of IGF1R sequences from various species. The phylogenetic
tree was constructed by the neighbour-joining method, using the multiple alignment
algorithms in the MegAlign package (DNAStar Inc., Madison, WI, USA). The full-length
nucleotide sequences of IGF1R mRNA were extracted from GenBank. The GenBank
database accession numbers are as follows AAI13611.1 for Human (Homo sapiens);
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XP_001100407 for Monkey (Macaca mulatta); DAA17722.1 for Cow (Bos taurus);
NP999337.1 for Pig (Sus scrofa); NP034643.2 for Mouse (Mus musculus); NP434694.1 for
Rat (Rattus norvegicus); NP990363.1 for Chicken (Gallus gallus); BAF73401 for Quail
(Coturnix japonica); AF055080.1 for Xenopus (Xenopus lavevis)
Table 3.1. Amino acid sequence homology of IGF1R from various species.
( %) 
Identity 
Human Monkey Pig Cow Mouse Rat 
Human 100
Monkey 99.6 100
Pig 98.4 98.5 100
cow 97.6 97.6 98.3 100
Mouse 95.7 95.8 95.5 94.7 100
Rat 95.3 95.4 95.2 94.4 98.9 100
 IGF1R and longevity
Longevity is associated with reduced levels of IGF1 signalling in C. elegans (Hansen et
al., 2007; Tullet et al., 2008), D. melanogaster (Giannakou & Partridge, 2007) and mouse
models (Andrzej, 2006). It is hypothesised that with lower levels of IGF1 signalling, the
metabolism of the organism shifts from growth and food intake to cellular maintenance and
stress resistance. This hypothesis has been investigated in caloric restricted rodent models
(Liang et al., 2003; Turturro et al., 1994). The caloric restricted rodents decrease the level of
IGF1R signalling. Reduced IGF1 signalling stimulates starvation responses, which reduces
plasma insulin levels and enhances insulin sensitivity as well as stress resistance. These
patterns or changes are also seen in long-lived mammals (Masoro, 2005).
Studies have shown that complete or partial loss-of-function mutations in genes
encoding components of the IGF1 signalling pathway result in extension of life-span in C. 
elegans (Kenyon, 2011), D. melanogaster (Clancy et al., 2001) and mice (Quarrie &
Riabowol, 2004). In nematodes, DAF2 is similar to the insulin receptors and IGF1 receptors
found in humans and other mammals. The nematode C. elegans lives for only a few weeks;
but mutation in daf-2 was found to double the life-span of the organism. In D. melanogaster,
mutations in the insulin/IGF1 receptor extend female life-span by approximately 85%. In
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mice, animals that lack one allele of the IGF1R gene show a 26% increase in mean life-span
(Holzenberger et al., 2003). It therefore appears to be that the IGF1 signalling pathways role
in longevity is evolutionarily conserved from nematodes to mammals and this suggests that
altered signalling in this pathway may also influence life-span in humans and other mammals
including sheep.
In humans, many studies have shown that genetic variation in IGF1R is associated with
longevity, including studies in Italian cohorts (Bonafè et al., 2003), Ashkenazi Jews (Suh et
al., 2008) and the Japanese (Kojima et al., 2004). In these studies, centenarians were more
likely to have the longevity-associated variation in IGF1R.
Although genetic variations in IGF1R that is associated with longevity have been
reported in a variety of mammals, there is little scientific literature about genetic variation in
the receptor gene or its relationship with longevity in sheep. In this chapter, part of intron 2
and exon 3 of ovine IGF1R, were characterised to identify genetic variation and the
association between this variation and longevity was tested.
3.1 Materials and Methods
3.1.1 Sheep investigated to define variation in IGF1R
To investigate genetic variation in ovine IGF1R, 100 New Zealand Romney sheep were
studied in detail.
3.1.2 Sheep studied for longevity and fecundity analysis
Blood samples from sheep of known age and with lambing records were used (See
chapter 2.2 for sheep studied and the collection of longevity and fecundity data) to assess the
effect of genetic variation of IGF1R on sheep longevity and fecundity.
3.1.3 DNA extraction from blood on FTA cards
Blood samples were collected onto FTA cards (Whatman BioScience, Middlesex,
U.K.), and genomic DNA was purified using the NaOH method described by H. Zhou (2006).
In this method, a 1.2-mm blood disc was punched from each blood spot and was transferred
into a 0.2 mL PCR tube. 200 µL of 20 mM NaOH solution was added to the tube and it was
incubated for 30 min at room temperature. The solution was then discarded, and the disc was
equilibrated in 200 µL of 1 × TE buffer (10 mM Tris-HCl, 0.1 mM EDTA, pH 8.0). After
removal of the TE buffer, the disk was air-dried, prior to use in PCR.
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3.1.4 PCR primer design and synthesis
Two PCR primers, 5’-CTCACACCCTGCCTGTC-3’ and 5’-
CACACTGACCTCTGGCTC -3’, were designed to amplify intron 2-exon 3 of the ovine
IGF1R gene. These were designed based on human and bovine IGF1R sequences (GenBank
accession number AY332722, Ensembl transcript ID ENSBTAT00000028690, respectively)
(Figure 3.5). The primers were synthesised by Integrated DNA Technologies (Coralville, IA,
USA).
Figure 3.5. Location of the IGF1R primers used in this study.
3.1.5 Polymerase Chain Reaction-Single-Strand Conformational
Polymorphism (PCR-SSCP) analysis
Amplification was performed in a 20 µL reaction containing the genomic DNA on one
1.2-mm punch of FTA paper, 0.25 µM of each primer, 150 µM of dNTPs (Eppendorf,
Hamburg, Germany), 1.5 mM of Mg2+, 0.5 U of Taq DNA polymerase and 1 × reaction buffer
supplied. Amplification was carried out in an iCycler (Bio-Rad Laboratories, Hercules, CA,
USA) and consisted of denaturation at 94 ºC for 2 min, followed by 35 cycles of 94 ºC for 30
s, 62 ºC for 30 s, and 72 ºC for 30 s, with a final extension step at 72 ºC for 5 min.
Amplicons were mixed with 7 µL of loading dye (98% formamide, 10 mM EDTA,
0.025% bromophenol blue, 0.025% xylene-cyanol), and after denaturation at 95 ºC for 5 min,
samples were rapidly cooled on wet ice and then loaded on 16 cm × 18 cm, 12%
acrylamide:bisacrylamide (37.5:1: Bio-Rad) gels with the addition of 3 % glycerol.
Electrophoresis was performed using Protean II xi cells (Bio-Rad), at 280 V for 18 h at 28 ºC
in 0.5 × TBE buffer. The gels were silver-stained according to the method of Sanguinetti et al.
(1994). Genomic DNA representative of the unique SSCP patterns was amplified using Pwo
SuperYield DNA polymerase (Roche Applied Science, Mannheim, Germany) and amplicons
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were ligated into the pCR4Blunt-TOPO vector (Invitrogen, Carlsbad, CA). Only those
plasmids for which the insert PCR-SSCP patterns matched with the genomic DNA template
patterns were sequenced in both forward and reverse directions.
3.1.6 DNA sequencing and analysis of sequence diversity
Amplicons representing unique banding patterns were sequenced at Lincoln University,
New Zealand. Sequence alignments, translations, phylogenetic tree, creation and comparisons
were carried out using DNASTAR (Madison, WI, USA) and DNAMAN (Version 5.2.10,
Lynnon BioSoft, Vaudreuil, Canada). The BLAST algorithm was used to search the NCBI
GenBank (http://www.ncbi.nlm.nih.gov/) and Ensembl (http://www.ensembl.org) databases
for homologous sequences of IGF1R in different species.
3.1.7 Genotyping of ovine IGF1R for longevity and fecundity trait analysis
A total of 1718 sheep were genotyped using the PCR-SSCP, conditions described
above. These sheep were ewes of the NZ Romney (n = 340), Corriedale (n = 318), Merino (n
= 322), Polwarth (n = 127), Kelso (n = 174) and Coopworth (n = 437) breeds from 36 flocks.
Overall there were nine hundred and fifty one older ewes and seven hundred and sixty-seven
young ewes (2 years old). Lambing information was available for six hundred and fifty-three
of the older ewes for assessing their fecundity.
3.1.8 Statistical analyses
Data were analysed using SPSS version 17 (SPSS Science Inc., Chicago, IL, USA) at a
significance level of α = 0.05.
Unadjusted analyses exploring the relationship between IGF1R sequences and longevity
and fecundity were undertaken using one-way analysis of variance. General linear mixed
effects models (GLMMs) were used to assess the effect of the presence of each of the IGF1R
sequences on longevity and fecundity. Sheep breed and flock were fitted as random factors in
the model to accommodate variation from farm to farm in flock management, breeding ewe
culling and replacement ewe selection. GLMMs were also used to explore the effects of the
more common IGF1R genotypes (frequency ≥ 10%) on longevity and fecundity. Where
significant or if tending towards significance these were further explored using pairwise
comparisons (least significant difference).
Pearson Chi-square analysis was used to ascertain whether or not IGF1R genotype
frequencies differed between older and younger ewes.
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AA BB AB BC AC CC
3.2 Results
3.2.1 Polymorphism of the ovine IGF1R
Amplicons of 346 bp were obtained with all the sheep DNA samples amplified. Upon
SSCP analysis, three distinct banding patterns were detected (Figure 3.6). Either one or two of
these patterns were observed for each sheep studied, which defines homozygous and
heterozygous genotypes of ovine IGF1R, respectively.
Cloning of PCR amplicons representative of the unique SSCP patterns followed by
DNA sequencing, revealed three different DNA sequences (Figure 3.7). All these sequences
shared high homology to the reported human sequence (GenBank accession number
AY332722) and sequences from other species, suggesting that they represent genuine ovine
IGF1R sequences. The IGF1R sequences were named A, B, and C and deposited into the
NCBI GenBank with the accession numbers EF669473-EF669475.
Figure 3.6. PCR-single-strand conformational polymorphism of the ovine IGF1R.
Representative sheep for the three unique SSCP patterns, corresponding to genotype-
combinations of three unique sequences (A, B and C) are shown
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Ovine IGF1R - A acaccctgcctgtccccacag TGTGTCCCAGCGCGTG
Ovine IGF1R - B ------------------g-----------------------------------------
Ovine IGF1R - C -------------------------------------------------------A---
Figure 3.7. Sequence variation in a selected region of intron 2 and exon 3 of the ovine
IGF1R. Bars represent nucleotides identical to the nucleotides of A sequence. Lower case and
upper case letters refers to intron 2 and exon 3, respectively. The arrow shows the first
nucleotide of exon 3 of ovine IGF1R, based on the human sequence (GenBank accession
number AY332722)
3.2.2 An association between sheep longevity and variation in ovine IGF1R
Table 3.2 shows the genotype frequencies for the three sequences of IGF1R. The
frequencies of each sequence in the sheep studied are shown in table 3.2. These frequencies
were compared between the older ewes and the two year old replacement ewes. Chi-square
test analysis suggested that there was a significant difference between them (P = 0.009).
Table 3.2. IGF1R genotype frequencies in older (3-16 years) and younger (2 years) ewe
groups.
In an analysis of all of the ewes (n = 1718), the IGF1R C sequence was associated with
sheep age across breeds and flocks (Table 3.3). When correcting for breed, the presence of
IGF1R C increased age by about half a year, with ewes that possess IGF1R C having a mean
age of 6.08 ± 0.20, whereas ewes that did not possess the sequence had a mean age of 5.52 ±
0.09 (P = 0.009). When correcting for flock, there was also a significant increase in age, for
the ewes carrying IGF1R C (P = 0.024). When the C sequence was present and absent, ewes
had mean of ages of 5.52 ± 0.21 and 5.02 ± 0.08 years, respectively (Table 3.3).
Genotype
AA AB AC BB BC CC Total (n)
Older
ewes
695
72.5%
90
9.4%
140
14.6%
2
0.2%
9
0.9%
15
1.6%
951
Younger
ewes
597
77.7%
78
10.2%
73
9.5%
6
0.8%
4
0.5%
9
1.2%
767
-7 14
Exon 3
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To assess the effect of IGF1R genotype on longevity, only the common genotypes AA, 
AB and AC were included (Table 3.4) as genotypes BB (n = 8), BC (n = 13) and CC (n = 23)
were rare. The GLMMs suggested an association, although not significant (P = 0.064)
between age and genotype. A pairwise comparison revealed the difference to be between AA
(5.0 ± 0.09 years) and AC (5.6 ± 0.22 years, P = 0.019) (Table 3.4).
The presence or absence of particular IGF1R sequences and IGF1R genotype GLMMs was
not found to have any effect on the fecundity in the unadjusted or adjusted models (Table
3.5).
Table 3.3. Association of the ovine IGF1R variants with variation in longevity.
Table 3.4. Association of the ovine IGF1R genotype with variation in longevity.
Sequence status n Age
(unadjusted means)
Breed
adjusted
Flock
adjusted
A
 
Present
Absent
1673
45
5.34 ± 0.12
5.67 ± 0.70
(P = 0.513)
5.61 ± 0.08
5.41 ± 0.46
(P = 0.664)
5.09 ± 0.08
4.98 ± 0.46
(P = 0.808)
B
 
Present
Absent
189
1529
5.30 ± 0.35
5.36 ± 0.13
(P = 0.806)
5.51 ± 0.23
5.62 ± 0.09
(P = 0.653)
5.60 ± 0.23
5.09 ± 0.08
(P = 0.894)
C
 
Present
Absent
250
1468
6.23 ± 0.31
5.20 ± 0.13
(P ≤ 0.001)
6.08 ± 0.20
5.52 ± 0.09
(P = 0.009)
5.52 ± 0.21
5.02 ± 0.08
(P = 0.024)
Genotype n Unadjusted model Flock adjusted model
AA 1292 5.2 ± 0.09a 5.0 ± 0.09a
AB 168 5.3 ± 0.25a 5.1 ± 0.25ab 
AC 212 6.3 ± 0.22b 5.6 ± 0.22b
 (P ≤ 0.001) (P = 0.064)
a,b Different superscripts indicate the pair of means was significantly different (p < 0.05) in pairwise
comparisons (least significant difference).
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Table 3.5. Association of the ovine IGF1R sequences with variation in fecundity.
3.3 Discussion
Mammalian IGF1R is an evolutionarily conserved key regulator of the insulin-like
signalling pathway and has been reported to influence metabolism and life-span in a variety of
species (Barbieri et al., 2003; Richardson et al., 2004; Sepp-Lorenzino, 1998). However, this
is the first report of an association between variation in this receptor and variation in life-span
in sheep. This finding is consistent with reports in other species.
Three novel sequences (A, B and C) of IGF1R were identified in fragment of 346bp,
which encodes part of intron 2 and exon 3 of this gene. The A and B sequences were
differentiated by variation in intron 2 and the C sequence was identified by a synonymous
substitution (bovine cDNA position at 211 G>A), which is located in exon 3.
In this study, the presence of the C sequence of ovine IGF1R was associated with ewe
longevity. While this synonymous substitution does not result in an amino acid change, it may
never-the-less be linked to other nucleotide changes in the coding regions, or to sequence
variation elsewhere in the gene. This may affect gene expression and/or the function of
IGF1R and hence affect sheep longevity.
Biochemical analyses and mutational studies have revealed that exon 3 of IGF1R,
which encodes a cysteine rich region, is very sensitive to genetic mutation (Adams et al.,
Sequence status n Average lambs/year
(Unadjusted means)
P values
A
 
Present
Absent
638
15
1.77 ± 0.19
1.77 ± 1.12
Unadjusted       P = 0.985
Breed adjusted P = 0.967
Flock adjusted P = 0.835
B
 
Present
Absent
73
580
1.83 ± 0.56
1.76 ± 0.20
Unadjusted       P = 0.275
Breed adjusted P = 0.565
Flock adjusted P = 0. 095
C
 
Present
Absent
103
550
1.83 ± 0.47
1.76 ± 0.21
Unadjusted       P = 0.157
Breed adjusted P = 0.125
Flock adjusted P = 0.535
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2000; Denley et al., 2005). While we detected no changes in the likely amino acids derived
from sequences A, B and C, the synonymous variation seen in C may affect mRNA
processing or stability, thereby changing gene expression and accordingly the IGF1 signalling
pathway. This would need to be investigated in a series of functional studies that focused on
either IGF1R mRNA levels or surface expression of the receptor. Neither would be
straightforward given the likely presence of the other chromosomal transcript of IGF1R.
Breeding sheep for homozygosity of the C sequence would facilitate this investigation.
It is interesting to speculate why the variation reported here in IGF1R occurs and/or
persists in the population of sheep studied. These sheep were selected for analysis and hence a
population-based analysis of Hardy-Weinberg equilibrium would be inappropriate. However,
the results suggest that despite C being more commonly found in older ewes, the A variant is
proportionally more common in the younger ewe population. A is also the most common
variant in the ewes studied, suggesting it may confer some advantage for ewes, especially
younger ewes.
According to the “rate of living theory of aging” (Pearl, 1928), reduced metabolic rates
in an animal should result in an increased life-span. That is, an inverse relationship exists
between cellular metabolic rate and life-span. In mammals, the IGF1 signalling pathway has
evolved to regulate metabolism and growth. Indeed, interventions such as dietary restriction
(Masoro, 2005), gene mutation (Kenyon, 2001) and removal of the germ-line stem cells (Hsin
& Kenyon, 1999), reduced the level of IGF1 signalling and are associated with increased life-
span in model organisms. Reduced levels of IGF1 signalling have also been associated with
stunted growth (dwarfism) and reduced adult body size in mammals (de Magalhães &
Faragher, 2008). Therefore, it could be speculated that the C variant identified here is
associated with lower growth rates in sheep, and the A variant is associated with higher
growth rates. This would need to be confirmed by a separate study of growth rate in sheep,
but this would be an anathema to sheep production.
In the genetic association study, longevity data was collected from different breeds that
were derived from 36 farms. Few of the farmers had more than one breed and there is
significant variation in longevity between farms presumably reflecting different management
policies for retaining or culling ewes. These were commercial stud farms and while sheep die
naturally, it is suspected that most sheep on these farms are culled by the farmers annually
and/or on an ongoing basis for a variety of reasons including failure to become pregnant.
Farm-related factors were a major determinant of longevity and hence “farm” needs to be
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incorporated into any statistical analysis of longevity. Given that most farms only have one
breed, then farm and breed are conflicted. Accordingly correcting for both factors in linear
models may create a compounded error.
In this study both breed and farm were corrected for in adjusting longevity data. As a
result, only the C sequence remained significantly associated (P = 0.009, P = 0.024,
respectively) with longevity when breed and farm corrections were included. Given that the
reason for culling sheep out of flocks are diverse and probably inter-related (e.g., combination
of age, lack of fertility and health) it is nevertheless conceivable that factors like variation in
fertility or resistance to disease may also explain the association we have found in this study.
In conclusion, the role of genetic variability at the IGF1R has been hypothesised to be
evolutionarily conserved throughout the animal kingdom (Murphy, 2006). Therefore, the
genetic variation found in ovine IGF1R in this study could be used as a potential way of
improving longevity in livestock, but that is assuming the variation in this gene has no
detrimental effects on sheep production.
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Chapter 4
Identification of variation in ovine FOXO3 and its
association with longevity
 The physiology of FOXO3
In mammals, the transcription factor FOXO3 regulates hormonal, nutrient and stress
responses and affects cell survival and metabolism. The ability to regulate FOXO3 activity is
important to controlling these cellular functions and is dependent on several post-translational
mechanisms, including phosphorylation, acetylation and ubiquitination (Boccitto & Kalb,
2011). These post-translational modifications alter FOXO3’s subcellular localisation and
affect its degradation, DNA-binding ability and transcriptional activity.
As a nuclear transcription factor, the primary function of FOXO3 is to bind to target
DNA sequences as a monomer unit. DNA-binding studies have identified a consensus
FOXO3 recognition element of sequence (G/C)(T/A)AA(C/T)AA (Biggs et al., 1999;
Furuyama et al., 2000). Sequences that resemble this consensus have been identified in the
promoters of many genes (Furuyama et al., 2000).
The best-defined FOXO3 targets include the cell-cycle inhibitors p27 and p21, growth
arrest-and DNA damage-inducible gene 45 (GADD45), the stress response genes for
manganese superoxide dismutase (MnSOD), the pro-apoptotic factor Bcl2-interacting
mediator of cell death (Bim), the Fas ligand and glucose-6-phosphatase (G6Pase) (Greer &
Brunet, 2005) (Figure 4.1). These target genes mediate various cellular processes including
cell-cycle arrest, DNA repair, detoxification of reactive oxygen species (ROS), apoptosis, cell
death and glucose metabolism. Taken together, these processes are crucial in enabling the cell
to respond to environmental stimuli, including the availability of nutrients, changes in energy
supply and other cellular stresses. Collectively, it could be concluded that FOXO3 either
regulates cell survival or of very least is implicitly involved in it.
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Figure 4.1. FOXO3 target genes and cellular roles. FOXO3 is located in the nucleus, where
it induces the transcription of a variety of target genes. BTG-1, B-cell translocation gene 1;
p21, cyclin-dependent kinase inhibitor 1A; p27, cyclin-dependent kinase inhibitor 1B;
MnSOD, manganese superoxide dismutase; G6Pase, glucose-6-phosphatase; PEPCK,
phosphoenolpyruvate carboxykinase; FasL, Fas ligand; GADD45, growth arrest and DNA
damage-inducible protein 45; DDB1 damage-specific DNA-binding protein1; DBE, DAF-16
family member-binding element (adapted from Greer and Brunet, 2005)
FOXO3’s ability to induce cell-cycle arrest and affect DNA repair and apoptosis,
suggests an important role in regulating tumour suppression (Greer & Brunet, 2005). For
example, a loss of FOXO3 function leads to a decreased ability to induce cell-cycle arrest,
which leads to tumour development. The decreased ability to repair damaged DNA, due to the
absence of FOXO3, could also lead to genomic instability. Abnormal cells that would
normally undergo apoptosis may instead survive in the absence of FOXO3, and this would
result in tumourigenesis.
FOXO3 “knockout-mouse” models have also been employed to understand the function
of FOXO3 in tumourigenesis (Johnson et al., 2008). This study revealed that FOXO3 null
mice have over-proliferation of helper T cells, as well as Fas ligand-induced neutrophil
apoptosis. The evidence also suggests that FOXO3 plays a tumour suppressor role in a variety
of cancers (Greer & Brunet, 2005), and that this may promote organismal longevity.
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In C. elegans, a homolog of FOXO3, called DAF-16, is a major mediator of defense
against oxidative stress (Lehtinen et al., 2006; Lin et al., 1997). Study of longevity in C. 
elegans has shown that DAF-16 regulates the detoxification of ROS by up-regulating the
expression of free radical scavenging enzymes, such as MnSOD (Honda & Honda, 1999). It
has also been observed that activation of FOXO3 in cultured fibroblasts and neuronal cells
results in resistance to oxidative stress (Kops et al., 2002). MnSOD is a major component of
cellular defence mechanisms against the toxic effects of superoxide radicals.
Longevity is known to be associated with increased oxidative stress resistance in a
variety of organisms (Beckman & Ames, 1998). The maintenance of highly regulated
mechanisms to control ROS levels is essential for normal cellular homeostasis. ROS such as
superoxide anions and hydrogen peroxide; the by-products of oxidative metabolism, are
involved in many cellular signalling processes (Beckman & Ames, 1998). However, excess
accumulation of ROS can result from defects in ROS scavenging and is believed to have an
impact on cellular aging and the senescence process. Conversely, the ability to withstand
oxidative stress has been correlated with enhanced longevity in several species (Beckman &
Ames, 1998).
FOXO3 appears to play roles in controlling cell-cycle arrest, cell development and
differentiation (Brenkman & Burgering, 2003). These roles are important in follicular
development. A study by Castrillon et al. (2003) has demonstrated that FOXO3 is a crucial
regulator of follicular development in mice. In this work, FOXO3 null mice show a distinctive
ovarian phenotype of global follicular activation leading to oocyte death, early depletion of
functional ovarian follicles, and secondary infertility. These mice also displayed signs of
premature aging. These symptoms resemble those seen in human premature ovarian failure
(POF). This suggests that FOXO3 may regulate fertility in mammals as well as organismal
longevity.
 The regulation of FOXO3 activity
FOXO3 activity is regulated at several levels and involves protein-protein interactions
with cofactors, repressors and adaptors; and various post-translational modifications such as
phosphorylation, acetylation, methylation and ubiquitination (Burgering, 2008; Calnan &
Brunet, 2008; van der Vos & Coffer, 2008). Among these activation mechanisms,
phosphorylation by the PI3K-AKT and AMPK pathways is known to tightly regulate FOXO3
transcriptional activity.
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Phosphorylation by PI3K-AKT controls a shuttling system that modulates FOXO3
cellular localisation and this confines FOXO3 to either the nucleus or the cytoplasm (van der
Heide et al., 2004) (see Figure 4.2).
Figure 4.2. Regulation of FOXO3 by the IGF1 pathway. IGF1: insulin-like growth factor
1; IGF1R: IGF1 receptor; PI3K: phosphoinositide 3-kinase; PIP3: phosphatidylinositol
(3,4,5)-trisphosphate; protein kinase B (PKB/AKT). FOXO3 mediates a transcriptional
response to insulin signalling. Under conditions of abundant nutrients, FOXO3 is retained in
an inactive state in the cytoplasm due to phosphorylation by AKT. When insulin levels fall,
FOXO3 is dephosphorylated and translocated into the nucleus, where it stimulates
transcription of other negative regulators of growth. In addition, activated FOXO3 increases
expression of the insulin receptor gene, which may result in increased insulin sensitivity under
low insulin conditions (adapted from Van Der Heide et al., 2004)
Regulation of FOXO3 requires activation of PI3K-AKT in response to cellular
stimulation by the growth factors IGF, IGF2 and insulin. Binding of the growth factors or
insulin to their receptors, triggers the recruitment and activation of PI3K, which in turn
activates AKT. Upon stimulation with high levels of IGF1, IGF2 or insulin, three sites on the
FOXO3 molecule (Thr32, Ser253, and Ser315 for human FOXO3, see also Figure 4.3 (c)) are
phosphorylated by the AKT pathway to inactivate the protein. PI3K-AKT induced
phosphorylation of FOXO3 generates binding sites for 14-3-3 proteins. Once phosphorylated,
FOXO3 binds to these 14-3-3 proteins in the nucleus immediately before it relocalises to the
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cytoplasm (Brownawell et al., 2001; Rena et al., 2001). The 14-3-3 proteins mask the nuclear
localisation signal (NLS) of FOXO3 to prevent nuclear translocation and serve as chaperone
molecules to escort FOXO3 from the nucleus to the cytoplasm, where it is degraded via an
ubiquitin-mediated process (Brunet et al., 1999; Brunet et al., 2001).
Low levels of the growth factors and insulin or oxidative stress, causes FOXO3 to
become dephosphorylated and activated. The activated FOXO3 translocates to the nucleus
where it acts to regulate the transcription of target genes (Murphy et al., 2003).
In the AMPK pathway, AMPK phosphorylation of FOXO3 is required to counteract the
effects of nutrient deprivation and to induce stress resistance; a cellular function that is
coupled with organismal longevity (Canto et al., 2009). The overall effect of AMPK
activation is to switch off energy-consuming pathways and switch on energy-producing
pathways. Greer et al. (2007) have shown that AMPK directly phosphorylates FOXO3 at six
regulatory sites in vitro (Thr179, Ser399, Ser413, Ser555, Ser588, Ser626) (Figure 4.3 (c))
and at least two sites in cells (Ser413 and Ser588). In contrast with AKT phosphorylation,
AMPK phosphorylation does not cause nuclear exclusion of FOXO3, but instead its
activation (Greer et al., 2007). The exact mechanisms involved remain unclear, but it has been
hypothesised that with five of the six phosphorylation sites being within the transactivation
domain, this might make this domain more acidic, thereby increasing its transcriptional
activation potential.
A genome-wide microarray analysis has shown that mutation of AMPK
phosphorylation sites in FOXO3 specifically impairs the expression of a subset of target
genes, including oxidative stress resistance and energy metabolism genes (Greer et al., 2007).
This supports the contention that AMPK phosphorylation of FOXO3 appears to enhance the
ability of transcription activity to up-regulate the expression of specific target genes.
Therefore, the regulation of FOXO3 by AMPK may play a critical role in fine-tuning gene
expression that controls energy balance and stress resistance in cells throughout their life.
 The structure of the FOXO3 gene (FOXO3)
The FOX family is characterised by having a conserved DNA-binding domain termed
the “Forkhead” box (FOX) (Carlsson & Mahlapuu, 2002). Since the discovery of the first
member of the family, the Drosophila Forkhead gene (daf-16); around 100 homologoues
have been identified in species ranging from yeast to human (Carlsson & Mahlapuu, 2002;
Gajiwala & Burley, 2000). FOX genes have recently been divided into 19 sub-families
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(FOXA to FOXS) according to the amino acid sequences of their DNA-binding domains
(Obsil & Obsilova, 2000).
In mammals, the FOXO sub-family contain four members: FOXO1 (FKHR), FOXO3
(FKHRL1), FOXO4 (AFX) and FOXO6. FOXO3 is the most abundant and most studied of
the mammalian FOXO proteins. It is expressed in almost all cells and highly expressed in the
heart, spleen, lung, kidney, ovary, adipose tissue and brain (Zhu et al., 2004).
The FOXO3 gene (FOXO3) typically consists of four exons and these produce a protein
of a 673 amino acids (M. J. Anderson et al., 1998). From the N-terminus to the C-terminus,
FOXO3 contains a proline-rich domain, a forkhead (FH) domain, a nuclear localisation signal
(NLS), a nuclear export signal (NES), an LxxLL motif and a transactivation domain (Figure
4.3 (c)). The proline-rich motif binds to the CH3 region of co-activators such as the CREB
binding protein-p300 and stabilizes the interaction between FOXO3 and the co-activators (van
der Heide & Smidt, 2005) .
The FH domain is composed of three major α-helices (H1-3), two large unstructured
wings (W1, W2), and three β-strands (S1-3) (Figure 4.3 (a)) (F. Wang et al., 2008). The FH
domain is specifically responsible for binding to the promoter region of target genes. The
central region of FOXO3 includes the NLS and NES domains and accounts for the cellular
localisation of FOXO3. The LxxLL motif is reported to bind to sirtuin (SIRT) and has an
important role in regulating its transcriptional activity (Nakae et al., 2006). SIRT is a
multifaceted enzyme that regulates a variety of cellular functions, from controlling gene
expression and genome maintenance, to longevity and metabolism (Jiang, 2008; Pallás et al.,
2008; D. Taylor et al., 2008). The C-terminus of FOXO3 contains the transactivation domain,
which plays several important roles in DNA binding (Tsai et al., 2007).
The domain-like structure of FOXO3 suggests its activity is tightly regulated at
different levels, including its intracellular translocation and transcriptional activity.
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Figure 4.3. NMR structure and domain structure of FOXO3. (a) The secondary structure
of the Forkhead (FH) domain derived from the NMR structure of the FH domain of FOXO3
(cylinders, α-helices; arrows, β-strands; lines, 1oops) is shown. (b) The domain-like structure
of FOXO3 is shown with the well-folded FH domain and three other conserved regions, CR1-
CR3, indicated. (c) The functional domain structure of FOXO3. The three amino acid residues
that can be phosphoylated by PI3K-AKT (T32, S253 and S315) are indicated in red. The six
AMPK amino acid residues are coloured blue; FH=Forkhead domain; X=any amino acid;
NLS=nuclear localisaiton signal; NES=nuclear export signal (based on F.Wang et al., 2008)
 Conservation of FOXO3 structure
To date, the evolutionary conservation of FOXO genes (FOXO1, FOXO3, FOXO4 and
FOXO6) has been revealed across a diversity of species (M. Wang et al., 2009). Figure 4.4 is
a phylogenetic tree based on the full-length coding sequences of FOXO genes from Xenopus,
zebrafish, rodents, cows and humans (Figure 4.4). They all contain a forkhead domain (FH),
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NLS and NES. They also share conserved post-translational modification sites. However, the
physiological roles of the various FOXO proteins seem functionally diverse (Arden, 2008).
In C. elegans and D. melanogaster, the only FOXO transcription factor is encoded by
DAF-16. A role for DAF-16 in promoting longevity has been established (Kenyon, 2005).
The daf-16 gene is most similar to mammalian FOXO3 with the amino-acid sequences of
DAF-16 and human FOXO3 being 27% identical over the full protein length and 82%
identical within the forkhead DNA-binding domain (Jünger et al., 2003). Furthermore, Table
4.1 shows the amino acid sequence of FOXO3 is about 95% identical within mammals. This
suggests that FOXO3 is highly conserved within mammalian species including sheep.
Figure 4.4. Phylogenetic tree of FOXOs from various species. The phylogenetic tree was
constructed by the neighbour-joining method, using the multiple alignment algorithms in the
MegAlign package (DNAStar Inc., Madison, WI, USA). The full-length nucleotide sequences
of mRNA FOXO3 were extracted from GenBank and Ensembl genome browsers (FOXO1:
NP_002006.2 (Homo sapiens) for human; XM_002691748.1 (Bos taurus) for cow;
CH466530.1 (Mus musculus) for mouse; NM_001191846.1 (Rattus norvegicus) for rat;
NP_001086417.1 for Xenopus laevis; NP_001070725.2 for Zebra fish, FOXO3:
NP_963853.1 (Homo sapiens) for human; gi|296484163 (Bos taurus) for cow; NP_062714.1
(Mus musculus) for mouse; NP_001099865.1(Rattus norvegicus) for rat; AAI70411.1 for
Xenopus laevis; NP_571160.1 for Zebra fish, FOXO4: NP_005929.2 (Homo sapiens) for
human; GJ063417.1 (Bos taurus) for cow; AL671926.11 (Mus musculus) for mouse;
NP_001100413.1 (Rattus norvegicus) for rat; FJ811896.1 for Xenopus laevis;
ENSDART00000078187 for Zebra fish, FOXO6: NP_002006.2 (Homo sapiens) for human;
ENSBTAT00000033274 (Bos taurus) for cow; AAH86628.1 (Mus musculus) for mouse;
Chapter 4: Identification of variation in ovine FOXO3 and its association with longevity
72
ENSRNOT00000050941 (Rattus norvegicus) for rat; NP_001152754.1 for Xenopus laevis;
ENSDARP00000103866 for Zebrafish)
Table 4.1. Amino acid sequence identity for FOXO3 from various species.
( %) 
Identity 
Human Cow Mouse Rat Xenopus Zebrafish 
Human 100
Cow 96.4 100
Mouse 94.8 94.2 100
Rat 94.6 94.2 97.8 100
Xenopus 71.2 70.9 70.6 70.4 100
Zebrafish 55.8 57.5 55.8 56.7 56.4 100
 FOXO3 variation and variation in longevity and fertility
Although studies in C.elegans and D. melanogaster point to there being a key role for
FOXO3 in controlling life-span in these organisms (Partridge & Bruning, 2008), the role of
the protein in mammalian aging has not yet been established. In humans, variant forms of
FOXO3 have been linked to longevity in seven populations located within different countries
(Kuningas et al., 2006). For example, Willcox et al. (2008) first identified that FOXO3 SNPs
(rs2764264, rs13217795 and rs2802292) were strongly associated with longevity in long-
lived (e.g., aged 95 and above) Americans of Japanese origin.
Flachsbart et al. (2009) confirmed this association using a large German population.
They also genotyped 16 other polymorphisms of FOXO3 and identified four SNPs
(rs6911407, rs9400239, rs3800231 and rs479744) that were associated with longevity in all
the German samples. FOXO3 variation has also been linked to longevity in centenarians from
southern Italian (Anselmi et al., 2009), Caucasians (Pawlikowska et al., 2009) and the Han
Chinese (Y. Li et al., 2009).
Studies of animal models suggest FOXO3 has an evolutionarily conserved role in
determining longevity (Fetterman et al., 2008). This would suggest that variation in FOXO3
may influence longevity in sheep. In mice, variation in FOXO3 has been implicated in the
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effects of insulin on glucose metabolism, as well as on age-dependent female infertility
(Castrillon et al., 2003; Hosaka et al., 2004). FOXO3 mutant mice exhibit defects in glucose
uptake (Castrillon et al., 2003), which may lead to age-related diseases such as diabetes and
hypertension. Interestingly, FOXO3-null mice suffer from cell death in several cell types,
especially ovarian follicles. These mice models have been shown to have accelerated
premature ovarian failure (POF), suggesting that FOXO3 regulates follicular development.
Several mutations within human FOXO3 have been noted in women with POF (Gallardo et
al., 2008; B. Wang et al., 2010; Watkins et al., 2006). These findings raised the possibility
that mutations or naturally occurring variation in FOXO3 might contribute to POF in other
mammals and once again including sheep.
There are few studies on FOXO3 variation in any livestock species, or whether this
variation is associated with longevity and fertility. In this chapter, as no sequence information
is available for sheep, sequences of the ovine FOXO3 were firstly identified. For the genetic
association study, the entire exon 2 of this gene was used to investigate genetic variation in
sheep longevity. The second exon of FOXO3 encodes part of the FH, CR2 and CR3 domains,
including the DNA-binding sites and is a region where DNA sequences are highly conserved
across species. If variation exists in this region of ovine FOXO3, then it might be useful for
subsequent genetic studies into longevity and fecundity in sheep.
4.1 Materials and Methods
4.1.1 Sheep investigated to define variation in FOXO3
The whole coding sequence of ovine FOXO3 and genetic variation in exon 2 of this
gene were initially investigated in 182 New Zealand cross-bred sheep. Blood samples were
collected from these animals onto FTA cards (Whatman BioScience, Middlesex, UK).
4.1.2 Sheep studied for longevity and fecundity analysis
Sheep blood samples along with longevity and fecundity data as described previously,
were used (See chapter 2.2) to assess the effect of variation in FOXO3 on sheep longevity and
fecundity.
4.1.3 DNA extraction from blood on FTA cards
(See chapter 3.1.3)
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4.1.4 PCR primer design and PCR-SSCP analysis
Six sets of PCR primers (Table 4.2) were designed based on the bovine FOXO3
sequences (GenBank Accession No. XM_615634) to amplify the entire coding region of
ovine FOXO3. These were synthesised by proligo (Boulder, CO. USA).
Table 4.2. Primers and annealing temperatures for ovine FOXO3 amplification.
Primer pairs Primer sequence (5’-3’) Primer location
(nucleotide no.)a
Size
(bp)b (˚C)c
Exon 1
Amplicon 1-up
Amplicon 1-dn
GCGAAGATGGCAGAGGCGC
CCTCCAGGAGCCAGCAGC
1-311 311 63
Exon 1
Amplicon 2-up
Amplicon 2-dn
GCTCTGGGTTGCTCCTGG
GCACCTTCCAGCAGGCAG
263-622 360 63
Exon 2
Amplicon 1-up
Amplicon 1-dn
AACTCTATCCGGCACAACC
GCCAGGATGGGGGACAG
619-983 365 62
Exon 2
Amplicon 2-up
Amplicon 2-dn
AACGCCAGCACAGTCAGC
CTTGTTCTCTTGGATGGTCT
943-1362 420 64
Exon 2
Amplicon 3-up
Amplicon 3-dn
GACCGTCGTCTCTGAACTC
TTGGCTGACCCGAGGCTG
1304-1703 400 63
Exon 2
Amplicon 4-up
Amplicon 4-dn
CATGGGCTTGAGCGACTC
TCCCCTTTCCTCAGTGAGC
1665-2040 376 63
FOXO3-up
FOXO3-dn
(Genotyping
PCR set)
AGAGCTTATGGTGGATCATC
GGTCGTCCATGAGGTTGTC
686-1165 480 62
a Nucleotide position is relative to the bovine FOXO3 reference sequence (GenBank
Accession No. XM_615634). b Expected amplicon size. c An annealing temperature for PCR.
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Amplification was performed in a 20 µL reaction containing the washed genomic DNA
on one 1.2-mm punch of FTA paper, 0.25 µM of each primer, 150 µM dNTPs (Eppendorf,
Hamburg, Germany), 1.5 mM of MgCl2, 0.5 U of Taq DNA polymerase (Qiagen, Hilden,
Germany) and 1 × reaction buffer supplied. Amplification was carried out in an iCycler (Bio-
Rad Laboratories, Hercules, CA, USA) and consisted of denaturation at 94 ºC for 2 min,
followed by 35 cycles of 94 ºC for 30 s, the optimized annealing temperature for any given
primer pair (Table 4.2) for 30 s, and 72 ºC for 30 s, with a final extension step at 72 ºC for 5
min. Amplicons were visualised by electrophoresis in 1% agarose (Quantum Scientific,
Queensland, Australia) gels, using 1× TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM
Na2EDTA) containing 200 ng of ethidium bromide/mL.
A 0.7 µL aliquot of each amplicons was mixed with 7 µL of loading dye (98%
formamide, 10 mM EDTA, 0.025% bromophenol blue, 0.025% xylene-cyanol), and after
denaturation at 95 ºC for 5 min, samples were rapidly cooled on wet ice and then loaded on to
16 cm × 18 cm, 12% acrylamide:bisacrylamide (37.5:1: Bio-Rad) gels. Electrophoresis was
performed using Protean II xi cells (Bio-Rad), at 200 V for 18 h at 25 ºC in 0.5 × TBE buffer.
Gels were silver-stained according to the method of Byun et al. (2009).
4.1.5 Cloning of regions covering the FOXO3 coding sequence
Sheep DNA samples that produced different SSCP patterns were selected for
amplification using the proof-reading enzyme Pwo SuperYield DNA polymerase (Roche
Applied Science, Mannheim, Germany) and using the conditions described previously.
Amplicons were ligated into the pCR4Blunt-TOPO vector (Invitrogen, Carlsbad, CA), and a 2
µL aliquot of the ligation mixture was used to transform competent Escherichia coli cells
(One Shot INVαF′, Invitrogen), following the manufacturer’s instructions. Ten insert positive
white colonies for each transformation were picked and incubated overnight in Terrific broth
(Invitrogen) at 37 ºC, in a shaking rotary incubator (225 rpm). Plasmid DNA was recovered
from bacterial cells by boiling for 10 min in 0.8% (vol/vol) Triton X-100, followed by
centrifugation at 12,000 × g. A 1 µL aliquot of the supernatant was used as a template for
PCR amplification using Taq DNA polymerase (Qiagen). Amplicons from these clones and
the corresponding genomic DNA were run adjacent to each other on SSCP gels for
comparison of the SSCP patterns, and only those clones for which the SSCP patterns matched
those of the corresponding original genomic DNA sample were selected for subsequent DNA
sequencing.
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4.1.6 DNA sequencing and sequence analysis
Plasmid DNA was extracted from overnight cultures using a QIAprep Spin Miniprep
Kit (Qiagen) and was sequenced in both directions using the M13-forward and reverse
primers. Identical sequences obtained from at least three separate clones from sheep were
sequenced at Lincoln University, New Zealand.
Sequence alignments, translations, phylogenetic tree, analyses and other comparisons
were carried out using DNASTAR (Madison, WI, USA) and DNAMAN (Version 5.2.10,
Lynnon BioSoft, Vaudreuil, Canada). The BLAST algorithm was used to search the NCBI
GenBank (http://www.ncbi.nlm.nih.gov/) and Ensembl (http://www.ensembl.org) databases
for homologous sequences to those that were amplified.
4.1.7 FOXO3 haplotype determination
As the exon 2 region of FOXO3 encodes part of FH and the transactivation domain,
(including the DNA-binding sites and other conserved regions), only this exon was screened
to identify if genetic variation exists and whether that genetic variation is associated with
variation in longevity.
To characterise the entire exon 2 region of ovine FOXO3, four fragments were
amplified using four separate sets of PCR primers (Table 4.2). Haplotypes were determined
by screening to find sheep homozygous for any one of the given amplicons, and then by
analysing those same sheep at the other amplicons to ascertain what sequence variation
extended through that region.
4.1.8 Genotyping of ovine FOXO3 for longevity and fecundity trait analysis
For the association study, a different genotyping primer set (table 4.2, FOXO3-up and
FOXO3-dn) was designed subsequently based on the seven haplotypes of ovine FOXO3 that
were identified initially. Sheep DNA samples were amplified using the new primer set and
amplicons were subject to PCR-SSCP analysis in 12% acrylamide:bisacrylamide (37.5:1:
Bio-Rad) gels at 200 V for 18 h at 25 ºC in 0.5 × TBE buffer.
The genetic association study was carried out on 1732 ewes from seven breeds
including NZ Romney (n = 324), Corriedale (n = 316), Merino (n = 314), Polwarth (n = 107),
Kelso (n = 171), Texel (n = 40) and Coopworth (n = 460) selected from 37 different flocks.
Overall, there were nine hundred and sixty-three older ewes and seven hundred and sixty-nine
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young ewes (2 years old). Lambing information was available for six hundred and thirty-one
of the older ewes.
4.1.9 Statistical analyses
Data was analysed using SPSS version 17 (SPSS Science Inc., Chicago, IL, USA), with
a two-tailed significance level of α = 0.05.
Unadjusted analyses exploring the relationship between FOXO3 haplotypes (A to G)
and longevity were undertaken using a one-way analysis of variance (ANOVA). Any
haplotypes showing significant associations with longevity from these analyses were then
further analysed using a general linear mixed model (GLMM) to assess whether the effects of
each of the FOXO3 haplotypes on longevity, persisted when breed and farm effects were
entered into the models.
4.2 Results
4.2.1 Identification of the coding sequence of ovine FOXO3
Using six sets of primers designed based on exon 1 and 2 of bovine FOXO3 (Table 4.2),
six overlapping DNA fragments were amplified and sequenced. Two of these fragments
produced a 618 bp sequence covering all of exon 1, while four produced a 1400 bp sequence
for exon 2. These sequences were assembled to produce a 2019 bp fragment using the bovine
sequence as a template for assembly and the fragment deposited into the NCBI GenBank with
the accession number JQ 894783. The construct covered the whole coding sequence of ovine
FOXO3. Figure 4.5 shows the entire coding sequence of ovine FOXO3 (JQ 894783) and the
putative amino acid sequence that it would produce.
The putative amino acid sequence derived for ovine FOXO3 was aligned with amino
acid sequences from cattle (GenBank Accession No. NP_001193012), human (GenBank
Accession No. NP_001446) and Xenopus laevis (GenBank Accession No. NP_001086418)
(Figure 4.6). The alignment revealed that this gene is conserved across species.
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1     ATGGCAGAGGCGCCGGCCTCCCCGGCCCCGATCTCTCCGCTGGAAGTGGAGCTGGACCCGGAGTTCGAGCCCCAG                                            
1      M  A  E  A  P  A  S  P  A  P  I  S  P  L  E  V  E  L  D  P  E  F  E  P  Q  
 
 
76    AGCCGGCCGCGCTCCTGTACGTGGCCCCTGCAGAGGCCGGAGCTCCAGGGGAGCCCGGCCAAGCCCTCTGGGGAG     
26     S  R  P  R  S  C  T  W  P  L  Q  R  P  E  L  Q  G  S  P  A  K  P  S  G  E   
 
 
151   GCGGCTGCTGACTCCATGATCCCCGAGGAGGAGGACGATGAAGACGACGAGGACGGTGGCGGTAGGGCCGGCTCG     
51     A  A  A  D  S  M  I  P  E  E  E  D  D  E  D  D  E  D  G  G  G  R  A  G  S   
 
 
226   GCCATGGCGATCGGCGGCGGCGGGGGCGGCCCGCTGGGCTCTGGGTTACTCCTGGAGGACTCGGCCCGGCTCTTG     
76     A  M  A  I  G  G  G  G  G  G  P  L  G  S  G  L  L  L  E  D  S  A  R  L  L   
 
 
301   GCTCCTGGAGGGCAGGACCCCGGGTCCGGGCCAGCCCCCGCGGCGGGCGCGCTGAGCGGGGGAACGCAGACACCG    
101    A  P  G  G  Q  D  P  G  S  G  P  A  P  A  A  G  A  L  S  G  G  T  Q  T  P   
 
 
376   CTGCAGCCTCAGCAGCCACTGCCACCGCCGCAGCCGGGGACGGCTGGGGGCTCCGGGCAGCCGAGGAAATGCTCG     
126    L  Q  P  Q  Q  P  L  P  P  P  Q  P  G  T  A  G  G  S  G  Q  P  R  K  C  S   
 
 
451   TCGCGGAGGAACGCCTGGGGGAACCTGTCCTACGCCGACCTGATCACTCGCGCGATCGAGAGTTCCCCAGACAAA     
151    S  R  R  N  A  W  G  N  L  S  Y  A  D  L  I  T  R  A  I  E  S  S  P  D  K   
 
 
526   CGGCTCACTCTGTCCCAGATCTATGAGTGGATGGTGCGCTGCGTGCCCTACTTCAAGGATAAGGGCGACAGCAAC      
176    R  L  T  L  S  Q  I  Y  E  W  M  V  R  C  V  P  Y  F  K  D  K  G  D  S  N   
 
                  
601   AGCTCTGCCGGCTGGAAGGAACTCTATCCGGCACAACCTGTCACTGCACAGCCATTCATGCGGGTCCAGAATGAG     
201    S  S  A  G  W  K  E  L  Y  P  A  Q  P  V  T  A  Q  P  F  M  R  V  Q  N  E   
 
 
676   GGGACCGGCAAGAGCTCATGGTGGATCATCAACCCGGATGGCGGGAAGAGTGGCAAGGCACCCCGGCGGCGGGCC     
226    G  T  G  K  S  S  W  W  I  I  N  P  D  G  G  K  S  G  K  A  P  R  R  R  A   
 
 
751   GTTTCCATGGACAACAGCAACAAGTACACCAAGAGCCGCGGCCGTGCCGCCAAGAAGAAGGCAGCCCTGCAGACC     
251    V  S  M  D  N  S  N  K  Y  T  K  S  R  G  R  A  A  K  K  K  A  A  L  Q  T   
 
 
826   GCCCCCGAATCAGCAGACGACAGTCCCTCCCAGCTCTCCAAGTGGCCCGGCAGCCCCACATCCCGCAGCAGCGAT     
276    A  P  E  S  A  D  D  S  P  S  Q  L  S  K  W  P  G  S  P  T  S  R  S  S  D   
 
 
901   GAGCTGGACGCGTGGACCGACTTCCGCTCACGCACCAATTCCAACGCCAGCACAGTCAGCGGCCGCCTGTCCCCC     
301    E  L  D  A  W  T  D  F  R  S  R  T  N  S  N  A  S  T  V  S  G  R  L  S  P  
 
 
 
976   ATTCTGGCGAGCACAGAGCTGGACGATGTCCAGGACGATGACGCACCACTGTCCCCCATGCTCTATAGCAGCTCG     
326    I  L  A  S  T  E  L  D  D  V  Q  D  D  D  A  P  L  S  P  M  L  Y  S  S  S   
 
 
1051  GCTAGCCTGTCGCCCTCTGTCAGCAAGCCGTGCACTGTGGAGCTGCCCCGGCTGACCGACATGGCGGGCACCATG     
351    A  S  L  S  P  S  V  S  K  P  C  T  V  E  L  P  R  L  T  D  M  A  G  T  M   
 
 
1126  AATCTGAACGATGGGCTGGCCGACAACCTCATGGACGACCTGCTGGACAACATCGCGCTCCCTGCATCCCAGCCA     
376    N  L  N  D  G  L  A  D  N  L  M  D  D  L  L  D  N  I  A  L  P  A  S  Q  P   
 
 
1201  TCGCCCCCGGGGGGGCTCATGCAGCGCAGCTCCAGCTTCCCGTACACCACCAAGGGCTCCGGCCTGGGCTCCCCC     
401    S  P  P  G  G  L  M  Q  R  S  S  S  F  P  Y  T  T  K  G  S  G  L  G  S  P   
 
 
 
Conserved region 1 (CR1), N-terminal PKB motif: involved in14-3-3 protein binding
Amino acid 150-250, Forkhead DNA-biding domain
↓ Exon 2
C-terminal PKB motif: involved in14-3-3 protein binding
Amino acid 236-258, NSL: nuclear localization signal
Amino acid 359-371, NES: nuclear export signal
*P
*P
*P
Amino acid 319-649, Transactivation domainConserved region 2 (CR2)
Conserved region 2 (CR2)
AMPK consensus motif
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1276  ACCAGCTCCTTCAGCAGCGCGGTATTTGGTCCCTCGTCTCTGAACTCCCTGCGCCAGTCTCCCATGCAGACCATC     
426    T  S  S  F  S  S  A  V  F  G  P  S  S  L  N  S  L  R  Q  S  P  M  Q  T  I   
 
 
1351  CAAGAGAACAAGCCAGCCACCTTCTCTTCCATGTCCCATTATGGCAACCAGACACTCCAGGACCTGCTCACGTCG     
451    Q  E  N  K  P  A  T  F  S  S  M  S  H  Y  G  N  Q  T  L  Q  D  L  L  T  S   
 
 
1426  GACTCACTCAGCCACAGCGATGTCATGATGACCCAGTCGGACCCCTTGATGTCTCAGGCCAGCACCGCTGTGTCC     
476    D  S  L  S  H  S  D  V  M  M  T  Q  S  D  P  L  M  S  Q  A  S  T  A  V  S   
 
 
1501  GCCCAGAACTCCCGCCGGAACGTGATGCTTCGCAGTGACCCAATGATGTCCTTTGCCGCCCAGCCTAACCAGGGG    
501    A  Q  N  S  R  R  N  V  M  L  R  S  D  P  M  M  S  F  A  A  Q  P  N  Q  G   
 
 
1576  AGTTTGGTCAATCAGAACTTGCTCCACCACCAGCACCAAACCCAGGGCGCTCTCGGTGGCAGCCGTGCCTTGTCG    
526    S  L  V  N  Q  N  L  L  H  H  Q  H  Q  T  Q  G  A  L  G  G  S  R  A  L  S  
 
 
1651  AATTCCGTCAGCAACATGGGCTTGAGCGACTCCAGCAGCCTCGGGTCAGCCAAACACCAGCAACAGTCTCCCGTC     
551    N  S  V  S  N  M  G  L  S  D  S  S  S  L  G  S  A  K  H  Q  Q  Q  S  P  V   
 
 
1726  AGCCAGTCTATGCAAACCCTCTCGGACTCTCTCTCAGGCTCCTCCTTGTACTCAACCAGTGCGAACCTTCCAGTC     
576    S  Q  S  M  Q  T  L  S  D  S  L  S  G  S  S  L  Y  S  T  S  A  N  L  P  V   
 
 
1801  ATGGGCCACGAGAAGTTCCCCAGCGACTTGGACCTGGACATGTTCAATGGGAGCTTGGAATGTGACATGGAGTCC     
601    M  G  H  E  K  F  P  S  D  L  D  L  D  M  F  N  G  S  L  E  C  D  M  E  S   
 
 
1876  ATTATCCGTAGTGAACTCATGGATGCTGATGGGTTGGATTTTAACTTTGATTCCCTCATCTCCACACAGAATGTT    
626    I  I  R  S  E  L  M  D  A  D  G  L  D  F  N  F  D  S  L  I  S  T  Q  N  V   
 
 
1951  GTTGGTTTGAACGTGGGGAGCTTCACTGGTGCTAAGCAGGCCTCATCTCAGAGCTGGGTGCCAGGCTGA     
651    V  G  L  N  V  G  S  F  T  G  A  K  Q  A  S  S  Q  S  W  V  P  G  •          
Figure 4.5. Nucleotide and predicted amino acid sequence of ovine FOXO3. The
nucleotide and predicted amino acid sequences (2019 bp and 672 amino acids, respectively)
of ovine FOXO3 are shown with numbering indicated at the beginning of each line. The
position of the stop codon is indicated by an “•”. Symbol (P*) denotes possible sites for PKB
phosphorylation based on the human protein (Tsai et al., 2007; Greer et al., 2007). LXXLL
motif- L; leucine, X; any amino acid
Amino acid 609-649, the conserved region 3 (CR3)
LXXLL
Conserved region 2 (CR2)
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DEL DAWT DF RS RTNSNAS TVSGRL SP I L AST EL DDVQDDDAPL SPML YSS SASL SP SVSKPCT VE L P RL TDMAGT M
310 320 330 340 350 360 370 380
DEL DAWT DF RS RTNSNAS TVSGRL SP I L AST EL DDVQDDDAPL SPML YSS SASL SP SVSKPCT VE L P RL TDMAGT M 
DEL DAWT DF RS RTNSNAS TVSGRL SP I L AST EL DDVQDDDAPL SPML YSS SASL SP SVSKPCT VE L P RL TDMAGT M 
DEL DAWT DF RS RTNSNAS TVSGRL SP I MAST EL DE VQDDDAPL SPML YSS SASL SP SVSKPCT VE L P RL TDMAGT M 
DEL DAWT DF RS RTNSNAS TI SGRL SP I P ATT EL DDVQDDDS PL SPML YSS PGSL SP SL SKPCT VE MP RI TDMAGT M 
 
NL NDGL ADNL MDDL L DNI AL PASQPS PP GGL MQRS SS F P YT TKGSGL GSP TS SF SS AVF GPSS L NSL RQSP MQTI Q
390 400 410 420 430 440 450
NL NDGL ADNL MDDL L DNI AL PASQPS PP GGL MQRS SS F P YT TKGSGL GSP TS SF SS AVF GPSS L NSL RQSP MQTI Q 
NL NDGL ADNL MDDL L DNI AL PASQPS PP GGL MQRS SS F P YT TKGSGL GSP TS SF SS AVF GPSS L NSL RQSP MQTI Q 
NL NDGL T ENL MDDL L DNI TL PP SQPS PT GGL MQRS SS F P YT TKGSGL GSP TS SF NS TVF GPSS L NSL RQSP MQTI Q 
NL NDGL P ENL MDDL L DDI SL TS SQQS SP GI L MQRS SS F T YGTKGSGI GSP SNTF NNTS SF NF P L T SL RQSP MQTI Q 
 
E NKPATF SS MS HYGNQTL QDL L TS DS L S HSDVMMT QS DP L MSQAST AVSAQNSRRNVML RSDP MMSF AAQP NQG- S
460 470 480 490 500 510 520 530
E NKPATF SS MS HYGNQTL QDL L TS DS L S HSDVMMT QS DP L MSQAST AVSAQNSRRNVML RSDP MMSF AAQP NQG- S  
E NKPATF SS MS HYGNQTL QDL L TS DS L S HSDVMMT QS DP L MSQAST AVSAQNSRRNVML RSDP MMSF AAQP NQG- S  
E NKPATF SS MS HYGNQTL QDL L TS DS L S HSDVMMT QS DP L MSQAST AVSAQNSRRNVML RNDP MMSF AAQP NQG- S  
E NKQATF SS I NHYS NQSL QDL L NT DT L S HSDVL MT QS DP L MSQAST AVTAQNTRRNI I L RNDP MMSF AAPS NQGGN 
 
L VNQNL L HHQHQTQGAL GGS RAL S NS VS NMGL S DS SS L GSAKHQQQSP VS QS MQTL SDSL SGS SL YS TS ANL P VMG
540 550 560 570 580 590 600
L VNQNL L HHQHQTQGAL GGS RAL S NS VS NMGL S DS SS L GSAKHQQQSP VS QS MQTL SDSL SGS SL YS TS ANL P VMG 
L VNQNL L HHQHQTQGAL GGS RAL S NS VS NMGL S DS SS L GSAKHQQQSP VS QS MQTL SDSVSGS SL YS TS ANL P VMG 
L VNQNL L HHQHQTQGAL GGS RAL S NS VS NMGL S ES SS L GSAKHQQQSP VS QS MQTL SDSL SGS SL YS TS ANL P VMG 
L VNQNSL HQQQSL NSF QGGS RAL S NNL S NTGL NDS SNL DST KHQQQSS VS HS MQTI SDTL SGS - L YS SAVNL P TL G 
 
HEKF P SDL DL DMF NGS L E CDME SI I RSE L MDADGL DF NF DS L I STQNVVGL NVGSF TGAKQAS SQSWVP G-
610 620 630 640 650 660 670
HEKF P SDL DL DMF NGS L E CDME SI I RSE L MDADGL DF NF DS L I STQNVVGL NVGSF TGAKQAS SQSWVP G.       
HEKF P SDL DL DMF NGS L E CDME SI I RSE L MDADGL DF NF DS L I STQNVVGL NVGSF TGAKQAS SQSWVP G.       
HEKF P SDL DL DMF NGS L E CDME SI I RSE L MDADGL DF NF DS L I STQNVVGL NVGNF TGAKQAS SQSWVP G.       
HEKF P TDL DL DI F NGS L E CDME TI I RNDL MDADGL DF NF DT L I SAQNV- S L S VGSF TGAKQTS SQSWVP G.       
 
MAE AP AS PAPI SPL EVEL DP EF EP QS RP RSCTWPL QRPE L QGS PAKPS GE AA- - - - ADSMI PE EE DDEDDE DGGGR
10 20 30 40 50 60 70
MAE AP AS PAPI SPL EVEL DP EF EP QS RP RSCTWPL QRPE L QGS PAKPS GE AA- - - - ADSMI PE EE DDEDDE DGGGR 
MAE AP AS PAPI SPL EVEL DP EF EP QS RP RSCTWPL QRPE L QGS PAKPS GE AA- - - - ADSMI PE EE DDEDDE DGGGR 
MAE AP AS PAPL SPL EVEL DP EF EP QS RP RSCTWPL QRPE L QAS PAKPS GE TA- - - - ADSMI PE EE DDEDDE DGGGR 
MAE AVPS L S P - - PGDVDI DP DF EP QS RP RSCTWPL QRPDSQGS PGKPNSGAGEAGDAS SMI PE EE DDDDE - - - - GS  
 
AGS AMAI GGGGG- GTL GS GL L L EDSARVL AP GGQDPGSGPATAAGAL S GGTQTP L QPQQP L PP PQPGTAGGSGQP R
80 90 100 110 120 130 140 150
AGS AMAI GGGGG- GPL GS GL L L EDSARL L AP GGQDPGSGPAPAAGAL S GGTQTP L QPQQP L PP PQPGTAGGSGQP R 
AGS AMAI GGGGG- GPL GS GL L L EDSARL L AP GGQDPGSGPAPAAGAL S GGTQTP L QPQQP L PP PQPGTAGGSGQP R 
AGS AMAI GGGGGSGTL GS GL L L EDSARVL AP GGQDPGSGPATAAGGL S GGTQAL L QPQQP L PP PQPGAAGGSGQP R 
GTT AT MVGT AGEKGTV- - VL L S GGDL TVL A- - - - S PVGGVE TL QAS L GGGGAG- - - - - - - - - - - GAQSGAT GQQQR 
 
KCS SRRNAWGNL SYADL I TRAI ES SP DKRL T L S QI YE WMVRCVPYF KDKGDS NS SAGWKNSI RHNL S L HSRF MRVQ
160 170 180 190 200 210 220
KCS SRRNAWGNL SYADL I TRAI ES SP DKRL T L S QI YE WMVRCVPYF KDKGDS NS SAGWKNSI RHNL S L HSRF MRVQ 
KCS SRRNAWGNL SYADL I TRAI ES SP DKRL T L S QI YE WMVRCVPYF KDKGDS NS SAGWKNSI RHNL S L HSRF MRVQ 
KCS SRRNAWGNL SYADL I TRAI ES SP DKRL T L S QI YE WMVRCVPYF KDKGDS NS SAGWKNSI RHNL S L HSRF MRVQ 
KCS SRRNAWGNMSYADL I TRAI ES SQDKRL T L S QI YDWMVRSVPYF KDKGDS NS SAGWKNSI RHNL S L HSRF I RVQ 
 
NEGTGKS SWWI I NP DGGKSGKAPRRRAVSMDNS NKYT KS RGRAAKKKAAL QT AP ES ADDS PSQL S KWPGSP TS RS S
230 240 250 260 270 280 290 300
NEGTGKS SWWI I NP DGGKSGKAPRRRAVSMDNS NKYT KS RGRAAKKKAAL QT AP ES ADDS PSQL S KWPGSP TS RS S  
NEGTGKS SWWI I NP DGGKSGKAPRRRAVSMDNS NKYT KS RGRAAKKKAAL QT AP ES ADDS PSQL S KWPGSP TS RS S  
NEGTGKS SWWI I NP DGGKSGKAPRRRAVSMDNS NKYT KS RGRAAKKKAAL QT AP ES ADDS PSQL S KWPGSP TS RS S  
NEGSGKS SWWMI NP EGGKGGKAPRRRAVSMDNS NKYT KS RGRAAKKKASL QAST DATDDS PSQL S KWPGSP TS RS S  
Figure 4.6. Amino acid alignment of sheep, cattle, human and toad FOXO3.
---FOXO3-Ovine 
---FOXO3-Bovine 
---FOXO3-Humans 
---FOXO3-Xenopus 
Chapter 4: Identification of variation in ovine FOXO3 and its association with longevity
81
4.2.2 Identification of seven haplotypes for ovine FOXO3
Variation in exon 2 of ovine FOXO3 was identified from 182 NZ cross-bred sheep
using four separate sets of PCR primers (Table 4.2).
Upon SSCP analysis, six and three distinct banding patterns were detected in amplicon
1 and 2, respectively (Figure 4.7). No SSCP variation was detected in amplicon 3 and 4
(Figure 4.7). Either one, or two distinct banding patterns were observed for each sheep, which
defines homozygous or heterozygous genotypes, respectively. Novel variants from amplicon
1 and 2 were sequenced, while there was only one sequence obtained from amplicon 3 and 4.
All the sequences identified shared high homology to the published bovine FOXO3 sequence
(GenBank Accession No. XM_615634), suggesting that these sequences represented variant
forms of ovine FOXO3.
Figure 4.7. PCR-single-strand conformational polymorphism of four fragments within
exon 2 of ovine FOXO3. Six and three unique SSCP patterns corresponding to six and three
variant sequences (01-06 and 01-03) are shown for amplicons 1 and 2, respectively, while no
SSCP variation was detected in amplicons 3 and 4
Seven extended haplotypes were assembled from the four amplicons (Table 4.3). The
seven haplotypes detected were named A to G and deposited into the NCBI GenBank with the
accession numbers GQ995521 to GQ995527. Sequence analysis revealed ten single
nucleotide substitutions in exon 2 (Table 4.4). One of the substitutions, an A to G substitution
at nucleotide position 601, leads to a putative amino acid substitution of M (methionine) with
01 02 01 03 01 02 02 01 01 01 01
02 03 04 05 06 02 03
a) Amplicon 1 b) Amplicon 2 c) Amplicon 3 d) Amplicon 4
(365 bp) (420 bp) (400 bp) (376 bp)
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V (valine) at position 201 (position 407 of the bovine sequence NCBI GenBank reference
sequence XM_002690117). It is notable that this methionine residue is highly conserved in a
diversity of species (Figure 4.8).
Table 4.3. The seven haplotypes derived from amplicon 1 and 2 of ovine FOXO3.
Haplotype Amplicon 1 — Amplicon 2
(365 bp) (420 bp)
Accession Numbers
A 01 —— 01 GQ995521
B 02 —— 01 GQ995522
C 02 —— 03 GQ995523
D 03 —— 02 GQ995524
E 04 —— 01 GQ995525
F 05 —— 01 GQ995526
G 06 —— 01 GQ995527
Table 4.4. Sequence variation in exon 2 of ovine FOXO3.
SNP Position1 Haplotype
A
Haplotype
B
Haplotype
C
Haplotype
D
Haplotype
E
Haplotype
F
Haplotype
G
Amino acid
substitution
G/A 93 G G G G A G G –
C/T 99 C C C C C C T –
T/C 135 T T T C T T T –
C/T 207 C T T C C T C –
A/G 216 A A A G A A A –
C/T 258 C C C C C T C –
C/T 327 C C C C C T C –
C/A 489 C C A C C C C –
T/C 519 T T T C T T T –
A/G 601 A A A G A A A M/V
Frequency2
(%)
49.0 30.0 0.2 14 0.1 0.3 0.1
1 Nucleotide position is given relative to the first nucleotide of exon 2 of a bovine FOXO3
reference sequence (GenBank Accession No. XM_615634). 2 In 182 New Zealand cross-bred
sheep.
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AMPK consensus motif: Hyd-(X, Basic)XXS/TXXX-Hyd
  407   412 
    *     * 
Sheep (haplotype D) QPSPPGGLVQRSSSFPY (GQ995524) 
Cattle QPSPPGGLMQRSSSFPY  (ref seq XM 002690117) 
African Bush Elephant QTSPPGALMQRSSSFPY (ref seq XM_003404305) 
Pig QPSPPGGLMQRSSSFPY (ref seq NM 001135959) 
Horse QPSPPGGLMQRSSSFPY (ref seq XM 001503987) 
Giant panda  QPSPTGGLMQRSSSFPY  (ref seq XM_002917347) 
Dog  QPSPTGGLMQRSSSFPY  (ref seq XM 863298) 
Rhesus monkey QPSPTGGLMQRSSSFPY  (ref seq XM_001093593) 
Common marmoset QPSPTGGLMQRSSSFPY (ref seq XM 002746951) 
Sumatran orang-utan QPSPTGGLMQRSSSFPY (ref seq XM 002817219) 
Chimpanzee QPSPTGGLMQRSSSFPY (ref seq XM_003311514) 
Gray short-tail opossum QPSPSAGLMQRSSSFPY (ref seq XM 001368456) 
Chicken QQSPTGGMMQRSSSFPY (ref seq XM_001234495) 
Turkey QQSPTGGIMQRSSSFPY (ref seq XR 118137) 
Xenopus sp. QQSSPGVLMQRSSSFTY (ref seq NM 001092949) 
Platypus QPSPSAGLLQRSATFPY (ref seq XM_001511115) 
Figure 4.8. The location of ovine FOXO3 AMPK site and the AMPK consensus motif. a)
The AMPK phosphorylation site of ovine FOXO3 at Ser412 b) Alignment of putative amino
acid sequences from NCBI GenBank reference sequences showing that the hydrophobic
methioine (residue 407 of the bovine sequence) is highly conserved across species. The
consensus recognition motif for AMPK is Hyd-(X, Basic)XXS/TXXX-Hyd (where
Hyd=M,L,I,F or V, Basic=R>K>H and S/T=phosporylation site)
a)
b)
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4.2.3 Development of a simpler FOXO3 genotyping method
Based on the DNA sequences obtained for the seven extended haplotypes, a new set of
PCR primers (FOXO3-up and FOXO3-dn, Table 4.2) were designed. These gave unique and
identifiable PCR-SSCP patterns that spanned the variable region of exon 2 and that could be
matched to the original seven haplotypes (A to G) (Figure 4.9). This genotyping method
allowed establishment of a simple and reliable method for typing large numbers of sheep.
Figure 4.9. The PCR-SSCP typing system developed for ovine FOXO3. Seven unique
SSCP patterns corresponding to seven different haplotypes of the ovine FOXO3 are shown
4.2.4 Genetic association with sheep longevity and fecundity
A total of 1732 ewes were typed using the improved genotyping method. The haplotype
frequencies are shown in Table 4.5. Haplotypes C, E, F and G were rare (< 2%) and a
univariate analysis revealed no significant association between them and longevity (Table
4.5).
In an analysis, without adjustment for breed and flock, three haplotypes (A, B and D) of
FOXO3 showed significant associations with sheep age (P <0.01, data not shown). However,
when sheep carrying these three haplotypes were adjusted for either breed or flock in a
  
AB DD BD AD CD BE BF AG
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GLMM, only the D haplotype remained significantly associated with longevity (Table 4.5).
When corrected for breed, the presence of D decreased age by about five months with a mean
age of 5.0 ± 0.2 years, whereas ewes that did not possess the haplotype had a mean age of 5.5
± 0.1 years (P = 0.006). When corrected for the flock, the presence and absence of the
FOXO3 D haplotype had a mean age of 4.7 ± 0.1 years and 5.1 ± 0.1 years (P = 0.034),
respectively (Table 4.5).
No FOXO3 haplotypes were found to have any effect on fecundity in either flock or
breed corrected models (Table 4.6).
Table 4.5. Association of ovine FOXO3 exon 2 variation and longevity.
1 Rounded frequencies in 1732 New Zealand sheep.
Haplotype Frequency
(%)1
Haplotype
status
n Age means
(Breed adjusted)
Age means
(Flock adjusted)
A
 
45.3 Present
Absent
1268
464
5.4 ± 0.1
5.5 ± 0.2
(P = 0.490)
5.0 ± 0.1
5.1 ± 0.2
(P = 0.562)
B
 
30.4 Present
Absent
693
1039
5.4 ± 0.1
5.4 ± 0.1
( P = 0.966)
4.9 ± 0.1
5.1 ± 0.1
( P = 0.240)
C 1.0
      
Present
Absent
24
1708
5.8 ± 0.6
5.4 ± 0.1
( P = 0.536)
5.1 ± 0.6
5.0 ± 0.1
( P = 0.829)
D
 
21.7 Present
Absent
486
1246
5.0 ± 0.1
5.5 ± 0.1
(P = 0.006)
4.7 ± 0.1
5.1 ± 0.1
(P = 0.034)
E 1.2 Present
Absent
69
1663
5.1 ± 0.4
5.4 ± 0.1
( P = 0.430)
4.8 ± 0.4
5.0 ± 0.1
( P = 0.667)
F 0.3 Present
Absent
14
1718
6.5 ± 0.8
5.4 ± 0.1
( P = 0.169)
6.0 ± 0.8
5.0 ± 0.1
( P = 0.187)
G 0.1 Present
Absent
21
1711
6.4 ± 0.1
5.4 ± 0.7
( P = 0.138)
5.9 ± 0.7
5.0 ± 0.1
( P = 0.180)
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Table 4.6. Association of ovine FOXO3 exon 2 variation and fecundity.
Haplotype Haplotype
status
n Fecundity means
(Breed adjusted)
Fecundity means
(Flock adjusted)
A
 
Present
Absent
176
455
1.8 ± 0.02
1.8 ± 0.03
(P = 0.328)
1.8 ± 0.02
1.8 ± 0.03
(P = 0.190)
B
 
Present
Absent
215
416
1.8 ± 0.03
1.8 ± 0.02
( P = 0.243)
1.8 ± 0.03
1.8 ± 0.02
( P = 0.675)
C Present
Absent
8
623
1.8 ± 0.13
1.8 ± 0.02
( P = 0.664)
1.9 ± 0.12
1.8 ± 0.01
( P = 0.398)
D
 
Present
Absent
186
445
1.8 ± 0.03
1.8 ± 0.02
(P = 0.371)
1.8 ± 0.03
1.8 ± 0.02
(P = 0.621)
E Present
Absent
23
608
1.9 ± 0.08
1.8 ± 0.02
( P = 0.616)
1.8 ± 0.08
1.8 ± 0.01
( P = 0.905)
F Present
Absent
8
623
2.0 ± 0.13
1.8 ± 0.02
( P = 0.297)
2.0 ± 0.12
1.8 ± 0.01
( P = 0.152)
G Present
Absent
11
620
2.0 ± 0.12
1.8 ± 0.02
( P = 0.328)
1.9 ± 0.11
1.8 ± 0.01
( P = 0.342)
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4.3 Discussion
The evolutionarily conserved FOXO3 transcription factor is a major target of insulin-
like signalling, and is therefore important in the regulation of development, metabolism and
longevity (Murphy, 2006).
This is the first report of an association between variation in ovine FOXO3 and
variation in life-span in sheep. In this study, the coding sequence of ovine FOXO3 was firstly
identified and compared with other species. Moreover, the sequence comparison revealed a
high level of similarity within mammals. This supports the contention that there is an
evolutionarily conserved role for FOXO3, including a likely role in controlling longevity in
sheep.
The entire coding region of the FOXO3 gene is contained within exon 1 and 2. Exon 2
encompasses the DNA-binding domain of the transcription factor, including part of the FH
domain and conserved regions (CR) 2 and 3. Recent NMR and biochemical studies have
demonstrated that the FH and CR domains play a central role in regulating DNA interaction
(Tsai et al., 2007), hence variation in this region of the gene may influence FOXO3 activity.
Accordingly I investigated exon 2 of ovine FOXO3 to ascertain if it was genetically variable,
and if so, whether this variation was associated with variation in longevity.
In this study, ten SNPs defining seven haplotypes (named A to G) were identified in the
1422-bp exon 2 fragment of ovine FOXO3 that was assembled (Table 4.3). In haplotype D, an
adenine to guanine substitution at nucleotide position 601 of exon 2 leads to a putative amino
acid substitution of methionine to valine at residue 201 (residue 407 of the bovine sequence
NCBI GenBank reference sequence XM_002690117). It is notable that the substitution in
haplotype D is located at the hydrophobic site of an AMPK consensus binding motif. In
mammals, FOXO3 contains an AMPK consensus phosphorylation motif, which is Hyd-
(X,Basic)XXS/TXXX-Hyd, where Hyd represents a hydrophobic residue, X represents any amino
acid residue, basic represents a basic residue and S/T represents a serine or threonine (see the
Figure 4.8). In the AMPK motif, a phosphorylation site (a serine or threonine residue) is flanked
by hydrophobic and basic residues, and the sequence around the phosphorylation site is highly
conserved across species. Generally, the consensus hydrophobic residue is methionine, but it can
also include leucine, isoleucine, phenylalanine and valine. In haplotype D, the hydrophobic
methionine is substituted by valine, which is also hydrophobic, but the methionine is highly
conserved within a diversity of species (Figure 4.8), the exception being the egg-laying
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monotreme platypus. This suggests the methionine residue is under some conformational
and/or functional constraint.
In humans, FOXO3 is phosphorylated by AMPK at Thr179, Ser399, Ser413, Ser555,
Ser588 and Ser626 (these would correspond to sheep Thr178, Ser398, Ser412, Ser554, Ser587
and Ser625). Among the six AMPK phosporylation sites, activation of FOXO3 at Ser412 by
AMPK appears to enhance the expression of genes implicated in cellular stress responses and
longevity (Greer et al., 2007). In this study, the D haplotype of the ovine FOXO3 defined by
variation in the consensus AMPK motif surrounding Ser412, was significantly associated with
a decreased mean age for the sheep. This supports the contention that the D haplotype may be
important in determining FOXO3 transcriptional activity.
It has been reported that a point mutation in murine Foxo3a exon 2 results in an amino
acid substitution (I 181 N), and that this is associated with a premature loss of fertility due to
abnormal early primordial follicle activation and subsequent abnormal folliculogenesis
(Youngson et al., 2011). Fertility loss has also been observed in a homozygous Foxo3a
“knockout” mouse model and is caused by an early depletion of functional follicles
(Castrillon et al., 2003). Thus the variation observed in this study in ovine exon 2 may affect
FOXO3 functionality, and in turn, reproductive ability. This may increase the likelihood of
sheep being culled as a consequence of not becoming pregnant at mating. This could explain
why the sequence variation in haplotype D is associated with a decreased life-span in these
stud sheep.
The rest of the genetic variation detected in this study are synonymous SNPs and
therefore potentially functionally neutral (Sharp et al., 1995). However, recently there has
been mounting evidence against this line of thought. For example, some reports suggest that
synonymous substitutions affect mRNA secondary structure and stability, and hence they may
have functional effects (Parmley et al., 2006; Qu et al., 2006). The apparently silent
polymorphism detected here could therefore also be functionally important and affect FOXO3
activity. They may also be in linkage with variation elsewhere in the gene that affects its
expression.
In farmed-sheep systems, life-span is controlled by death rates and culling decisions.
Farmers’ cull their breeding stock for a variety of reasons. These include their reproductive
performance, genetic performance, propensity to ill-health, incisor wear, age and
combinations of these factors. Variation in the value of products that will be derived from the
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sheep is also a key reason for culling and given market variation in product prices, culling
decisions are also sensitive to market and season.
McGregor (McGregor, 2011) argues that sheep farmers use the wear and loss of
permanent incisors as a major reason for culling sheep and it appears that both farmers and
scientists regard the impact of permanent incisor wear and loss on the production and
premature wastage of ewes as an inevitable outcome of advancing age in sheep. Accordingly,
in commercial sheep production systems, casting sheep for age is often driven by knowledge
of when permanent incisor condition is likely to deteriorate. In one New Zealand study, 65%
of farmers culled ewes because of incisor faults and there was additional culling of ewes with
faulty incisors because of their poor body condition (Orr et al., 1986). However, despite the
widespread practices of culling adult sheep at the entry of replacement ewes to the breeding
flock; and the casting of sheep for age; there are surprisingly few objective reports of the
reasons for culling ewes, or of the effectiveness of culling. Hence, in the absence of clear
objective evidence, New Zealand farmers have generally adopted the “safe” path of casting
ewes at a particular age.
This was one of the reasons why stud ewes were chosen in this study. As a consequence
of their enhanced value, breeding sheep are frequently retained longer in flocks than
commercial sheep and therefore are less likely to have simply been culled based on their age.
This is a requirement for studying ewe longevity, as age-based culling in a commercial system
would likely mask any under-lying genetic effects on life-span. What-is-more, while incisor
loss may be pronounced in these stud sheep, their maintenance in a stud is likely to be more
affected by their ongoing reproductive success and genetic merit.
Given the variation in longevity between flocks and within a given breed, farm-related
factors are a major determinant of longevity. Accordingly “farm” needs to be incorporated
into any statistical analysis of life-span. However most farms in this study only have one
breed of sheep and hence, farm and breed are confounded. Accordingly, breed and flock were
corrected for in separate models. Given that the reasons for culling sheep out of flocks are
diverse and potentially inter-related, it is nevertheless conceivable that factors like variation in
fertility or resistance to disease may also explain the association we have found.
Four of the haplotypes are not commonly found suggesting that they offer little
productive advantage in the sheep studied. The reason for their low frequency can only be
speculated upon, but would not preclude them also affecting longevity, fertility and/or other
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production traits. In conclusion, genetic variability in FOXO3 may potentially affect sheep
longevity either directly, or indirectly by impacting on factors that lead to reduced
productivity and increased likelihood of culling. This requires further study.
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Chapter 5
An investigation of variation in ovine CAST and its
association with longevity and fecundity
Calpastatin (CAST) is the only known endogenous inhibitor of calpain and is
ubiquitously expressed. Calpains refer to a family of intracellular, calcium-dependent cysteine
proteases, which comprises several tissue-specific isoforms (n-calpains) as well as two
ubiquitous isozymes (µ- and m-calpains or calpain I and II, respectively) (Goll et al., 2003).
These proteins have been identified in nearly every animal cell type studied, but the amount
of each protein varies from tissue to tissue (Goll et al., 2003). CAST is generally found at a
higher concentration than the calpains.
The calpains and CAST constitute the calpain system, which is involved in a variety of
cellular processes, including cytoskeletal remodelling, cellular signalling, apoptosis and cell
survival (Rivett, 1990; Sorimachi et al., 2011; Sorimachi et al., 1997).
Calpains are totally dependent on Ca2+ for their catalytic activity and function in various
cellular activities (Goll et al., 2003). µ- and m-calpain, which have different Ca2+
requirements (micromolar and milimolar concentration, respectively) are well studied in
mammals. Both µ- and m-calpains are heterodimers, consisting of distinct 80-kDa large
subunits and a 30-kDa regulatory subunit (Figure 5.1).
In general, the calpains exist in the cytosol as inactive enzymes and translocate to
membranes in response to increased cellular calcium levels. At the membrane, calpain is
activated in the presence of calcium and phospholipids (Khorchid & Ikura, 2002). Activated
calpain cleaves a variety of protein substrates at hinge regions including between
neighbouring functional and regulatory domains. This leads to activation, inactivation, or
destruction of the substrate. Over 100 calpain substrates have been identified including
cytoskeletal proteins (desmin, -actinin, vimentin, spectrin, integrin, cadherin), membrane
proteins (growth factor receptors, adhesion molecules, ion transporters), enzymes (kinases,
phospholipases, phosphatases), myofibrillar proteins (troponin, tropomyosin, myosin light
chain kinase), as well as cytokines and various transcription factors and other proteins (Goll et
al., 1983). It also acts upon proteins involved in apoptotic signalling (Squìer et al., 1994).
Chapter 5: An investigation of variation in ovine CAST and its association with longevity and fecundity
92
Figure 5.1. Schematic domain representation of calpain and calpastain. Calpain domains
I to IV make up the large 80 kDa subunit and the small 30 kDa subunit comprises domains V
and VI. Protease activity is localised to domain II, domains IV and VI are the calcium binding
segments that are implicated in the activation and regulation of the enzyme. 5 potential
calcium binding EF-hands (penta-EF hands, the major Ca2+ binding domains) are represented
as stars. Calpastatin sub-domain B is responsible for calpain inhibition, sub-domain A and C
bind to the calmodulin-like domain IV and VI of the calpain large subunit (L-CaMLD)
(adapted from Goll et al., 2003)
Calpain therefore plays an important regulatory role in cellular processes, including the
remodelling of cytoskeletal proteins, the control of signal-transduction pathways, the
degradation of enzymes controlling progression through the cell-cycle, the regulation of gene
expression and control of apoptotic pathways. Inappropriate calpain activation could therefore
result in various pathological states, leading to irreversible alterations and loss of functionality
for the calpain substrate. Furthermore, an over-activated calpain system has been shown to
participate in a number of pathological conditions including hypoxia, ischemia, spinal cord
injury, Alzheimer disease, muscular dystrophy and cataract formation (Bertipaglia & Carafoli,
2007; Zatz & Starling, 2005).
As the activation of calpain is an irreversible reaction, calpain activation must be strictly
controlled, particularly in neurons, which are vulnerable and exhibit limited regeneration.
CAST regulates calpains by inhibiting both the proteolytic activity of the enzymes and their
binding to membranes (Goll et al., 2003).
5 EF-hands
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In mammalian cells, there are known to be eight different isoforms of CAST, resulting
from both alternative splicing of the primary transcript and proteolytic processing. Most of the
CAST isoforms are expressed ubiquitously and only some of them are restricted to particular
organs and cell types (Melloni et al., 1998; Melloni et al., 1992). It is suggested that different
CAST isoforms inhibit different calpain isoforms within a single cell (Averna et al., 1999).
Table 5.1 summarises the splicing sites found in the CAST gene and describes how the sites
are important for generating different CAST isoforms in specific physiological roles.
CAST has an internal repeat of four homologous domains which allows it to
simultaneously inhibit multiple calpain molecules. Each inhibitory domain has three
subdomains, called A, B, and C (Figure 5.1). The three subdomains of CAST mediate calpain
inhibition. Sub-domains A and C bind to the calmodulin-like domain IV and VI of the calpain
large subunit (L-CaMLD), respectively, while B binds to domain II of calpain which contains
the protease activity (Figure 5.1). Thus, interaction between the inhibitory domain of CAST
and calpain is essential for calpain activity, and this suggests the regulation of calpain activity
is tightly controlled by CAST.
Although the calpain system has been implicated in regulating a number of cellular
processes, including longevity (Nixon et al., 1994), there has been no specific study of the
potential influence of CAST on longevity in sheep. In this chapter, the role of CAST in
longevity was investigated as well as an investigation of its roles in muscle growth and
fecundity.
 A role for CAST in longevity?
Changes in the rate or efficiency of proteolysis have featured in many hypotheses on the
mechanism of aging. Calpain activity specifically is of interest in regulation of cellular protein
metabolism and homeostasis. Lynch et al. (1986) first showed that calpain activity may be
related to the rate of aging. They found that members of the Chiroptera order (Bats), that have
extended life-spans, also have decreased calpain activity in the brain (five to sevenfold lower)
when compared with its activity in other similar-sized mammals, like mice.
Calpain activity increases in cells and tissues during normal aging. For example, in
mammals, an overactive calpain system has been associated with a variety of age-related
disorders, including Alzheimer and Parkinson diseases, cerebral ischemia, ischemic
myocardial infarction, spinal cord injury, muscular dystrophy, rheumatoid arthritis and
cataract formation (Higuchi et al., 2005; Karlsson et al., 1995; K. K. Wang & Yuen, 1994).
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The process of cataract formation is a particularly well-established degenerative phenomenon
of aging. This process seems to result from the specific proteolytic cleavage of α-crystallin,
leading to its denaturation (David et al., 1992). In vertebrate eyes, α-crystallin is a major
structural protein of the lens and plays an important role in maintaining its transparency by
preventing the aggregation or inactivation of several proteins (Groenen et al., 1994; Horwitz,
2003; Reddy et al., 2000).
It has been suggested that aging reflects deterioration of cell cytoskeletal elements
(Halbhuber et al., 1987; Kay et al., 1989; Kelley & Perdue, 1980). Calpains are also known to
regulate many interactions between the membrane and the intra-cellular environment (Nixon,
1989), and this could play a role in cell differentiation, exfoliation and aging. CAST is the
only natural inhibitor of both μ–and m–calpains, thus during aging, calpain activity in protein
degradation is regulated by CAST. This suggests a role for CAST in the aging process (Goll
et al., 2003). In mammals, several lines of evidence also suggest that CAST is implicated in
age-related pathologies (Averna et al., 2007; Vaisid et al., 2007). Rao et al.(2008) provided
evidence that CAST is a regulator of constitutive calpain activity in the process of neural
aging. Working with Alzheimer disease brains, transgenic mice and other cell models, they
demonstrated that CAST depletion can accelerate calpain-mediated activation of specific
protein kinases and cytoskeleton disruption. This can ultimately lead to cell death.
Furthermore, they have shown that over-expression of CAST in transgenic mice, suppressed
calpain activity and created protective effects on the onset of aging in neurons (Rao et al.,
2008). This suggests that the life-span of animals might be regulated by the expression of
CAST.
Although CAST is now thought to play a role in regulating longevity, its function in
livestock has primarily been studied in relation to meat quality, and specifically meat
tenderness (Kemp et al., 2010). To date, there has been only one study suggesting that genetic
variation in CAST may affect longevity in dairy cattle (Garcia et al., 2006). In the research
described here CAST is investigated as gene that might affect longevity in sheep.
 A role for CAST in fecundity?
Several studies of the expression of CAST in reproductive tissues and organs such as
the human pituitary gland (Eto et al., 1995), the human placenta (Thompson et al., 2002), the
human oocyte (Ben-Aharon et al., 2005), the bovine corpus luteum (Orwig et al., 1994) and
the mouse testis (Li & Goldberg, 2000), have suggested that CAST may play an important
role in mammalian reproduction.
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During fertilisation in mammals, the sperm cell triggers a unique signal-transduction
mechanism within the egg, leading to its activation (Yanagimachi & Bhattacharyya, 1988).
This event requires membrane fusion between the sperm cell and the oocyte. Sperm calpain is
associated with the cell membrane fusion process that takes place during penetration of the
oocyte (Rojas et al., 1999). Thus, given CAST’s role elsewhere in regulating calpain, it might
participate in regulating the breakdown of cytoskeletal proteins during fertilisation.
In addition, research on fertilisation in rats and humans has revealed that the calpain
system may play a role in regulating mammalian oocyte activation. For example, Ben Aharon
et al. (2005) and Haim et al. (2006) have suggested that CAST mediates rat oocyte activation.
Ben-Aharon et al. (2005) also reported the expression of the calpain-calpastatin system in
human oocytes.
A recent study has investigated genetic variation in bovine CAST and it was suggested
that CAST may influence fertility (Garcia et al., 2006). Taken together this would suggest that
CAST is a worthy candidate for studying in relation to fecundity in sheep.
 A role for CAST in muscle growth and regulation of birth weight?
In cattle (Chung et al., 1999; Ciobanu et al., 2004), and pigs (Koćwin-Podsiadła et al.,
2003; Z. Li et al., 2009), CAST is reported to affect various muscle traits, including weight.
The role of calpain in muscle protein-turnover is determined by the balance between muscle
protein synthesis and muscle protein degradation and is important for muscle growth (Goll et
al., 1992). Since muscle growth is the major determinant of the performance of meat-
producing animals, many animal scientists have focussed their research on increasing the rate
of muscle growth by increasing muscle protein synthesis, or decreasing muscle protein
degradation.
The calpain system is essential for fetal growth and prenatal skeletal muscle
development (myogenesis) (Du et al., 2004; Wu et al., 2006), and this may therefore affect
birth weight traits. In the livestock industry, weight traits are important factors, because the
process of early organization of muscles greatly influences an animal’s growth as well as
wool production in sheep specifically.
Expression of the calpain system has been negatively correlated with birth weight and
fractional rate of growth (Z. Li et al., 2009; van den Hemel-Grooten et al., 1997). Z. Li et al.
(2009) have shown that decreased levels of calpain expression during neonatal development
in pigs are associated with higher protein accumulation. This suggests that protein
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accumulation is related to a reduction in the proteolytic capacity of the muscle and largely due
to increased CAST activity. Thus, CAST activity is involved in the control of muscle growth
and birth weight traits.
 The structure of CAST
In mammals, CAST is translated to produce two main isoforms, a 110-kDa muscle
tissue type and a 70-kDa erythrocyte type (Goll et al., 2003; Takano et al., 2000) Typical
CAST molecules have non-inhibitory N-terminal domains (domain-L and domain-XL) and
four repetitive inhibitory domains (domain I to domain IV) (Figure 5.2). In mice, the CAST
isoforms (I to IV) consist of 29 coding exons, and the first exon of each type of CAST started
lxa, lxb, 1u and 14t (Table 5.1) (Takano et al., 2000).
The CAST binding region is localised in the L-domain containing the amino acid
sequences encoded by exons 2-8 (Melloni et al., 2006). Recently, the L domain of CAST has
been shown to have a pivotal role in regulating Ca2+ channels (Minobe et al., 2006). Exons 4-
7 of domain L contain sequences that are involved in the regulation of Ca2+, specifically to
induce calpain-CAST interaction (Melloni et al., 2006). This suggests that the exons encoding
CAST domain L could be an important regulator of calpain activity.
Cong et al. (1998) have identified an additional CAST N-terminal peptide sequence
(XL, 68 amino acids) in bovine heart and some of liver tissues. These are phosphorylated by
protein kinase A (PKA) (Figure 5.2). They also found that the XL domain plays a regulatory
role in altering phosphorylation patterns in the protein.
The individual inhibitory domains of CAST (domain I to domain IV) inhibit both µ–and
m-calpains, but the ability of these domains to inhibit the calpains has been reported to vary in
the following order: domain I> domain IV> domain III> domain II, from most to least
effective (Kawasaki et al., 1989). Within each inhibitory domain there exists three highly
conserved sequences designated A, B and C (Goll et al., 2003). Regions A and C bind calpain
in a strictly Ca2+-dependent manner, but have no inhibitory activity; whereases region B
inhibits calpain on its own as it contains a well-conserved sequence, GxxE/DxTIPPxYR
which is thought to be involved in exerting the inhibitory function (Figure 5.2).
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Table 5.1. The genetic structure of mouse CAST isoforms. (Takano et al., 2000)
CAST
isoform type
Exon
number
Splicing
acceptor site
Coding
length (bp)
Splicing
donor site
Intron length
(kb)
Type I 1xa --- 75 gtagaggtag 4.3
1y atatttttag 63 gtaatttctg 3.8
1x tgtttctaag 72 gtcagtcaat 3.4
Domain 2 tcctttctag 60 gtaaagaaac 3.9
L 3 cttctattag 57 gtgatgtagt 0.6
4 cccactttag 39 gtaagtaggt 1.5
5 gaaattacag 54 gtgagtgata 0.5
6 tgcacgtcag 114 gtgagcttga 1.3
7 ctgctctcag 90 gtgagcatac 3.4
8 ctccctctag 69 gtatggagcc 1.2
1 9 ctatttctag 99 gtatgtgttg 1.5
10 tttcttccag 81 gtaagttatc 0.6
11 tttggttcag 39 gtgagttgaa 0.8
12 ttttctctag 87 gtattgattt 0.1
13 tcttttttag 90 gtacttaaat 1.6
2 14 tttttaacag 102 gtaatgactt 3.3
15 ttttcatcag 84 gtaagcgctc 1.3
16 ttattacag 48 gttggagaat 2.0
17 cttcttacag 90 gtagaagtat 1.2
18 cttttctcag 96 gtgagtgatg 1.8
3 19 gctcttgcag 102 gtaatggcag 0.5
20 ttttatttag 84 gtaacaggct 3.2
21 ctctgaatag 51 gtaagcaatc 0.2
22 cttcttgcag 72 gtaagtatac 6.9
23 ttaataaaag 99 gtaagcaaca 3.0
4 24 taccttttag 105 gtaaaagatc 1.0
25 atgtttgtag 93 gtaaactaat 1.0
26 tatttttaag 36 gtaaatacta 0.5
27 acatgttaag 93 gtacctacac 2.0
28 attgctttag 69 gtaaacatgg 3.5
29 tcccccttag 51 ---
Type II 1xb --- 30 gtaaatagaa 3.7
Type III 1u --- - gtgagtactg 1.1
Type IV 14t 165 gtgcacatta 2.1
120 gtaatatagct 2.1
The CAST genomic DNA sequences are based on Acc. No. AB044310-AB044334
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Figure 5.2. Schematic diagrams of three different calpastatin isoforms. Schematic
diagram shows the domain structure of three different calpastatin isoforms. The calpastatin
isoforms containing an L and/or XL domain are found in a number of tissues from a number
of different species. A, B and C are three subdomains within each inhibitory domain and the
B subdomain from a number of species contains the conserved sequence indicated. Three sites
on domain XL that are phosphorylated by protein kinase A are marked,*** (adapted from
Goll et al., 2003)
 Variation in CAST
A number of variants forms of the CAST gene that affect muscle growth traits have
been described in cattle (Barendse et al., 2007) and pigs (Ciobanu et al., 2004), but little is
known about the effect of these variants and longevity and fecundity.
Variation in CAST in cattle has been the subject of several studies. These have detected
variation in both the coding (Chung et al., 1999) and non-coding regions (Schenkel et al.,
2006), as well as the 3’ un-translated region (Casas et al., 2006). To date, in sheep, variation
in the ovine CAST has been reported and in both exon 6 (H. Zhou et al., 2007a) and intron 12
(Palmer et al., 1998; Roberts et al., 1996). Five and three variant sequences respectively, have
been identified in exon 6 and intron 12 of the ovine gene. Exon 6 encodes part of the CAST L
domain, which is involved in the regulation of Ca2+-induced proteolysis. This suggests that
variation within exon 6 might affect the function of CAST and therefore potentially birth
weight, muscle growth, longevity and fecundity traits. In this chapter, variation in this region
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was assessed in sheep that were of varying age and for which fecundity records were
available.
As haplotypes of multiple markers typically have a higher information content
compared with single markers for assessing the genetic basis of traits, haplotypic diversity of
the ovine CAST was also investigated. This involved studying the extended haplotyes defined
by variation in both CAST exon 6 and intron 12.
5.1 Materials and methods
5.1.1 Sheep investigated to define haplotypic diversity
To investigate haplotypic diversity of ovine CAST, 1200 New Zealand cross-bred sheep
(Romney, Coopworth and Perendale) were studied. These sheep were randomly selected from
around New Zealand.
5.1.2 Sheep studied for birth weight and growth rate analysis
A total of 519 NZ Romney lambs from 17 sire lines were investigated. Birth weight,
birth rank (single or multiple birth) and weaning weight were recorded. Growth rate was
expressed as weight gain per day, which is the difference between weaning weight and birth
weight, divided by age in days. Gender was also recorded (see appendix K for the data).
5.1.3 Sheep studied for longevity and fecundity analysis
Blood samples from sheep with longevity and fecundity data were used (See chapter 2.2
for sheep studied and the collection of longevity and fecundity data) to assess the effect of
variation in CAST on longevity and fecundity.
5.1.4 DNA extraction from blood on FTA cards
(See chapter 3.1.3)
5.1.5 PCR primer design and synthesis
Exon 6 of ovine CAST was amplified using the primers described previously by H.
Zhou et al. (2007). These were 5’-GTTATGAATTGCTTTCTACTC-3’ and 5’-
ATACGATTGAGAGACTTCAC-3’ and their location is shown in Figure 5.3. In order to
study haplotypic diversity within ovine CAST, intron 12 of ovine CAST was also investigated
in conjunction with the genotyping of exon 6. As variation in intron 12 of this gene has been
reported previously by Roberts et al. (1996), two primers specific for this region were
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designed based on the sequences of the bovine (GenBank accession no. L14450) (Killefer &
Koohmaraie, 1994), and ovine CAST genes (Roberts et al., 1996, AF016006-AF016008).
These primers were 5’-CTCCCACTTTAAGACAACAAC-3’ and 5’-
AGCCTCTTCTGTAGATTTCTG-3’ (See Figure 5.3). The BLAST algorithm was used to
search the National Centre for Biotechnology Information (NCBI) GenBank
(http://www.ncbi.nlm.nih.gov/) for homology and ensure the primers were specific to CAST.
Primer secondary structures, primer dimerisation, primer melting temperatures and GC
content were analysed using DNAMAN (Version 5.0, Lynnon BioSoft, Vaudreuil, Canada).
The primers were synthesised by Integrated DNA Technologies (Coralville, IA, USA). Figure
5.3. shows the two regions of primer binding in ovine CAST.
Figure 5.3. The location of PCR primers designed to amplify two regions of ovine CAST.
The gene structure is based on bovine CAST sequences (GenBank accession no. AY 834770
and AY834771). The light blue region represents a schematic structure of bovine CAST.
Domain L and 1 are shown. The exons that encode these domains are shown in light yellow.
Primer binding sites for exon 6 and intron 12 are indicated. Amplicon 1 contains part of intron
5, intron 6 and the entire exon 6 of ovine CAST, while amplicon 2 contains part of intron 12
L 1Calpastain Domain
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5.1.6 PCR-SSCP analysis
Amplification was performed in a 20-µL reaction containing the genomic DNA on one
1.2-mm punch of FTA paper, 0.25 µM of each primer, 150 µM of dNTPs (Eppendorf,
Hamburg, Germany), 2.5 mM Mg2+, 0.5 U of Taq DNA polymerase and 1 × the reaction
buffer supplied. Amplification was carried out in an iCycler (Bio-Rad Laboratories, Hercules,
CA) and consisted of denaturation at 94 ºC for 2 min, followed by 35 cycles of 94 ºC for 30 s,
55 ºC (amplicon 1-exon 6) or 60 ºC (amplicon 2-intron 12) for 30 s, and 72 ºC for 30 s, with a
final extension step at 72 ºC for 5 min. Amplicons were visualised by electrophoresis in 1%
agarose (Quantum Scientific, Queensland, Australia) gels, using 1 × TBE buffer (89 mM Tris,
89 mM boric acid, 2 mM Na2EDTA) containing 200 ng of ethidium bromide/mL.
A 0.7 µL aliquot of each amplicon was mixed with 7 µL of loading dye (98%
formamide, 10 mM EDTA, 0.025% bromophenol blue, 0.025% xylene-cyanol) and after
denaturation at 95 ºC for 5 min, samples were rapidly cooled on wet ice and then loaded on to
16 cm × 18 cm, 12% (amplicon 1-exon 6) or 8% (amplicon 2-intron 12)
acrylamide:bisacrylamide (37.5:1: Bio-Rad) gels. Electrophoresis was performed using
Protean II xi cells (Bio-Rad), at either 270 V at 12 ºC (amplicon 1-region 1) or 390 V at 4 ºC
(amplicon 2-region 2), for 18 h in 0.5 × TBE buffer. Gels were silver-stained according to the
method of Sanguinetti (1994).
5.1.7 Haplotype determination
The PCR-SSCP method does not determine specific haplotypes, but instead reveals
what variant forms of the exon 6 and intron 12 regions a sheep carries. However, using the
PCR-SSCP technique, haplotypes were indirectly determined. A population of 1200 samples
from New Zealand cross-bred sheep was genotyped at exon 6 (amplicon 1), and sheep
homozygous at exon 6 were subjected to genotyping at intron 12 (amplicon 2). Haplotypes
through the two regions were then determined based on inference from the genotypes of the
exon 6 homozygous individuals. Amplicons representative of the known CAST sequences
were included in each polyacrylamide gel, and their banding patterns were used as standards
for identification of individual samples.
5.1.8 Genotyping of ovine CAST exon 6 for birth weight, growth rate, longevity
and fecundity analysis
For the genetic association study, sheep for which birth weight, growth rate, longevity
and fecundity data were available were studied. This included 519 NZ Romney lambs for
which birth and growth rate data were available and 1726 ewes from six breeds for which
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longevity and fecundity data were available. These included NZ Romney (n = 340),
Corriedale (n = 318), Merino (n = 326), Polwarth (n = 129), Kelso (n = 174) and Coopworth
(n = 439) selected from 36 different flocks. Overall there were nine hundred and fifty-eight
older ewes and seven hundred and sixty-eight young ewes (2 years old). Lambing information
(fecundity data) was available for six hundred and fifty-eight of the older ewes.
5.1.9 Statistical analyses
Data was analysed using SPSS version 17 (SPSS Science Inc., Chicago, IL, USA), with
a two-tailed significance level of α = 0.05.
To assess whether any of the exon 6 CAST sequences (A to E) affected birth weight and
growth rate, an ANOVA was performed using the significance level of α = 0.05 to assess the
effect of variant sequence presence (or absence), sire and birth rank (as well as the
interactions of these factors) on birth weight and growth rate. To investigate the relationship
between birth weight and growth rate to weaning, a Pearson Correlation was performed.
A general linear mixed model (GLMM) was used to assess the effect of the
presence/absence of each of the exon 6 CAST sequences (A to E) on longevity and fecundity.
These analyses were run as unadjusted models and additionally, in separate models adjusting
for flock and breed effects, which were included as random factors.
5.2 Results
Haplotyping all the sheep available in this study would have been too costly financially
and in time. Accordingly, exon 6 of ovine CAST was chosen for the genetic association study.
Exon 6 is the most variable and spans the L domain, which is involved in the regulation of
Ca2+ channels and calpain activity. Figure 5.4 shows five unique banding patterns
corresponding to five unique sequences DNA of ovine CAST.
A simple and efficient PCR-SSCP method for genotyping part of intron 12 of ovine
CAST gene was developed, and using this method in conjunction with the genotyping of exon
6, haplotypic diversity over an extended region of CAST could be analysed.
Using the primers designed for intron 12 (Figure 5.3), amplicons of the expected size
(approximately 448 bp) were obtained. These amplicons were subjected to SSCP analysis,
and four distinct banding patterns were obtained (Figure 5.5). Previously, Roberts et al (1996)
had described three sequences at intron 12, but the amplicon that was used to reveal these
sequences was too large for optimal use in PCR-SSCP. Therefore new primers within this
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region were designed to amplify a smaller fragment which included all the known
polymorphic sites and which resulted in the detection of not just the three previously reported
sequences, but a new sequence as well (Table 5.2). The newly identified sequence has been
deposited into the NCBI GenBank with accession No. EF669476.
Figure 5.4. PCR-single-strand conformational polymorphism of exon 6 of ovine CAST.
Representative sheep for the five unique SSCP patterns corresponding to known five
sequences (A-E)
Figure 5.5. PCR-single-strand conformational polymorphism of intron 12 of ovine
CAST. Sheep homozygous for the four unique SSCP patterns are shown plus some
heterozygous sheep
AA AB BB BC CC CD DD DE EE
AA AD DD BD BB BC CC
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5.2.1 Haplotypic diversity within ovine CAST
The polymorphism found in region 1 (exon 6) and 2 (intron 12) allowed the
determination of CAST haplotypes. Nine haplotypes were identified and these results are
presented in table 5.3. The haplotypes identified suggest that historically at least one
intragenic recombination event has occurred in ovine CAST, somewhere between the two
amplified regions (Figure. 5.6).
Table 5.2. Sequences of intron 12 of ovine CAST.
a Position is given relative to the ovine CAST reference sequences (GenBank accession numbers
AF016006-AF016008 for sequences A-C, respectively), with the new sequence D (GenBank accession
number EF669476). Bars represent nucleotides identical to the nucleotides of sequence A and dots
show the absence of nucleotides in this position of the A, B, C sequences compared with sequence D
Table 5.3. Nine different haplotypes spanning region 1 and region 2 of ovine CAST.
Haplotype Region 1 ——— Region 2
(intron 5-exon 6) (intron 12) 
1    A ——— A
2    A ——— B
3    A ——— C
4    B ——— A 
5    B ——— C
6   C ——— B
7   C ——— D
8   D ——— A
9                            E ——— C
Nucleotide
Positiona A B C D 
78 T G — —
114 A — G —
200 G A — —
233 G — A —
266 G A — —
271 G — T —
287 C T — —
357 A G — —
440 C T — —
453    T
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Figure 5.6. Diagram showing recombination between region 1 (part of intron 5-entire
exon 6) and 2 (part of intron 12) revealed by CAST haplotype analysis.
5.2.2 Association of ovine CAST variation in exon 6 and birth weight and
growth rate to weaning
A significant positive correlation between birth weight and growth rate to weaning
existed (Pearson correlation coefficient, r = 0.306; P≤0.001). However, birth weight was a
poor predictor of growth rate to weaning with an accuracy of 9.4% (r2 = 0.094). For each
CAST sequence, an ANOVA was performed using the significance level of α = 0.05 to assess
the effect of sequence presence (or absence), sire and birth rank (as well as the interactions of
these factors) on birth weight and growth rate.
The presence of the CAST A had a significant effect on birth weight, but was not found
to have a significant effect on growth rate to weaning (Table 5.4). A significant interaction
between birth rank and CAST A (P = 0.005) was also detected for birth weight. When the data
was split by birth rank and the analysis repeated, the significant effect of CAST A on birth
weight, was only observed in single born lambs (P = 0.007) with those lambs possessing
CAST A having a mean birth weight of 6.890 ± 0.183 kg (n = 27), whereas lambs that did not
possess the sequence had a mean birth weight of 6.328 ± 0.130 kg (n = 70). No effect was
observed in the multiple born lambs (P = 0.597).
The presence of CAST B had no significant effect on birth weight or growth rate (Table
5.4). However, for growth rate, an interaction between birth rank and CAST B was observed
(P = 0.038). When the data were split by birth rank and the analysis repeated, no significant
effect of the presence of CAST B on growth rate to weaning was detected in either singles (P 
= 0.077) or multiples (P = 0.186).
Region 1 Region 2
02
A 01
C 
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The presence of CAST C had a significant effect on birth weight, but did not have a
significant effect on growth rate (Table 5.4). A significant interaction between birth rank and
the presence of CAST C on growth rate was observed (P = 0.034). When these data were split
by birth rank and the analysis repeated, the presence of CAST C had a significant effect on
single born lambs (P = 0.034), with those lambs possessing the sequence having a mean
growth rate of 336.032 ± 11.092 g/day (n = 16), whereas lambs that did not possess the CAST 
C sequence had a mean growth rate of 319.544 ± 6.167 g/day (n = 78). No effect of the
presence of CAST C on growth was detected in multiples (P = 0.338).
Analyses of variance (α = 0.05) were also used to assess the effect of sequence copy
number (0, 1 or 2 copies), sire and birth rank (as well as the interactions of these factors) on
birth weight and growth rate. Unfortunately, limited homozygosity (AA, n = 3; BB, n = 261;
CC, n = 3) in the lamb population precluded analyses for CAST A and CAST C. The copy
number of CAST B sequences was not found to effect either birth weight or growth rate to
weaning (P = 0.287 and P = 0.664, respectively). A full factorial model was employed to test
the effect of genotype of ovine CAST on birth weight. A significant difference was observed
between the mean birth weight of those animals with the AB or BB genotypes when compared
to those with the BC genotype (LSD, P = 0.001 and P = 0.005, respectively). The mean birth
weight of those animals with the BC CAST genotype was lighter (AB 6.161 ± 0.100, BB 6.017
± 0.076, BC 5.591 ± 0.130, P = 0.004, Table 5.4).
In general, birth weight has a positive phenotypic correlation with growth rate.
Therefore, a Pearson Correlation was performed to investigate the relationship between birth
weight and growth rate up until weaning. However, the CAST birth weight effect appears to
be independent of growth grate as the presence of the CAST A, B and C sequences did not
have a significant effect on growth rate (P = 0.774, P = 0.384 and P = 0.229), respectively.
This result suggests that those ovine CAST sequences associated with heavier and lighter
mean birth weight, have no effect on growth rate.
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Table 5.4. Associations between variation in ovine CAST exon 6 and birth weight and
growth rate, estimated by analyses of variance.
5.2.3 No association between variation in ovine CAST exon 6 and either
longevity or fecundity in sheep
Genotypes AA (n = 320, 18.6%), AB (n = 594, 34.6%), AC (n = 83, 4.8%), AD (n = 5,
0.3%), BB (n = 556, 32.4%), BC (n = 142, 8.3%), BD (n = 4, 0.2%), CC (n = 13, 0.8%), CD
(n = 1, 0.1%) and BE (n = 1, 0.1%) were observed, with sequence frequencies of A (38.4%), B
(53.8%), C (7.4%) and D (0.4%) respectively. The rare E sequences were not included in
further statistical analysis. Each CAST sequence was tested for its effect on both longevity and
fecundity, using a significance level of α = 0.05. A univariate GLMM (general linear mixed
model) was utilized to analyse the effect of the presence or absence of each variant sequence
on the traits (Table 5.5 and Table 5.6). The effect of breed and flock was corrected for as a
direct effect. There was no significant association between either longevity or fecundity and
variation in the CAST gene when adjusted for major effects (Table 5.5 and Table 5.6).
CAST Status n Birth weight (kg) Growth rate (g)
A Present
Absent
137
325
6.08 ± 0.09
5.91 ± 0.07
(P = 0.019)
291.09 ± 5.29
299.13 ± 3.83
(P = 0.774)
B Present
Absent
443
19
6.02 ± 0.06
5.57 ± 0.22
(P = 0.143)
297.53 ± 3.36
285.67 ± 11.88
(P = 0.384)
C Present
Absent
77
385
5.53 ± 0.12
6.14 ± 0.07
(P ≤ 0.001)
292.74 ± 6.92
296.23 ± 3.86
(P = 0.229)
AB          
BB 
BC 
121
263
61
6.16 ± 0.10
6.08 ± 0.08
5.59 ± 0.13
(P = 0.004)
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Table 5.5. Association between ovine CAST variation in exon 6 and variation in
longevity by unvariate analyses.
CAST Status n Age
(Unadjusted means)
Age
(Breed adjusted)
Age
(Flock adjusted)
A Present
Absent
1007
719
5.23 ± 3.31
5.54 ± 3.22
(P = 0.052)
5.67 ± 0.10
5.57 ± 0.13
(P = 0.535)
5.11 ± 0.10
5.09 ± 0.13
(P = 0.867)
B
 
Present
Absent
1302
424
5.37 ± 3.21
5.35 ± 3.47
(P = 0.924)
5.59 ± 0.10
5.74 ± 0.16
(P = 0.410)
5.08 ± 0.09
5.15 ± 0.16
(P = 0.730)
C
 
Present
Absent
239
1487
6.17 ± 3.18
5.23 ± 3.37
(P = 0.001)
5.94 ± 0.20
5.57 ± 0.09
(P = 0.098)
5.35 ± 0.21
5.065 ± 0.081
(P = 0.203)
D
 
Present
Absent
10
1716
5.60 ± 3.89
5.36 ± 3.27
(P = 0.818)
5.89 ± 0.98
5.62 ± 0.08
(P = 0.785)
5.197 ± 0.10
5.101 ± 0.08
(P = 0.924)
Table 5.6. Association between ovine CAST variation in exon 6 and variation in
fecundity by unvariate analyses.
CAST Status n Average lambs/year
(Unadjusted means)
Average
lambs/year
(Breed adjusted)
Average
lambs/year
(Flock adjusted)
A Present
Absent
402
256
1.71 ± 0.46
1.86 ± 0.47
(P = 0.001)
1.72 ± 0.02
1.72 ± 0.03
(P = 0.962)
1.77 ± 0.02
1.78 ± 0.02
(P = 0.808)
B
 
Present
Absent
494
164
1.81 ± 0.47
1.65 ± 0.47
(P = 0.001)
1.71 ± 0.02
1.74 ± 0.03
(P = 0.305)
1.77 ± 0.02
1.79 ± 0.03
(P = 0.546)
C
 
Present
Absent
73
585
1.87 ± 0.42
1.76 ± 0.48
(P = 0.063)
1.79 ± 0.04
1.71 ± 0.02
(P = 0.105)
1.82 ± 0.04
1.77 ± 0.01
(P = 0.189)
D
 
Present
Absent
4
654
1.49 ± 0.29
1.77 ± 0.47
(P = 0.229)
1.93 ± 0.19
1.72 ± 0.01
(P = 0.263)
2.01 ± 0.17
1.77 ± 0.01
(P = 0.153)
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5.3 Discussion
There are a number of studies reporting variation in CAST exon 6 (H. Zhou et al.,
2007a) and intron 12 (Palmer et al., 1998; Palmer et al., 2000; Roberts et al., 1996). In this
chapter, using a large number of sheep, I investigated these regions to identify if more
variation exists and if this variation is associated with various production traits including
longevity and fecundity in sheep.
Previously, three sequences had been described at intron 12 of ovine CAST (Roberts et
al., 1996), but the PCR product that was used to reveal these was too large for optimal use in
PCR-SSCP analysis. I therefore designed new primers within this region to amplify a smaller
fragment, that included all known polymorphic sites and which in turn resulted in the
detection of a four sequences.
All the previously described nucleotide variation in exon 6 was found in the sheep
studied, along with a new intron 12 sequence. An analysis of the extended haplotypes through
the exon 6 to intron 12 region revealed nine haplotypes and with evidence of recombination
between the two regions that were typed. At least one recombination event had occurred
historically in the region between exon 6 and intron 12 (Figure 5.6).
As no complete ovine CAST gene sequence is yet available, the bovine CAST gene
sequence was searched for potential sequence motifs associated with DNA recombination.
Multiple chi sequences (5’-GCTGGTGG-3’) were presented in intron 4, intron 7 and intron
17 of bovine CAST. In addition, chi-like sequences (GCTGGG) are found in a few intron
regions of the bovine gene and the reported ovine mRNA sequences. Finally an 8-mer perfect
inverted repeat sequence (CAATATGT/ACATATTG) was found between nucleotides -40
and -49 upstream of the ovine CAST exon 6 locus. Inverted repeat (or palindromic) sequences
have been reported to be associated with break points during recombination events. The
presence of chi sequences (5’-GCTGGTGG-3’) (Giordano et al., 1997), chi-like sequences
(GCTGGG) (Matsuno et al., 1992) and palindromic sequences (Krawinkel et al., 1986) has
been reported to be important for gene conversion, and so it might be hypothesised that this is
generating new haplotypes at the ovine CAST gene. Intragenic recombination is not
uncommon, and recently there have been reports of it occurring in the Norwegian goat casein
genes (Hayes et al., 2006) and European rabbit casein CSN3 (Carneiro & Ferrand, 2007).
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Several studies have reported genetic variation in bovine CAST, including coding region
variation (Chung et al., 1999) and non-coding region variation (Juszczuk-Kubiak et al., 2008;
Schenkel et al., 2006).
Extended haplotypes of CAST have not been reported in cattle and accordingly,
undetected variation potentially including intragenic recombination may well occur in this
species. This may weaken the utility of the current bovine CAST gene-markers for meat
tenderness, which are based around the testing of single nucleotide variation in CAST. For
example, the Igenity Tender-GENE marker panel consists of two μ-calpain SNPs and a CAST
SNP known as UoG-CAST (Schenkel et al., 2006). The UoG-CAST marker is a G/C
nucleotide substitution in the intronic sequence between exon 5 and 6 of CAST (base 282 of
accession # AY008267). In contrast, a A2959G SNP in the 3’ un-translated region (UTR) is
used in the GeneSTAR Tenderness test panel (Genetic Solutions Pty. Ltd., Albion, Australia).
The finding of nine extended haplotypes in sheep suggests that cattle may also be more
polymorphic at CAST than has been reported. This contention would be supported by the four
haplotypes described in a reasonably small (n = 570) sample of pigs (Barendse, 2002). The
failure to recognise more extensive or complex polymorphism in bovine CAST and the
possibility of intragenic recombination may also explain why a recent large-scale study of
Argentine beef cattle failed to confirm the value of the commercial gene-marker tests (Corva
et al., 2007). This study utilised the GeneSTAR Tenderness test. If the single nucleotide
substitutions typed in this commercial test was associated with variation elsewhere in the gene
that was not consistent with what Barendse et al. (2002) had described previously and that
also affected meat tenderness in a different way, then Corva et al. (2007) results could be
explained. In effect a single nucleotide substitution would not be revealing the true
complexity of the genome or its potential phenotypic effects.
Haplotypic diversity in ovine CAST seems to be high with evidence of recombined
haplotypes. This might be important in generating even greater genetic diversity. It is however
conceivable that further genetic variation exists, especially when more sheep from different
breeds are analysed and as genotyping methods are developed that enable variation across the
extended CAST gene region to be easily assessed. An understanding of the nature and extent
of CAST genetic diversity across a large number of breeds should enable more comprehensive
study of association between CAST and various phenotypes to be undertaken.
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In the association study reported here a large number of sheep of known phenotype
were studied. Phenotypic measures included birth weight, growth rate, longevity and
fecundity. Exon 6 encoding 114 amino acids is the largest exon in the L domain (Table 5.1).
The L domain has no known calpain inhibitory function, but it is known to be responsible for
binding to biological membranes at the hydrophobic phospholipids (Mellgren et al., 1989). In
addition, Melloni et al. (2006) have shown that the L domain binds to the catalytic domain II
of calpain and that calpain undergoes a conformational change, increasing its ability to act as
a protease at physiological levels of Ca2+ ions.
Barendse et al. (2007) have shown that nucleotide substitutions found in bovine CAST
may have a role in affecting the activation of calpain by changing its hydropathy. They have
assessed several non-synonymous amino acid substitutions, which are located in the L
domain, inhibitory domains and the 3’ UTR region and calculated the change in hydropathy
(Kyte & Doolittle, 1982). Amino acid substitutions CAST:c.155C>T (Pro52Leu) and
CAST:c.143A>G (Ser48Gly) located in the second exon of the L domain (NM_174003.2),
change bovine CAST hydropathy. Pro52Leu has the largest hydropathy change from -1.6 to
+3.8, while Ser48Gly changes hydropathy from -0.4 to -0.8. Pro52Leu was also associated
with beef tenderness traits in the study (Barendse et al., 2007). This suggests that the
increased hydropathy is associated with CAST binding activity.
Among the CAST sequences (A to E) reported at exon 6 (H. Zhou et al., 2007a), CAST C 
would create a non-synonymous substitution at position 134 (Gln to Leu) of the peptide.
Interestingly, this amino acid substitution changes hydropathy from -3.5 to +3.8. This change
is even greater than the substitution of Pro52Leu in cattle. It could therefore influence the
binding of CAST to cell membranes and in the case of CAST C, the hydropathy change would
seem to suggest a large increase in membrane-binding activity.
It has been suggested that one role of CAST in skeletal muscle growth in cattle (Chung
et al., 2001), pig (Kurly et al., 2003) and sheep (Nassiry et al., 2006) may contribute to
maintaining body weight in livestock. In sheep, Sumantri et al. (2008) have reported that
polymorphism in CAST is associated with body weight. In addition, other studies have
reported that genetic variation of ovine CAPN 3 (Chung et al., 2007) and porcine CAST (Choi
et al., 2006) are associated with birth weight and body weight in sheep and pigs respectively.
Calpain 3 (CAPN3) is a muscle-specific calpain species and has special function in
maintaining muscle cells. The ubiquitous calpains (µ-calpain and m-calpain), calpain 3 and
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CAST seem to have essential but distinct roles during the onset of myogenesis. CAST is
therefore an excellent candidate gene for controlling growth in livestock.
Birth weight in sheep is one of the greatest influences upon lamb mortality due to
starvation and cold exposure (Gudex et al., 2005). Lamb survival is a critical issue in
attempting to increase lambing percentage, which is a major contributor to higher profits on
New Zealand sheep farms. In the sheep industry, many sheep breeders and farmers have
selected and bred ewes for increased fecundity. The increasing fecundity in modern sheep
breeds has led to higher numbers of twins and triplets in the sheep industry. As a result, the
increased proportion of ewes having triplets is of concern to farmers and to industry as lamb
death is higher in multiple-born lambs than single born lambs (Everett-Hincks et al., 2007;
Everett-Hincks et al., 2005b; Kerslake et al., 2005). Lambs from multiple births are typically
smaller at birth.
There is a clear relationship between lamb birth weight and the survival rate of lambs.
This indicates that increasing birth weight could be an advantage to the survival of twin and
triple lambs. On the other hand, lambs with heavier birth weights have been reported to be the
predominant factor leading to lambing problems or dystocia in sheep (Fogarty, 1992).
Traditionally, heavier lambs were thought to contribute to the incidence of dystocia in sheep
(Alexander, 1984), especially with single lambs (Fogarty, 1992) and that this leads to the
death of many lambs and ewes. In contrast, it has recently been suggested that dystocia plays
a significant role in triplet-born lamb deaths (Everett-Hincks & Dodds, 2008; Kerslake et al.,
2005) Everett-Hincks et al, 2008), which collectively would suggest that overly light and
overly heavy lambs would cause issues with lamb survival. Accordingly, although increasing
birth weight might improve lamb survival, it needs to be balanced against possible increases
in dystocia. Equally while increasing fecundity may improve productivity, it might also lead
to increased number of dystocia prone triplets, suggesting a “balance” is needed between
lamb size and fecundity.
Ovine CAST variation in exon 6 had a significant effect on birth weight in single lambs,
but not on growth rate in sheep (Table 5.4). The presence of CAST A was associated with
increased average birth weight (6.084 ± 0.093, P = 0.019) while the presence of CAST C was
associated with decreased average birth weight (5.529 ± 0.122, P ≤ 0.001). This suggests that
CAST is a regulator of birth weight in sheep and it may enable better management of
optimum birth weight.
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There was no significant association between either longevity or fecundity and variation
in ovine CAST exon 6 in any of the analyses (Table 5.5 and 5.6). This would suggest that
either 1) the sequences described in H. Zhou et al. (2007) may not affect longevity or
fecundity in sheep, or 2) that the variation that may affect longevity or fecundity is found in
another region of the CAST gene or 3) that in sheep, unlike cattle (Garcia et al., 2006) this
gene does not affect these traits.
Other studies have not found genetic associations with longevity and fertility in
different livestock. It might therefore be that the CAST variation in cattle may affect some
other trait or traits that would lead indirectly to a cow being culled. In dairy cattle, the major
“risk factors” for being culled are reduced milk production, increased lameness and mastitis
susceptibility. If CAST affects any of these traits directly, then indirectly it may also affect
longevity and fertility in dairy cattle. In this respect it might be interesting to look at the effect
of ovine CAST variation on longevity and fertility in milking sheep.
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Chapter 6
A role for TLR4 in longevity and fecundity?
Toll-like receptors (TLRs) are highly conserved trans-membrane proteins that play an
important role in the recognition and elimination of microbial pathogens (Uematsu & Akira,
2006). Recognition of their ligands leads to stimulation of a series of signalling pathways
resulting in acute host responses (Blander, 2008; Netea et al., 2008). These signalling
pathways play an important role in immune response and inflammation, and are critical for
host survival.
One of the best understood TLR members is TLR4, identified at the genetic level as the
first human homologue of the Drosophila Toll gene (Hashimoto et al., 1988; Medzhitov et al.,
1997). TLR4 is expressed on different immune cells, including classic antigen-presenting
cells (dendritic cells, monocytes and macrophages), as well as B and T cells. This suggests
that the receptor has a primary function in both innate and acquired immunity (Blander, 2008;
Netea et al., 2008; Richards et al., 2008). Different tissues can also respond to inflammatory
stimuli via TLR4, with its expression being observed on epithelial cells, including cells in the
skin, respiratory, intestinal and genitourinary tracts, and on endothelial and smooth muscle
cells (Lu et al., 2008).
Structurally, TLR4 consists of three domains: an extracellular leucine-rich repeat (LRR)
domain, a trans-membrane domain and an intracellular Toll-interleukin-1 receptor (TIR)
domain (Figure 6.1). The extracellular LRR domain is involved in recognition of the
lipopolysaccharide (LPS) of Gram-negative bacteria, the prototypic TLR4 ligand. Other
known exogenous TLR4 ligands are the fusion protein of respiratory syncytial virus and the
envelope protein of mouse mammary tumour virus (Lu et al., 2008; Uematsu & Akira, 2008).
In addition, endogenous molecules can directly or indirectly interact with TLR4, such as heat-
shock proteins (HSPs), hyaluronic acid, β-defensin-2, oxidized-LDL, fibronectin, and amyloid
peptide (Lu et al., 2008; Tsan & Gao, 2004). Thus, TLR4 can be activated by a variety of
exogenous ligands, as well as endogenous molecules.
Activation of TLR4 mediates the activation of transcription factors, such as NF-kB, and
consequently the production of different inflammatory mediators including various cytokines
and chemokines (Lu et al., 2008; Tsan & Gao, 2004). TLR4 activation also induces the
expression of co-stimulatory molecules and the major histocompatibility complex class II
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antigens, molecules which contribute to the establishment of an acquired immune response
(Blander, 2008; Miyake, 2007; Netea et al., 2008; Richards et al., 2008; Zeytun et al., 2007).
Figure 6.1. The structure of bovine TLR4. (a) Trans-membrance proteins with an
extracellular leucine-rich repeat (LRR) domain and a cytoplasmic tail, referred to as the Toll-
interleukin 1 receptor (TIR) domain. (b) Structural domain organization of bovine TLR4:
signal sequence (1-23), putative co-receptor-binding region 1(24-273), putative ligand-
binding region (274-368), putative co-receptor-binding receptor 2 (369-632), transmembrane
region (633-653), proximal cytoplasmic region (654-672), TIR domain (673-819) and distal
cytoplasmic region (820-839) (Takeda et al., 2003; White et al., 2003)
 A role for TLR4 in longevity?
During the aging process, the function and expression of TLR4 may impair activation of
the immune response, leading to an increasing incidence of infectious and age-related
diseases. This may consequently contribute to a decrease in longevity. What-is-more, in
elderly humans, many alterations in the immune system have been observed and recorded as
deleterious, leading to definition of the term immunosenescence to describe this state (Ostan
et al., 2008; Vasto & Caruso, 2004).
N-terminus
C-terminus
Extracellular
Intracellular
LRR-leucine rich repeats
TIR (Toll/IL-1) receptor domain
(a)
(b) LRR domain TIR domain
1 631 662 841
exon 1, 2 exon 3
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Chronic antigen loading from bacteria, viruses, fungi seems to be the major factor in
immunosenescence, and it impacts by reducing the number of naïve T cells while filling the
“immunological space” with expended memory cells (Wherry & Ahmed, 2004). The immune
system therefore loses its ability to mount effective acquired responses, especially to new
antigens. Antigenic stress can also continuously stimulate the immune system through the
activation and generation of inflammatory responses. The increase in inflammation has been
shown to be a factor in age-related diseases such as atherosclerosis and cardiovascular
diseases, Alzheimer disease (Balistreri et al., 2009) and cancer (Grivennikov et al., 2010).
These are all causes of morbidity and mortality in the elderly.
Evidence of a role for TLR4 in aging was initially derived from studies on the LPS-
mediated cytokine responses in blood samples from younger and older subjects (Krabbe et al.,
2004; Pedersen & Bruunsgaard, 2003; Rink et al., 1998). In these studies, TLR4 expression
on neutrophils and lymphocytes was assessed in the young and the elderly subjects using a
flow cytometry approach (Fulop et al., 2004; Van Duin & Shaw, 2007). Interestingly, no
changes in TLR4 expression on neutrophils was observed with aging, but increased TLR4
expression was found in specific membrane-signalling micro-domains (called lipid rafts) and
non-raft membranes in older subjects without LPS stimulation, when compared to the
neutrophils of the younger subjects (Fulop et al., 2004).
It has also been demonstrated that aging of the brain is associated with regulation of
TLR4 expression. Its expression is up-regulated in mouse brains as age increased (Huang et
al., 2008). The increased TLR4 expression in the brain may contribute to increased chronic
inflammation, which is associated with the onset of age-related neurodegenerative diseases.
Thus, longevity might be affected by things that affect the expression of TLR4.
 A role for TLR4 in fecundity?
TLR4 is involved in innate immunity in both the female and male reproductive systems
and plays an important role in eliminating pathogens in the reproductive cells (Girling &
Hedger, 2007; Herath et al., 2007; Shimada et al., 2008). Interactions between the innate
immune system and reproductive system have important consequences for fecundity and
reproductive health in general. In the female, TLR4 has been implicated in critical aspects of
ovarian, endometrial and placental function, as well as in ovarian cancer and pelvic
inflammatory disease (Fazeli et al., 2005; Horne et al., 2008). In the male, TLR4 appear to
play a role in the control of testicular steroidogenesis and spermatogenesis in disease, and
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potentially during normal function as well (Palladino et al., 2007; Rodrigues et al., 2008).
Recent studies have suggested a role for TLR4 in prostate cancer (Cheng et al., 2007).
There is increasing evidence for the involvement of TLR4 in fertilisation, and the
physiology of reproduction. In female mouse, cow and human ovaries, TLR4 is expressed and
induced in granulose and cumulus cells (Salustri et al., 2004; Varani & Matzuk, 2002).
During fertilisation, sperm cells induce cumulus cells to release specific cytokines and
chemokines. Shimada et al. (2008) have shown that this event is dramatically reduced in the
presence of TLR4 blocking antibodies and suggest that the expression of TLR4 may be
important in regulating the interaction between sperm cells and cumulus cell-oocyte
complexes.
TLR4 expression has also been reported in uterine (Soboll et al., 2006) and oviductal
tissue and it is reported to affect pre-term labour (Girling & Hedger, 2007). TLR4 may also
respond to factors in addition to sperm that enter the reproductive tract, including bacteria
(Girling & Hedger, 2007). Based on these observations, the role of TLR4 in the reproduction
system has received significant attention from reproduction biologists, and the possibility that
it directly affects fecundity in sheep is certainly worthy of investigation.
 Variation in TLR4
A cDNA sequence for bovine TLR4 has been reported, with 72% and 65% amino acid
similarities to human and mouse TLR4, respectively (Werling & Jungi, 2003). In addition,
table 6.1 shows that bovine, porcine, human, murine and avian TLR4 share the same genomic
structure. This suggests that the TLR4 gene is conserved, with a similar genetic structure
among various species, including sheep.
Table 6.1. Comparison of the size in bp of various parts of the human, pig, cattle, mouse
and chicken TLR4 gene. Adapted from (Leveque et al., 2003)
 Human Pig Cow Mouse Chicken  
Exon1-cds 93a 93 93 93 105
Intron 1 3997 3866 4547 5972 934
Exon 2 167b 167 167 167 167
Intron 2
Exon 3-cds
3659 2582 2749 5168 984
2260 2265 2266 2251 2260
a-Same size found in sheep, pygmy chimpanzee and live baboon
b-Same size found in sheep, gorilla, pygmy chimpanzee and olive baboon
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Sequencing of TLR4 in individual mammals has identified, intra-species genetic
variation in the LRR ligand-recognition domain (Smirnova et al., 2000), while the TIR
domain was highly conserved across species. The diversity in the LRR domain seems to
accommodate recognition of different pathogen-associated molecular patterns (PAMPs) in
different species, and this is hypothesised to be the result of evolutionary pressure induced by
pathogens on the host (Mushegian & Medzhitov, 2001).
The LRR domain of TLR4 contains LRRs of different size and abundance. These LRRs
are protected by special LRR-N terminal end and LRR-C-terminal end motifs. The defining
feature of an LRR repeat is the highly conserved 11-residue hallmark sequence
LxxLxLxxNxL (with ‘x’ being any amino acid). Other hydrophobic residues can substitute
the leucine residues at the consensus positions (Matsushima et al., 2007). Within each LRR
repeat, the conserved residues provide a rigid structural framework, whereases variable
residues are available for interaction with ligands. This interaction is further supported by
insertions into the highly conserved 11 amino acid segment (Bell et al., 2003; Kajava et al.,
1995; Kobe & Deisenhofer, 1995) (Table 6.2).
There is evidence that variation in the LRRs of TLR4 is associated with altered immune
responses to pathogens and results in variation in disease susceptibility. Smirnova et al.
(2001) have sequenced the entire TLR4 gene of 348 humans of different ethnic background
and reported on the presence of SNPs in both the extracellular and cytoplasmic domains. They
found Asp299Gly and Thr399Ile in the TLR4 extracellular domain in Caucasian populations.
These occur in the LRR region of LRR11 and LRR 15, respectively (Table 6.2). These
substitutions have recently been shown to reduce TLR signalling (Arbour et al., 2000) and
change the ligand-binding properties of the receptor (Rallabhandi et al., 2006), and this may
negatively influence immune responses. In this respect, they might be considered to be
mutations. In addition, Ohara et al. (2006) reported that one mutation, Thr135Ala in LRR5,
was associated with gastric carcinoma. Variation in TLR4 could therefore become important
in understanding the role of genetically encoded control of immunity, which might affect both
longevity and fecundity.
Mounting evidence for associations between TLR4 variation and immunological-related
traits in mammals, has important implications for livestock. TLR4, is a major sensor of
infections by Gram-negative bacteria, and is a strong candidate gene for variation in response
to a number of commercially important animal diseases related to impaired respiratory
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immune protection (Chapes et al., 2001; Hawn et al., 2005) and intestinal infections
(Eckmann, 2006; Fukata et al., 2005).
Table 6.2. The twenty-three reported LRRs in human TLR4.
TLR4 LRR Position a Leucine-rich (LxxLxLxxNxL) repeat Mutation
LRR1 35-55 NITYQCMELNF  YKIPDNLPFS 
LRR2 56-79 TKNLDLSFNPL  RHLGSYSFFSFPE 
LRR3 80-103 LQVLDLSRCEI  QTIEDGAYQSLSH 
LRR4 104-127 LSTLILTGNPI  QSLALGAFSGLSS 
LRR5 128-151 LQKLVAVETNL  ASLENFPIGHLKT T135A
LRR6 152-176 LKELNVAHNLI  QSFKLPEYFSNLTN 
LRR7 177-204 LEHLDLSSNKI  QSIYCTDLRVLHQMPLL 
LRR8 205-227 NLSLDLSLNPM  NFIQPGAFKEIR 
LRR9 228-254 LHKLTLRNNFD  SLNVMKTCIQGLAGLE 
LRR10 255-284 VHRLVLGEFRN  EGNLEKFDKSALEGLCNLT 
LRR11 285-309 IEEFRLAYLDY  YLDDIIDLFNCLTN D299G
LRR12 310-331 VSSFSLVSVTI  ERVKEFSYNFG 
LRR13 332-352 WQHLELVNCKF  GQFPTLKLKS 
LRR14 353-374 LKRLTFTSNKG  GNAFSEVDLPS 
LRR15 375-400 LEFLDLSRNGL  SFKGCCSQSDFGTTS T399I
LRR16 401-423 LKYLDLSFNGV  ITMSSNFLGLEQ 
LRR17 424-448 LEHLEFQHSNL  KQMSEFSVFLSLRN 
LRR18 449-472 LIYLDISHTHT  RVAFNGIFNGLSS 
LRR19 473-497 LEVLKMAGNSF  QENFLPDIFTELRN 
LRR20 498-521 LTFLDLSQCQL  EQLSPTAFNSLSS 
LRR21 522-545 LQVLNMSHNNF  FSLDTFPYKCLNS 
LRR22 546-570 LQVLDYSLNHI  MTSKKQELQHFPSS 
LRR23 571-595 LAFLNLTQNDF  ACTCEHQSFLQWIK 
a Amino acid position relative to the human TLR4 reference sequence (GenBank accession
number AAF05316). Some reported missense mutations are highlighted in red.
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In sheep, 14 SNPs have been detected in exon 3 of ovine TLR4 which contains a
putative ligand binding region, while only seven SNPs are found in the corresponding regions
of bovine TLR4 (H. Zhou et al., 2007b). This suggests that sheep are more diverse than cattle
at this locus, although the reason for this is not known.
The effect of genetic variation in exon 3 of ovine TLR4 has not been studied and
nothing is known of if effects on longevity and fecundity. Exon 3 encodes the LRR, and in
this chapter, using a large number of sheep, I investigated this region to identify if more
variation exists, and if this variation is associated with ovine longevity and fecundity.
6.1 Materials and Methods
6.1.1 Sheep investigated to define genetic variation in exon 3 of TLR4
In total 1670 Merino, Corriedale, NZ Romney, Poll Dorset, and other NZ cross-bred
sheep were investigated in this study. These sheep were selected from different stud farms in
New Zealand.
6.1.2 Sheep and data collection for assessing longevity and fecundity
Sheep blood samples with sheep longevity and fecundity data were used (See chapter
2.2 for sheep studied and the collection of longevity and fecundity data) to assess the effect of
genetic variation of TLR4 on sheep longevity and fecundity.
6.1.3 DNA extraction from blood on FTA cards
(See chapter 3.1.3)
6.1.4 PCR primer design and synthesis
To amplify fragments of suitable size for SSCP analysis, PCR primers were designed
based on the published ovine sequences (H. Zhou et al., 2007b) (Figure 6.2), to amplify a 256
bp fragment within exon 3 of the ovine TLR4. These were TLR4-up2 (5’-
TCTTTAGGAAGTCTACAAGC-3’) and TLR4-dn2 (5’-AATGCTTCAGGTTGGTTGTC-
3’). The primers were synthesised by Integrated DNA Technologies (Coralville, IA, USA).
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Figure 6.2. The location of PCR primers in ovine TLR4. The position of TLR4 cDNA is
related to the bovine TLR4 sequences (GenBank accession no. AY277040). LRR=leucine rich
region; TIR=Toll-interleukin 1 receptor domain
6.1.5 PCR-SSCP analysis
Amplifications were performed in a 20 µL reaction containing the genomic DNA on a
1.2 mm punch of FTA card, 0.25 µM of each primer, 150 µM dNTPs (Eppendorf, Hamburg,
Germany), 0.5 U Taq DNA polymerase, and 1x the reaction buffer supplied with the enzyme
(containing 1.5 mM MgCl2) (Qiagen, Hilden, Germany). Amplification was carried out in an
iCycler (Bio-Rad Laboratories, Hercules, CA, USA ) and consisted of denaturation at 94 ºC
for 2 min, followed by 35 cycles of 94 ºC for 30 s, 60 ºC for 30 s, and 72 ºC for 30 s, with a
final extension step at 72 ºC for 5 min. Amplicons were visualised by electrophoresis in 1%
Seakem LE agarose (Bio Whittaker Molecular Applications, Rockland, ME) gels, using 1 x
TBE buffer (89 mM Tris, 89 mM boric acid, 2 mM Na2EDTA) containing 200 ng/mL
ethidium bromide.
A 0.7 µL aliquot of each amplicon was mixed with 7 µL of loading dye (98%
formamide, 10 mM EDTA, 0.025% bromophenol blue, 0.025% xylene-cyanol), and after
denaturation at 95 ºC for 5 min, samples were rapidly cooled on wet ice and then loaded on 16
cm × 18 cm, 14% acrylamide:bisacrylamide (37.5:1: Bio-Rad) gels. Electrophoresis was
performed using Protean II xi cells (Bio-Rad), at 300 V for 18 h at 4 ºC in 0.5 × TBE buffer.
The gels were silver-stained according to the method of Sanguinetti et al. (1994).
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6.1.6 DNA sequencing and sequence analysis
(See chapter 3.1.6 and 4.1.6)
6.1.7 Genotyping of the ovine TLR4 for longevity and fecundity trait analysis
The genetic association study was carried out on 1726 ewes from seven breeds which
are NZ Romney (n = 340), Corriedale (n = 318), Merino (n = 326), Polwarth (n = 129), Kelso
(n = 174), Coopworth (n = 439) and selected from 36 different flocks. Overall there were nine
hundred and fifty eight older ewes and seven hundred and sixty-eight young ewes (2 years
old). Lambing information was available for six hundred and fifty-eight of the older ewes for
assessing their fecundity. These sheep were genotyped using the above method.
6.1.8 Statistical analyses
Data was analysed using SPSS version 17 (SPSS Science Inc., Chicago, IL, USA), with
a two-tailed significance level of α = 0.05.
A general linear mixed model (GLMM) was used to assess the effects of each of the
TLR4 sequences. The effect of the presence of sequences A, B, C and D at TLR4 on longevity
and fecundity was assessed with this model. These analyses were run as unadjusted models
and additionally, in separate models adjusted for flock and breed effects. These were included
as random factors.
6.2 Results
6.2.1 Development of a PCR-SSCP technique for detecting variation in ovine
TLR4
Amplicons of 256 bp were obtained with all the sheep DNA samples using the TLR 4-
up2 and -dn2 primers. Upon SSCP analysis, seven patterns (A-G) where observed (Figure
6.3). Either one or two of these patterns were observed for each sheep studied, which defines
homozygous and heterozygous genotypes at the ovine TLR4 locus, respectively.
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Figure 6.3. PCR-single-strand conformational polymorphism of ovine TLR4.
Representative sheep for the seven unique SSCP patterns.
Four of the PCR-SSCP patterns (A-D) were obtained from nucleotide sequences that
had been reported previously, while E-G represented three new nucleotide sequences and
these were deposited into the NCBI GenBank with accession numbers EU786152-4 giving a
total of seven sequences in a 256 bp fragment of this gene (Table 6.3). This variation leads to
10 different amino acid changes in the putative ligand-binding region summarised in (Table
6.3).
A B C D E F G
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Table 6.3. Sequences variation in ovine TLR4.
SNP Positiona A  B   C D Eb Fb Gb Amino acid
substitution
T/C 955 T T T T T C T Ser/Pro
T/C 1013 T T T T C T T No change
G/C 1032 G G C G G G G Lys/Asn
A/G 1045 A A A A A G A Lys/Glu
G/A 1052 G G A G G G A Arg/His
T/C 1066 T C T T T T T Phe/Leu
A/G 1088 A A G G A A A Asp/Gly
T/C 1091 T T C C T T T Val/Ala
C/G 1097 C C G G C G C Thr/Ser
C/T 1132 C C T T C C C No change
G/C 1166 G G G G G C G Ser/Thr
G/T 1183 G G T T G G G Asp/Tyr
Sequence
Frequency
(n = 1670)
% 47.1 35.8 11.5 4.7 0.3 0.3 0.3
a Nucleotide position relative to the bovine TLR4 reference sequence (GenBank accession
number AY297040). List accession numbers of A-D (DQ451551-DQ451554). bGenBank
accession numbers for the three newly identified sequences E-G are EU786152 – EU786154,
respectively).
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Table 6.4. Position of amino acid substitutions in ovine TLR4.
a Amino acid position relative to the human TLR4 reference sequence (GenBank accession
number AAF05316). Residues of missense mutations are highlighted in red.
6.2.2 No association between variation in ovine TLR4 and longevity, but
possible association with fecundity
Table 6.5 shows the frequencies of the ovine TLR4 genotypes in the young and old
sheep. A and B are the most common sequences and account for over 80% of the total
frequency.
Table 6.5. TLR4 genotype frequencies in older and younger ewe groups.
TLR4
LRR
aPosition Ovine TLR4 A sequence
Leucin-rich (LxxLxLxxNxL) repeat
TLR4
sequence
Mutation
LRR12 310-331 VSVISLLSISL GSLQALLKDFR TLR4 F S319P
LRR13 332-352 WQHLEMINCDF DKFPALKLRS TLR4 C K344N
 TLR4 F K349E
 TLR4 C,G R351H
LRR14 353-374 LKKFVFTDNKD VSTFTKTELPS TLR4 B F356L
 TLR4 C,D D363G
 TLR4 C,D V364A
 TLR4 C, D, F T366S
LRR15 375-400 LQYLDLKRNHL SFKSCCSHTDFGTTN TLR4 F S389T
 TLR4 C,D D395Y
Category AA AB AC AD BB 
  
BC             
 
BD
 
CC 
 
CD DD Total
Old n
(%)
182
19.0
218
22.8
91
9.5
46
4.8
189
19.7
144
15.0
32
3.3
43
4.5
9
0.9
4
0.4
958
100
Young n
(%)
183
23.8
159
20.7
73
9.5
38
4.9
145
18.9
87
11.3
33
4.3
31
4.0
14
1.8
5
0.7
768
100
Total n
Frequency (%)
365
21.1
377
21.8
164
9.5
84
4.9
334
19.4
231
13.4
65
3.8
74
4.3
23
1.3
9
0.5
1726
100
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In an analysis of all of the ewes (n = 1726), sequences, A, B, C and D of ovine TLR4
were assessed to see if they were associated with longevity and fecundity. Table 6.6 and 6.7
show the effect of longevity and fecundity for the each TLR4 sequences in the unadjusted
model, and flock and breed adjusted models.
There was no significant association between longevity and variation in the ovine TLR4
in any adjusted models (Table 6.6).
In the fertility analysis, the unadjusted model suggests a relationship between the A, B,
C sequences of TLR4 and fecundity (P = 0.001) (Table 6.7). The presence of TLR4 C was
associated with decreased fecundity when the model was corrected for breed (1.64 ± 0.03, P =
0.004). The presence of TLR4 A also tended to decrease fecundity when the model was
corrected for flock (1.75 ± 0.02, P = 0.066). Other TLR4 sequences had no association with
either an increase, or decrease, of fecundity in any adjusted models.
Table 6.6. Association of variation in ovine TLR4 with variation in longevity by
univariate analysis.
Sequence Status n Age
(Unadjusted means)
P values
A
 
Present
Absent
999
736
5.41 ± 3.34
5.30 ± 3.19
Unadjusted         P = 0.470
Breed adjusted   P = 0.859
Flock adjusted    P = 0.928
B
 
Present
Absent
1007
719
5.45 ± 3.22
5.24 ± 3.34
Unadjusted         P = 0.275
Breed adjusted   P = 0.313
Flock adjusted    P = 0.275
C Present
Absent
492
1234
5.39 ± 3.19
5.35 ± 3.31
Unadjusted         P = 0.818
Breed adjusted   P = 0.479
Flock adjusted    P = 0.298
D
 
Present
Absent
181
1545
4.71 ± 2.96
5.44 ± 3.30
Unadjusted         P = 0.004
Breed adjusted   P = 0.219
Flock adjusted    P = 0.590
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Table 6.7. Association of variation in ovine TLR4 with variation in fecundity by
univariate analysis.
6.3 Discussion
Genetic variation in TLR4 has been associated with altered immune responses to
pathogens, and variation in disease susceptibility in humans and other mammals. In this
chapter, using a large number of sheep, I investigated genetic variation in ovine TLR4 and if
this variation is associated with longevity and fecundity.
Genetic variation in exon 3 of ovine TLR4 has been described previously with four
sequences identified (H. Zhou et al., 2007b). However, a simple and reliable genotyping
method for ovine TLR4 variation was required to enable the study of large numbers of sheep.
In this chapter, PCR-SSCP conditions were developed to detect variation in exon 3, and so as
to supersede less reliable methods including PCR-restriction fragment length polymorphism
analysis (X. Chen & Sullivan, 2003; Lorenz et al., 2001), sequence-based typing (Bochud et
al., 2007; X. Chen & Sullivan, 2003), and allele-specific oligonucleotide hybridization
(Rickert et al., 2005). The PCR-SSCP method developed could not only reveal the four
sequences (A to D) that had been reported previously, but also revealed a further three new
sequences (E to G) in a population of 1670 NZ sheep. Given this result, it is possible that
PCR-SSCP approaches could also be readily adaptable to typing different TLRs in both sheep
Sequence Status n Average
lambs/year
(Unadjusted means)
Average
lambs/year
(Flock adjusted)
Average
lambs/year
(Breed adjusted)
A
 
Present
Absent
386
272
1.65 ± 0.45
1.95 ± 0.45
(P = 0.001)
1.75 ± 0.02
1.80 ± 0.02
(P = 0.066)
1.72 ± 0.02
1.73 ± 0.03
(P = 0.656)
B
 
Present
Absent
392
266
1.86 ± 0.46
1.63 ± 0.46
(P = 0.001)
1.79 ± 0.02
1.75 ± 0.02
(P = 0.143)
1.74 ± 0.02
1.70 ± 0.02
(P = 0.327)
C
 
Present
Absent
152
506
1.90 ± 0.44
1.73 ± 0.48
(P = 0.001)
1.73 ± 0.03
1.78 ± 0.02
(P = 0.124)
1.64 ± 0.03
1.75 ± 0.02
(P = 0.004)
D
 
Present
Absent
77
581
1.76 ± 0.56
1.77 ± 0.46
(P = 0.878)
1.77 ± 0.04
1.77 ± 0.01
(P = 0.961)
1.76 ± 0.04
1.72 ± 0.02
(P = 0.341)
Chapter 6: A role for TLR4 in longevity and fecundity?
128
and other species, and in the context of TLR4 typing it seems possible that further genetic
variation might be found as more sheep of different breeds are typed.
The human and ovine TLR4 extracellular domain consists of 23 predicted LRRs that
interact with different types of ligands (Ohara et al., 2006). The central region of the
extracellular domain of human TLR4 (LRR9 to LRR14), is involved in binding putative co-
receptors and ligands (Bell et al., 2003) and mutations in this region have been significantly
associated with a response to LPS (Arbour et al., 2000) and with susceptibility to a variety of
diseases (Hawn et al., 2005; Lorenz et al., 2002; Mockenhaupt et al., 2006). This suggests that
variation in this region of TLR4 in sheep may also affect the function of TLR4 in immune
response.
The seven TLR4 sequences (A to G) identified in the sheep studied, would if expressed,
result in amino acid substitutions located in LRR13, 14 and 15 (Table 6.4), which contain a
putative ligand binding region (amino acids 274-368). Most of the amino acid substitutions
were conservative with the amino acid replaced by a similar type of amino acid. However,
TLR4 C and D sequences would result in substitutions that were semi-conservative or radical
(Lys344Asn, Asp363Gly and Asp395Tyr). Lys344Asn and Asp395Tyr are changes from
charged to non-charged amino acids, while Asp363Gly is a change from a polar to a non-
polar (hydrophobic) amino acid. The TLR4 C sequence contains all of these amino acid
substitutions.
In humans, two TLR4 missense mutations, Asp299Gly and Thr399Ile, have been
associated with longevity (Balistreri et al., 2009). These mutations were found in LRR11 and
15, respectively (see table 6.2) and both of the mutations have been predicted to affect a
ligand-binding and co-receptor-binding region, respectively (White et al., 2003). Although the
effect of Asp299Gly and Thr399Ile mutations on TLR4 structure has not been well explained,
Rallabhandi et al. (2006) have revealed a structural model of the extracelluar domain of TLR4
with these mutations. In this structure, the mutations lie on the same face of the scaffold and
form a saddle-like structure that may provide a docking site for either ligand or co-receptor.
Asp299Gly removes both a potential negative charge, and increases rotational freedom about
the peptide bond, which may affect secondary structure immediately adjacent to this residue.
Thus, this structural change in TLR4 could potentially affect ligand interaction.
Ferwerda et al. (2007) have suggested that in humans Asp299Gly and Thr399Ile
mutations have been under evolutionary pressure from pathogens. They have found a high
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variability in the occurrence of these mutations in different ethnic groups. Asp299Gly and
Thr399Ile have been observed at a high frequency in African population, while population
from Asia (Han Chinese, Indonesian, and Papuan) and America (Trio Indians in Surinam) had
very low frequencies (Ferwerda et al., 2007). This suggests that the interaction between the
host innate immune system and infectious disease pressures in particular environments may
have shaped the genetic variation and function of our immune system during the “out-of-
Africa” migration of modern humans.
In the sheep population studied, TLR4 Asp299Gly and Thr399Ile variation was not
found. Position 299 was occupied by asparagine and 399 by threonine. This suggests these
mutations are either very rare, or don’t exist, and therefore they may not be an important
factor in determining ovine longevity. However, in this study, the human missense mutation
at amino acid 363 (Asp363Gly) was also observed in LRR14 of ovine TLR4. Asp363Gly
could change the negative charge of LRR14, and this may affect PAMP recognition.
Ovine TLR4 variation in exon 3 had no significant effect on longevity, but tends to be
associated with fecundity in sheep. The presence of TLR4 C was associated with decreased
fecundity when the model was corrected for “breed” (1.64 ± 0.03, P = 0.004), but not when
corrected for flock. The presence of TLR4 A tended to decrease fecundity, when the model
was corrected for “flock” (1.75 ± 0.02, P = 0.066). Breed and flock were confounded in this
study because most flocks studied were of a single breed. If the association between TLR4 C
and fecundity is to be believed, then it needs to be validated on a larger number of sheep,
where breed and flock are not confounded. If the association is real, then potentially TLR4
variation may be a useful marker of variation in fecundity in sheep.
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Chapter 7
General summary and future directions
This thesis focused on assessing the genetic variation in potential longevity genes and
its impact on longevity and fecundity traits in sheep. The genes studied were chosen based
upon them having been shown to affect longevity or fecundity in humans and/or other
species. The genes chosen were involved in either the control of energy metabolism (IGF1R
and FOXO3; Chapter 3 and 4), protein degradation (CAST; Chapter 5) or immune response
(TLR4; Chapter 6).
In studying sheep longevity it is necessary to investigate whether increasing their life-
span is associated with a decrease in fertility or fecundity as would be suggested by “the
trade-off” concept (Kirkwood & Holliday, 1979). In this study the relationship between
longevity and fecundity in sheep was weak and negative (Chapter 2). This suggests that
selection for increased longevity is unlikely have a major effect on ewe fecundity. Long-lived
ewes could in effect provide both improved production and reproductive performance.
Three novel sequences (A, B, and C) of ovine IGF1R were identified in exon 3 of this
gene and the presence of the C sequence was associated with increased ewe longevity
(Chapter 3). This could be used as a potential way of improving sheep life-span, but only if
further investigations confirm that the C sequence has no negative pleiotropic effect.
Ten nucleotide substitutions defining seven haplotypes (A to G) across the coding
region of ovine FOXO3 were identified and characterised. Haplotype D was subsequently
associated with a decreased mean age in the sheep studied (Chapter 4). However, once again
further study is required to ascertain how genetic variability in ovine FOXO3 may specifically
affect sheep longevity and whether the gene also either directly or indirectly impacts on
factors that may lead to reduced productivity and/or an increased likelihood of culling.
An analysis of the extended haplotypes through the exon 6 to intron 12 region of ovine
CAST revealed nine haplotypes, and subsequent analysis suggested that DNA recombination
may have occurred (Chapter 5). It is still conceivable that even more genetic variation exists,
as more sheep from different breeds are analysed and genotyping methods are developed that
enable variation across the whole CAST gene to be easily assessed in large numbers of sheep.
Thus, further study is needed to characterise the extent of CAST genetic diversity, and across a
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large number of breeds. This would better facilitate more comprehensive study of associations
between CAST variation and phenotypic variation.
No association was observed between variation in the ovine CAST gene and either
longevity or fecundity in sheep studied (Chapter 5), but the CAST variation had a significant
effect on birth weight (Chapter 5). This suggests that CAST might be a regulator of birth
weight in sheep and this finding if better understood may enable better management of
optimum birth weight and also potentially improve lamb survival.
A simple and reliable genotyping method for ovine TLR4 variation was developed and
readied for the study of large numbers of sheep (Chapter 6). Ovine TLR4 variation sequence
variants (A to D) in exon 3 had no significant effect on longevity, but tended to be associated
with fecundity in sheep. The presence of TLR4 A and TLR4 C was associated with decreased
fecundity when the model was corrected for “flock” (1.75 ± 0.02, P = 0.066) and “breed”
(1.64 ± 0.03, P = 0.004), respectively. This result suggests that TLR4 variation may be a
useful marker of variation in fecundity in sheep. Further study with a larger number of
samples in different breeds and flocks would be required to confirm this result.
Recent, advances in molecular genetics and statistical methodology have contributed to
the identification and estimation of the effects of major genes in animal production, and their
potential use in the genetic improvement of livestock. However, there is little research work
the establishment of effective genetic selection methods for increased longevity. While the
work presented in this thesis points to genetic variation in the IGF1R and FOXO3 genes as
potential markers for longevity, and variation in CAST and TLR4 genes as potential markers
for birth weight and fecundity respectively, these are certainly “early” findings and to have
value they will first need to be reproduced and second the underlying biochemistry of the
effect of the genetic variation will likely need greater understanding.
In the genetic association study, longevity data was collected from different breeds that
belonged to 36 flocks of sheep. Few of the farmers had more than one breed and there is
significant variation in longevity between flocks within a given breed, presumably reflecting
different management policies for retaining or culling ewes on different farms. Given that
most farms only have one breed of sheep, then farm and breed are conflicted. Correcting
statistical models for both factors may have created a compounded error, thus either breed or
flock, and not both, needs to be incorporated into in the GLMMs. Alternatively, future
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research needs to be better orchestrated to remove the possibility of having confounded
factors such as breed and farm effects.
It is clear that the results in this study need to be reproduced in order to minimise the
potential error from breed and farm-related factors. This will be needed to illustrate that the
associations haven’t occurred by chance. It would be appropriate that further investigation
involves a larger number of samples and with better control. While this is easy to say, the
logistics of doing this may be challenging.
This study has investigated sheep longevity and its relationship with reproductive
performance, because lamb is currently the main source of income for New Zealand farmers.
It should be possible to obtain increase longevity and maintain the reproductive performance
needed for economic profitability. However, future work needs to be undertaken to find if
links exist between sheep longevity and other production traits.
In cattle, there is relationship between longevity and other production traits including
the weight of the calf and its muscularity (Forabosco et al., 2004). These traits appear to be
important in culling decisions and farmers seems to avoid animals that have calving
difficulties and to retain muscle development. A similar system of culling decision-making
occurs in both commercial and stud sheep farming; therefore it would also be worth
investigating whether sheep longevity affects these traits.
Furthermore, teeth condition is also an important determinant of longevity in
herbivorous animals, and it as reported healthy and long-lasting teeth are heritable (Mekkawy
et al., 2009) in sheep, then this too needs to be considered in future design.
Finding genes involved in dental health would be valuable. For example, the
transcription factor Ctip2 is a critical regulator of the enamel secreting cells during teeth
development and growth (Golonzhka et al., 2009). Enamel is the outermost layer of the tooth
and is important for the prevention of tooth decay or infection. Combined with the use of the
potential longevity genes identified here, such a study could provide more accurate criteria for
selecting sheep for longevity.
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Diagrammatic summary of this thesis
Potential longevity and fecundity genes in sheep
IGF1R gene
(Insulin-like growth factor 1 receptor)
FOXO3 gene
(Forkhead box class O3)
CAST gene
(Calpastatin)
Exon 6 of CAST
L domain region-254bp
Exon 3 of TLR4
Ligand binding region-256bp
Longevity and fecundity data
 1018 older ewes (3 to 16 years old)
 808 young ewes (2 years old)
 698 ewes with fecundity data
 (the average lambs per year
ranged from 1.4 to 2.27)
Birth weight data
 519 NZ Romney lambs (the birth
weight ranged from 2.75 to 8.75)
Assessment of
genetic variation
Statistical analyses
IGF1R
C variant sequence
associated with
increased longevity
FOXO3
D haplotype
associated with
decreased longevity
CAST
C variant sequence
associated with
decreased birth weight
TLR4
C variant sequence
associated with
decreased fecundity
 A hormone receptor
 Lipid & carbohydrate
metabolism
 Regulation of life-span
 A transcription factor
 Regulation of life-span
and fertility
 Control of gene expression
 An endogenous
protease inhibitor
 Regulation of protein
break-down
 Age-related diseases
 Regulation of
body weight
3 variant
sequences
(A to C)
Identification of genetic variation
(PCR-SSCP method, sequencing analysis)
Exon 3 of IGF1R
Ligand binding region-346bp
Exon 2 of FOXO3
DNA binding region-480bp
7 haplotypes
(A to G)
5 variant
sequences
(A to E)
9 haplotypes
with intron 12
 A trans-membrane
receptor
 Regulation of
immunosenescence
 Regulation of
reproductive immunity
TLR4 gene
(Toll-like receptor 4)
7 variant
sequences
(A to G)
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Appendix A: Examples of DNA tests used in improving production and
disease resistance traits in livestock
Trait
category
Species Gene Marker Reference
Congenital
defects
Dairy Cattle
Cattle
Dairy Cattle
Dairy Cattle
Cattle
Pig
BLAD
Citrulinaemia
DUMPS
CVM
Maple syrup urine
RYR
Shuster et al. (1992)
Dennis et al. (1989)
Schwenger et al. (1993)
Borchersen (2001)
Dennis & Healy (1999)
Fuji et al. (1991)
Appearance Pig
Cattle
Cattle
Cattle/Pig
Beef Cattle
CKIT
Red coat colour
Black coat colour
MC1R/MSHR
MGF
Marklund et al. (1998)
Dekker (2004)
Van Eenemmaam et al. (2007)
Genetic
disorder
Cattle Mannosidosis
Dwarfism
Weaver syndrome
Platelet bleeding
Albinism
Berg et al. (1997)
Van Eenemmaam et al. (2007)
Milk quality Dairy Cattle κ-Casein 
β-lactoglobulin
FMO3
Medrano & Aquilar-Cordova (1990)
Lunden et al. (2002)
Feed intake Pig  MC4R Kim et al. (2000)
 
Reproduction
Sheep Booroola
Inverdale
Hanna
Wilson et al. (2001)
Galloway et al. (2000)
McNatty et al. (2001)
Growth and
Composition
Pig
Pig
Beef Cattle
Sheep
Pig
MC4R
IGF-2
Myostatin
Callipyge
CAST
Kim et al. (2000)
Jeon et al. (1999)
Grobet et al. (1998)
Freking et al. (2002)
Ciobanu et al. (2004)
Meat quality Cattle/Pig CAST
CAPN1
CAPN2
RN/PRKAG3
Ciobanu et al. (2004)
Van Eenemmaam et al. (2007)
Ciobanu et al. (2001)
Disease
resistance
Sheep Footrot
Scrapie
Prp
Cold tolerance
Hickford et al. (2004)
Hickford et al. (2008)
Belt et al. (1995)
Forrest et al. (2007)
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Appendix B: DNA variation and effects on reproduction traits in cattle, goat,
pig and sheep
Gene Species DNA variation Effect on trait Reference
ADIPOQ
(Adiponectin)
Pig c.178G>A Fewer stillborn
piglets, shorter
weaning-to-oestrus
intervals
Houde et al.
(2008)
ADIPOR1
(Adiponectin
receptor 1)
Pig c.129A>C Liveborn piglets Houde et al.
(2008)
ADIPOR2
(Adiponectin
receptor 2)
Pig c.112G>A Weaning-to-
oestrus intervals
Houde et al.
(2008)
BMPR-IB
(Bone
morphogenetic
protein receptor
IB)
Sheep FecB mutation,
A746G (Gln249Arg)
Hyperprolific trait
in Booroola
Merino
Mulsant et al.
(2001)
Wilson et al.
(2001)
BMPR-15
(Bone
morphogenetic
protein receptor -
15)
Sheep FecXG mutation,
C718T (Gln239stop)
FecXI mutation,
(Val31Asp)
FecXH mutation,
(Q23stop)
FecXL mutation,
(Cys53Tyr)
FecXB mutation,
(Ser99Ile)
Ovulation rate,
sterility
Inverdale sheep
Hanna sheep
Lacaune sheep
Belclare sheep
Hanrahan et al.
(2004)
Chu et al. (2007)
Galloway et al.
(2000)
Galloway et al.
(2000)
Bodin et al.
(2007)
Hanrahan et al.
(2004)
GDF9
(Growth
differentiation
factor 9)
Sheep FecGHmutation,
(Ser77Phe)
Ovulation rate,
sterility in Belclare
sheep
Hanrahan et al.
(2004)
ESR1
(Estrogen
receptor 1)
Pig c.1227C>T in exon 5 Number of piglets Muñoz et al.
(2007)
FSHβ
(Follicle-
stimulating
hormone β)
Pig BamHI mutation Litter size Li et al. (1998)
PRLR
(Prolactin
receptor)
Pig C1217T, C1283A
G1439A, T1528A
G1600A, G1789A
The number of
corpora lutea
Tomas et al.
(2006)
STAT
(Signal
transducer and
activator of
transcription5A)
Cattle A3117G (intron 4)
C13244T (intron 4)
A13244G (intron 9)
G12195C (exon 8)
Embryonic
survival rate
Khatib et al.
(2008)
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Appendix C: Instruction for Sheep Blood Collection on FTA® Cards
Step 1: Make a small cut about ½ cm into the
bottom edge or tip of the ear of the sheep
using electrical side-cutters (“diags”).
Clean the side-cutters in large amount of 
             water if they are contaminated with blood 
             from previous animals. 
Step 2: Collect blood from the cut onto the FTA
cards. One card is designed for FOUR
sheep.
Step 3: Label the FTA cards clearly with a unique
ID (e.g. a brass tag number and year) for
each blood spot.
Gene-Marker Laboratory 
Agriculture & Life Sciences Division 
PO Box 84, Lincoln University 
Canterbury, NEW ZEALAND 
Ph:  0064 3 3253803 
       0508 FOOTROT 
Fax: 0064 3 325 3851 
Step 3: Blood samples are air-dried and then can be easily posted (together with a current
New Zealand Ministry of Agriculture and Forests Import Permit if from overseas as)
to: Gen-Marker Laboratory, Agriculture & Life Science Division
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Appendix D: Exon 3 of ovine IGF1R (alignment of sequences A, B and C with
exon 3 of bovine IGF1R)
 
 
IGF1Rex3A    CTCACACCCTGCCTGTCCCCACAGTGTGTCCCAGCGCGTGCGGGAAGCGGGCGTGCACGG 60     
IGF1Rex3B    -----------------g------------------------------------------ 60     
IGF1Rex3C    -------------------------------------a---------------------- 60     
IGF1R-Bovine ----------------------------c--------------------------t---- 60     
 
IGF1Rex3A    AGACCCACGAGTGCTGCCACCCCGAGTGCCTGGGCAGCTGCAGCGCGCCCGACAACGCCA 120    
IGF1Rex3B    ------------------------------------------------------------ 120    
IGF1Rex3C    ------------------------------------------------------------ 120    
IGF1R-Bovine -------t---------------------------------------------------- 120    
 
IGF1Rex3A    CGGCCTGCGTGGCCTGCCGCCACTACTACTACGCCGGCATCTGCGTGCCCAGCTGCCCGC 180    
IGF1Rex3B    ------------------------------------------------------------ 180    
IGF1Rex3C    ------------------------------------------------------------ 180    
IGF1R-Bovine --------------------------------------g--------------------- 180    
 
IGF1Rex3A    CCAACACCTACCGCTTCGAGGGCTGGCGCTGCGTGGACCGCGACTTCTGCGCCAACATCC 240    
IGF1Rex3B    ------------------------------------------------------------ 240    
IGF1Rex3C    ------------------------------------------------------------ 240    
IGF1R-Bovine ------------------------------------------------------------ 240    
 
IGF1Rex3A    CCAACGCCGAGAGCAGCGACTCCGAGGGCTTCGTCATCCACGACGGCGAGTGCATGCAGG 300    
IGF1Rex3B    ------------------------------------------------------------ 300    
IGF1Rex3C    ------------------------------------------------------------ 300    
IGF1R-Bovine ------------------------------------------------------------ 300     
 
IGF1Rex3A    AGTGCCCGTCGGGCTTCATCCGCAACGGGAGCCAGAGGTCAGTGTG 346                  
IGF1Rex3B    ---------------------------------------------- 346                 
IGF1Rex3C    ---------------------------------------------- 346          
IGF1R-Bovine ---------------------------------------------- 346          
IGF1R exon 3 A to C: Accession number EF669473 to EF669475
Bovine IGF1R: Accession number NM_001244612.1
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Appendix E: Exon 2 of ovine FOXO3 (alignment of haplotypes A through G
with exon 2 from cattle)
Haplotype A to G: Accession number GQ995521 to GQ995527
Bovine FOXO3: Accession number XM_615634.1
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Appendix F: Alignment of full coding sequence of FOXO3 in sheep, cattle,
human and Xenopus sp.
 
 
FOXO3-ovine   ATGGCAGAGGCGCCGGCCTCCCCGGCCCCGATCTCTCCGCTGGAAGTGGA     50 
FOXO3-bovine  -----------------------------------------c--------     50 
FOXO3-human   -----------a-----t------------c----------c--------     50 
FOXO3-Xenopus --------a--a-t-.--------ct---cgc--ga-.....--c-----     44 
 
FOXO3-ovine   GCTGGACCCGGAGTTCGAGCCCCAGAGCCGGCCGCGCTCCTGTACGTGGC    100 
FOXO3-bovine  ---a----------------------------------------------    100 
FOXO3-human   ------------------------------t-----a-------------    100 
FOXO3-Xenopus ca-a--------c----g---g-----t--a--t--g--t--c-------     94 
 
FOXO3-ovine   CCCTGCAGAGGCCGGAGCTCCAGGGGAGCCCGGCCAAGCCCTCTGGGGAG    150 
FOXO3-bovine  --------------------------------------------------    150 
FOXO3-human   -------a--------------a-c------t-----------g------    150 
FOXO3-Xenopus ----------a-ta--ctc---a--c-------g------gaa-a-t-gc    144 
 
FOXO3-ovine   GCGGCTGCTGACTCCATGATCCCCGAGGAGGAGGACGATGAAGACGACGA    200 
FOXO3-bovine  --------------------------------------------------    200 
FOXO3-human   a----c--c-----------------------------------------    200 
FOXO3-Xenopus --t-gg-aa-c-g-agac-cgt--tctat-atcccg--g--g--g--t--    194 
 
FOXO3-ovine   GGACGGTGGCGGTAGGGCCGGCTCGGCCATGGCGATCGGTGGCGGCGG..    248 
FOXO3-bovine  ---------------------------------------c--------..    248 
FOXO3-human   ------c--g--ac-------------------------c--------cg    250 
FOXO3-Xenopus t---ta--ag--agct--ta-ta-a----ct-t-.ct--g-a-a----..    241 
 
FOXO3-ovine   .GGGCGGCCCGCTGGGCTCTGGGTTACTCCTGGAGGACTCGGCCCGGCTC    297 
FOXO3-bovine  .------------------------g-----------------------g    297 
FOXO3-human   g-a-----a----------c---c-g-----t---------------g-g    300 
FOXO3-Xenopus ....................---ac-.......---g-a--ttggt---g    264 
 
FOXO3-ovine   TTGGCTCCTGGAGGGCAGGACCCCGGGTCCGGGCCAGCCCCCGCGGCGGG    347 
FOXO3-bovine  c-------------------------------------------------    347 
FOXO3-human   c----a--c--------a-----------t---------a----------    350 
FOXO3-Xenopus c--agcggc----aatc--ga-aact-g---t--tg--gt-ac-t-tt--    314 
 
FOXO3-ovine   CGCGCTGAGCGGGGGAACGCAGACACCGCTGCAGCCTCAGCAGCCACTGC    397 
FOXO3-bovine  ---------------g----------------------------------    397 
FOXO3-human   --g------------t--a---g-g-t---------------a--g----    400 
FOXO3-Xenopus g-g-g--...-aaacgct----gttt----cgg-gg-..-a--gag-a-g    359 
 
FOXO3-ovine   CACCGCCGCAGCCGGGGACGGCTGGGGGCTCCGGGCAGCCGAGGAAATGC    447 
FOXO3-bovine  -------------------------------t------------------    447 
FOXO3-human   -----------------g-------------------------------t    450 
FOXO3-Xenopus ggg-----tgag---t-....-a--a--acagca-----a---------t    405 
 
FOXO3-ovine   TCGTCGCGGAGGAACGCCTGGGGGAACCTGTCCTACGCCGACCTGATCAC    497 
FOXO3-bovine  -----------------------------------------t--------    497 
FOXO3-human   ---------c-------------a--------------g-----------    500 
FOXO3-Xenopus --a--c--c--a--t--------c---a----------t-----t-----    455 
 
FOXO3-ovine   TCGCGCGATCGAGAGCTCCCCAGACAAACGGCTCACTCTGTCCCAGATCT    547 
FOXO3-bovine  ------------------t-------------------------------    547 
FOXO3-human   c-----c--------------g----------------------------    550 
FOXO3-Xenopus -a-g--c---------a---ag--t-----------c-------------    505 
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FOXO3-ovine   ATGAGTGGATGGTGCGCTGCGTGCCCTACTTCAAGGATAAGGGCGACAGC    597 
FOXO3-bovine  --------------------------------------------------    597 
FOXO3-human   -c--------------t---------------------------------    600 
FOXO3-Xenopus ----t--------c----c------------------------a------    555 
 
FOXO3-ovine   AACAGCTCTGCCGGCTGGAAGAACTCTATCCGGCACAACCTGTCACTGCA    647 
FOXO3-bovine  --------------------------------------------------    647 
FOXO3-human   --------------------------c-----------------------    650 
FOXO3-Xenopus -----------a-----------t--a--------t--t--------a--    605 
 
FOXO3-ovine   CAGCCGATTCATGCGGGTCCAGAATGAGGGGACCGGCAAGAGCTCATGGT    697 
FOXO3-bovine  ------g-----------------------a--------------g----    697 
FOXO3-human   t--t--------------------------a--t-----------t----    700 
FOXO3-Xenopus t---a-g--t--ta-a--t-----------ct-t--a--a-----t----    655 
 
FOXO3-ovine   GGATCATCAACCCGGATGGCGGGAAGAGTGGCAAGGCACCCCGGCGGCGG    747 
FOXO3-bovine  -------------t--c--------------------g------------    747 
FOXO3-human   -------------t-----g--------c--a--a--c------------    750 
FOXO3-Xenopus ----g--------a--g--t--t--ag----a--------aa-aa-a--t    705 
 
FOXO3-ovine   GCCGTTTCCATGGACAACAGCAACAAGTACACCAAGAGCCGCGGCCGTGC    797 
FOXO3-bovine  -----c--------------------------------------------    797 
FOXO3-human   --t--c-----------t-----------t-----------t-----c--    800 
FOXO3-Xenopus --t-----a--------t--t-----------------t-----ga-a--    755 
 
FOXO3-ovine   CGCCAAGAAGAAGGCAGCCCTGCAGACCGCCCCCGAATCAGCAGACGACA    847 
FOXO3-bovine  a-----------------------------------g--------t----    847 
FOXO3-human   a--------------------------a--------------t-------    850 
FOXO3-Xenopus a--a-----a--a---t--t-----g-at-tt-t--tg-ta----t--t-    805 
 
FOXO3-ovine   GTCCCTCCCAGCTCTCCAAGTGGCCCGGCAGCCCCACATCCCGCAGCAGC    897 
FOXO3-bovine  --------------------------------------------------    897 
FOXO3-human   -------------------------t-----------g--a--------t    900 
FOXO3-Xenopus -c--t--a-----g--a--------a--t--t-----c--a--t--t--t    855 
 
FOXO3-ovine   GATGAGCTGGACGCGTGGACCGACTTCCGCTCACGCACCAATTCCAACGC    947 
FOXO3-bovine  --------------------------------g-----------------    947 
FOXO3-human   -----------t--------g--------t--------------t-----    950 
FOXO3-Xenopus ---a-a--t--ta-c-----a-----t--a--t--t--a--c--t--t--    905 
 
FOXO3-ovine   CAGCACAGTCAGCGGCCGCCTGTCCCCCATTCTGGCGAGCACAGAGCTGG    997 
FOXO3-bovine  ------------------------------c-----------g-------    997 
FOXO3-human   ------------t-----------g-----ca----a---------t---   1000 
FOXO3-Xenopus ---t--ta-a--t--t--gt----t--a----ca--t-c---t--a--t-    955 
 
FOXO3-ovine   ACGATGTCCAGGACGATGACGCACCACTGTCCCCCATGCTCTATAGCAGC   1047 
FOXO3-bovine  ----c--------------t------------------------------   1047 
FOXO3-human   -t--a--------------t--g--t--c--g-----------c------   1050 
FOXO3-Xenopus -t-----t--a--t-----tt-t--c--------t---t-g----a----   1005 
 
FOXO3-ovine   TCGGCTAGCCTGTCGCCCTCTGTCAGCAAGCCGTGCACTGTGGAGCTGCC   1097 
FOXO3-bovine  -----c--------------c-----------------------------   1097 
FOXO3-human   --a--c--------a--t--a--a--------------g-----a-----   1100 
FOXO3-Xenopus c-a-g---tt----c--a--ca-a--t--a--a-----a------a----   1055 
 
FOXO3-ovine   CCGGCTGACCGACATGGCGGGCACCATGAATCTGAACGATGGGCTGGCCG   1147 
FOXO3-bovine  ---------------------------------------c----------   1147 
FOXO3-human   a--------t--t-----a-----------------t---------a-t-   1150 
FOXO3-Xenopus aa-aa-a--t--t-----t-aa--------ct-a--t--c--at--c-g-   1105 
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FOXO3-ovine   ACAACCTCATGGACGACCTGCTGGACAACATCGCGCTCCCTGCATCCCAG   1197 
FOXO3-bovine  ----------------------------t---------------------   1197 
FOXO3-human   -a-----------------------t------a-------gc--------   1200 
FOXO3-Xenopus -g-----------t---t-------tg----tt-t---a--t-t--a---   1155 
 
FOXO3-ovine   CCATCGCCCCCGGGGGGGCTCATGCAGCGCAGCTCCAGCTTCCCGTACAC   1247 
FOXO3-bovine  --------------------------------------------------   1247 
FOXO3-human   ---------a-t-----a-----------g-----t-----------t--   1250 
FOXO3-Xenopus -a---at-t--c--t-tc---------a-a--t--------ta-a--tgg   1205 
 
FOXO3-ovine   CACCAAGGGCTCCGGCCTGGGCTCCCCCACCAGCTCCTTCAGCAGCGCGG   1297 
FOXO3-bovine  --------------------------------------------------   1297 
FOXO3-human   ------------g--------------a-----------t-a----a---   1300 
FOXO3-Xenopus ---t--------a---a-t-----t--at-g-ataat--t-a--a-a-t-   1255 
 
FOXO3-ovine   TATTTGGTCCCTCGTCTCTGAACTCCCTGCGCCAGTCTCCCATGCAGACC   1347 
FOXO3-bovine  --------------------------------------------------   1347 
FOXO3-human   -g--c--a--t--a--------------a---------------------   1350 
FOXO3-Xenopus gtagcttcaa--ttc-ct---ca--t--a-----------------a--g   1305 
 
FOXO3-ovine   ATCCAAGAGAACAAGCCAGCCACCTTCTCTTCCATGTCCCATTATGGCAA   1397 
FOXO3-bovine  -----------------------------------------c--c-----   1397 
FOXO3-human   --------------------t-----------------a--c-----t--   1400 
FOXO3-Xenopus --------------a-a---t--a--t---------aat------a-t--   1355 
 
FOXO3-ovine   CCAGACACTCCAGGACCTGCTCACGTCGGACTCACTCAGCCACAGCGATG   1447 
FOXO3-bovine  ------------------------a-------------------------   1447 
FOXO3-human   ------------------------t-----------t-------------   1450 
FOXO3-Xenopus ----t-tt-g--a------t-g-ata-a---a-c----------------   1405 
 
FOXO3-ovine   TCATGATGACCCAGTCGGACCCCTTGATGTCTCAGGCCAGCACCGCTGTG   1497 
FOXO3-bovine  --------------------------------------------------   1497 
FOXO3-human   ----------a---------------------------------------   1500 
FOXO3-Xenopus -gt-a-----------t--t--gc-c-----a--a-----t--t--a--a   1455 
 
FOXO3-ovine   TCCGCCCAGAACTCCCGCCGGAACGTGATGCTTCGCAGTGACCCAATGAT   1547 
FOXO3-bovine  --------------------------------------------------   1547 
FOXO3-human   --t--------t-------------------------a---t--g-----   1550 
FOXO3-Xenopus a-t--t-----tag-a-aa-a--ta-c--t--ga-a-a---t--t-----   1505 
 
FOXO3-ovine   GTCCTTTGCCGCCCAGCCTAACCAGGGGAG...TTTGGTCAATCAGAACT   1594 
FOXO3-bovine  ------------------------------...-----------------   1594 
FOXO3-human   ---------t-----------------a--...-----------------   1597 
FOXO3-Xenopus ---t-----a-----a--------a--ag-aaac-----t-----a----   1555 
 
FOXO3-ovine   TGCTCCACCACCAGCACCAAACCCAGGGCGCTCTCGGTGGCAGCCGTGCC   1644 
FOXO3-bovine  --------------------------------------------------   1644 
FOXO3-human   ----------------------------------t---------------   1647 
FOXO3-Xenopus c---g-----g-----gtctctta-ctcttt--aa---------------   1605 
 
FOXO3-ovine   TTGTCGAATTCCGTCAGCAACATGGGCTTGAGCGACTCCAGCAGCCTCGG   1694 
FOXO3-bovine  --------------------------------------------------   1694 
FOXO3-human   -----------t--------------------t--g-----------t--   1697 
FOXO3-Xenopus -----a--caatt-a-------ct--t--a-at---ag-----t-t-g-a   1655 
 
FOXO3-ovine   GTCAGCCAAACACCAGCAACAGTCTCCCGTCAGCCAGTCTATGCAAACCC   1744 
FOXO3-bovine  --------------------------------------------------   1744 
FOXO3-human   ------------------g--------t----------------------   1747 
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FOXO3-Xenopus a---a-------------g-----ct-a--g--t--t------------a   1705 
 
FOXO3-ovine   TCTCGGACTCTCTCTCAGGCTCCTCCTTGTACTCAACCAGTGCGAACCTT   1794 
FOXO3-bovine  -----------g--------------------------------------   1794 
FOXO3-human   -------------------------------------t-----a-----g   1797 
FOXO3-Xenopus ----c---a-g--------a--...---------ct-ag-c-t--c----   1752 
 
FOXO3-ovine   CCAGTCATGGGCCACGAGAAGTTCCCCAGCGACTTGGACCTGGACATGTT   1844 
FOXO3-bovine  -----------t--------------------------------------   1844 
FOXO3-human   --c-----------t-----------------------------------   1847 
FOXO3-Xenopus ---acac----a--t--a-----t----ct--t-----------t--t--   1802 
 
FOXO3-ovine   CAATGGGAGCTTGGAATGTGACATGGAGTCCATTATCCGTAGTGAACTCA   1894 
FOXO3-bovine  ------------------------------------------c-------   1894 
FOXO3-human   --------------------------------------------------   1897 
FOXO3-Xenopus ---------t-----------t------a-g--a--t--c-ac--t----   1852 
 
FOXO3-ovine   TGGATGCTGATGGGTTGGATTTTAACTTTGATTCCCTCATCTCCACACAG   1944 
FOXO3-bovine  --------------------------------------------------   1944 
FOXO3-human   --------------------------------------------------   1947 
FOXO3-Xenopus -------a-----------------t-----ca----------ag-t---   1902 
 
FOXO3-ovine   AATGTTGTTGGTTTGAACGTGGGGAGCTTCACTGGTGCTAAGCAGGCCTC   1994 
FOXO3-bovine  --c-----------------------------------------------   1994 
FOXO3-human   -------------------------a------------------------   1997 
FOXO3-Xenopus --...---ca--c-atct--a--c--t------------------a-a--   1949 
 
FOXO3-ovine   ATCTCAGAGCTGGGTGCCAGGCTGA                            2019 
FOXO3-bovine  -------------------------                            2019 
FOXO3-human   -------------------------                            2022 
FOXO3-Xenopus ---a---------------------                            1974 
 
Ovine FOXO3: Accession number JQ894783
Bovine FOXO3: Accession number XM_615634
Human FOXO3: Accession number NM_201559
Xenopus FOXO3: Accession number NM_001092949
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Appendix G: Statistical analyses for association of longevity and variation in
IGF1R, FOXO3, CAST and TLR4-breed correction model
Univariate Analysis of Variance-IGF1R A
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 5191.638 1 5191.638 88.567 .000
Error 398.633 6.801 58.618a
Breed Hypothesis 2448.573 5 489.715 52.583 .000
Error 15934.961 1711 9.313b
IGF1RA Hypothesis 1.760 1 1.760 .189 .664
Error 15934.961 1711 9.313b
a. .103 MS(Breed) + .897 MS(Error)
b. MS(Error)
Estimated Marginal Means-IGF1R A
Dependent Variable:age
IGF1RA Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.409 .458 4.510 6.308
1 5.611 .082 5.451 5.771
Univariate Analysis of Variance-IGF1R B
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 19351.782 1 19351.782 101.353 .000
Error 1015.402 5.318 190.935a
Breed Hypothesis 2452.384 5 490.477 52.665 .000
Error 15934.841 1711 9.313b
IGF1RB Hypothesis 1.880 1 1.880 .202 .653
Error 15934.841 1711 9.313b
a. .377 MS(Breed) + .623 MS(Error)
b. MS(Error)
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Estimated Marginal Means-IGF1R B
Dependent Variable:age
IGF1RB Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.618 .085 5.450 5.786
1 5.510 .227 5.065 5.955
Univariate Analysis of Variance-IGF1R C
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 26202.910 1 26202.910 119.060 .000
Error 1151.182 5.231 220.081a
Breed Hypothesis 2284.738 5 456.948 49.257 .000
Error 15872.661 1711 9.277b
IGF1RC Hypothesis 64.060 1 64.060 6.905 .009
Error 15872.661 1711 9.277b
a. .471 MS(Breed) + .529 MS(Error)
b. MS(Error)
Estimated Marginal Means-IGF1R C
Dependent Variable:age
IGF1RC Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.519 .087 5.348 5.689
1 6.079 .197 5.692 6.466
Univariate Analysis of Variance-FOXO3 A
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 23355.518 1 23355.518 107.885 .000
Error 1354.616 6.257 216.485a
FOXO3A Hypothesis 4.265 1 4.265 .478 .490
Error 15387.303 1724 8.925b
Breed Hypothesis 2564.154 6 427.359 47.881 .000
Error 15387.303 1724 8.925b
a. .496 MS(Breed) + .504 MS(Error)
b. MS(Error)
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Estimated Marginal Means-FOXO3 A
Dependent Variable:age
FOXO3A Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.508 .164 5.186 5.830
1 5.385 .107 5.175 5.595
Univariate Analysis of Variance-FOXO3 B
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 27254.011 1 27254.011 111.729 .000
Error 1509.542 6.188 243.930a
Breed Hypothesis 2481.212 6 413.535 46.320 .000
Error 15391.552 1724 8.928b
FOXO3B Hypothesis .017 1 .017 .002 .966
Error 15391.552 1724 8.928b
a. .581 MS(Breed) + .419 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 B
Dependent Variable:age
FOXO3B Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.413 .118 5.182 5.645
1 5.420 .135 5.156 5.684
Univariate Analysis of Variance-FOXO3 C
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 2796.674 1 2796.674 88.241 .000
Error 353.129 11.142 31.694a
Breed Hypothesis 2569.885 6 428.314 47.986 .000
Error 15388.145 1724 8.926b
FOXO3C Hypothesis 3.424 1 3.424 .384 .536
Error 15388.145 1724 8.926b
a. .054 MS(Breed) + .946 MS(Error)
b. MS(Error)
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Estimated Marginal Means-FOXO3 C
Dependent Variable:age
FOXO3C Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.411 .097 5.220 5.602
1 5.794 .618 4.582 7.006
Univariate Analysis of Variance-FOXO3 D
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 21126.783 1 21126.783 103.324 .000
Error 1283.922 6.279 204.470a
Breed Hypothesis 2484.754 6 414.126 46.591 .000
Error 15323.668 1724 8.888b
FOXO3D Hypothesis 67.900 1 67.900 7.639 .006
Error 15323.668 1724 8.888b
a. .483 MS(Breed) + .517 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 D
Dependent Variable:age
FOXO3D Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.530 .105 5.323 5.736
1 5.035 .169 4.704 5.366
Univariate Analysis of Variance-FOXO3 E
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 6503.790 1 6503.790 93.911 .000
Error 525.168 7.583 69.255a
Breed Hypothesis 2594.855 6 432.476 48.459 .000
Error 15386.014 1724 8.925b
FOXO3E Hypothesis 5.554 1 5.554 .622 .430
Error 15386.014 1724 8.925b
a. .142 MS(Breed) + .858 MS(Error)
b. MS(Error)
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Estimated Marginal Means-FOXO3 E
Dependent Variable:age
FOXO3E Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.429 .098 5.236 5.622
1 5.135 .369 4.412 5.859
Univariate Analysis of Variance-FOXO3 F
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1885.930 1 1885.930 83.382 .000
Error 354.332 15.666 22.618a
Breed Hypothesis 2595.961 6 432.660 48.515 .000
Error 15374.702 1724 8.918b
FOXO3F Hypothesis 16.866 1 16.866 1.891 .169
Error 15374.702 1724 8.918b
a. .032 MS(Breed) + .968 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 F
Dependent Variable:age
FOXO3F Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.409 .097 5.218 5.600
1 6.519 .808 4.934 8.104
Univariate Analysis of Variance-FOXO3 G
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 2599.752 1 2599.752 91.468 .000
Error 347.183 12.215 28.423a
Breed Hypothesis 2613.693 6 435.616 48.855 .000
Error 15371.894 1724 8.916b
FOXO3G Hypothesis 19.674 1 19.674 2.207 .138
Error 15371.894 1724 8.916b
a. .046 MS(Breed) + .954 MS(Error)
b. MS(Error)
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Estimated Marginal Means-FOXO3 G
Dependent Variable:age
FOXO3G Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.391 .099 5.197 5.584
1 6.428 .688 5.078 7.778
Univariate Analysis of Variance-CAST A
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 44084.931 1 44084.931 106.311 .000
Error 2086.800 5.032 414.678a
Breed Hypothesis 2411.407 5 482.281 51.651 .000
Error 16050.713 1719 9.337b
CASTA Hypothesis 3.587 1 3.587 .384 .535
Error 16050.713 1719 9.337b
a. .857 MS(Breed) + .143 MS(Error)
b. MS(Error)
Estimated Marginal Means-CAST A
Dependent Variable:age
CASTA Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.565 .125 5.320 5.810
1 5.665 .104 5.461 5.869
Univariate Analysis of Variance-CAST B
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 34531.214 1 34531.214 104.928 .000
Error 1677.271 5.097 329.094a
Breed Hypothesis 2453.694 5 490.739 52.566 .000
Error 16047.949 1719 9.336b
CASTB Hypothesis 6.351 1 6.351 .680 .410
Error 16047.949 1719 9.336b
a. .664 MS(Breed) + .336 MS(Error)
b. MS(Error)
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Estimated Marginal Means-CAST B
Dependent Variable:age
CASTB Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.739 .161 5.423 6.055
1 5.586 .092 5.405 5.768
Univariate Analysis of Variance-CAST C
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 24319.075 1 24319.075 117.079 .000
Error 1092.653 5.260 207.715a
Breed Hypothesis 2292.241 5 458.448 49.166 .000
Error 16028.815 1719 9.324b
CASTC Hypothesis 25.485 1 25.485 2.733 .098
Error 16028.815 1719 9.324b
a. .442 MS(Breed) + .558 MS(Error)
b. MS(Error)
Estimated Marginal Means-CAST C
Dependent Variable:age
CASTC Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.573 .086 5.403 5.742
1 5.937 .206 5.534 6.340
Univariate Analysis of Variance-CAST D
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1276.539 1 1276.539 62.533 .000
Error 333.048 16.315 20.414a
Breed Hypothesis 2447.612 5 489.522 52.417 .000
Error 16053.606 1719 9.339b
CASTD Hypothesis .695 1 .695 .074 .785
Error 16053.606 1719 9.339b
a. .023 MS(Breed) + .977 MS(Error)
b. MS(Error)
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Estimated Marginal Means-CAST D
Dependent Variable:age
CASTD Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.623 .081 5.465 5.781
1 5.890 .980 3.969 7.812
Univariate Analysis of Variance-TLR4 A
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 43622.046 1 43622.046 102.540 .000
Error 2139.410 5.029 425.417a
Breed Hypothesis 2441.797 5 488.359 52.292 .000
Error 16054.005 1719 9.339b
TLR4A Hypothesis .296 1 .296 .032 .859
Error 16054.005 1719 9.339b
a. .869 MS(Breed) + .131 MS(Error)
b. MS(Error)
Estimated Marginal Means-TLR4 A
Dependent Variable:age
TLR4A Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.606 .129 5.352 5.860
1 5.636 .105 5.431 5.841
Univariate Analysis of Variance-TLR4 B
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 44535.263 1 44535.263 103.756 .000
Error 2157.675 5.027 429.230a
Breed Hypothesis 2440.535 5 488.107 52.295 .000
Error 16044.809 1719 9.334b
TLR4B Hypothesis 9.491 1 9.491 1.017 .313
Error 16044.809 1719 9.334b
a. .877 MS(Breed) + .123 MS(Error)
b. MS(Error)
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Estimated Marginal Means-TLR4 B
Dependent Variable:age
TLR4B Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.530 .123 5.288 5.772
1 5.695 .107 5.486 5.904
Univariate Analysis of Variance-TLR4 C
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 38206.976 1 38206.976 103.364 .000
Error 1871.817 5.064 369.635a
Breed Hypothesis 2451.361 5 490.272 52.511 .000
Error 16049.622 1719 9.337b
TLR4C Hypothesis 4.678 1 4.678 .501 .479
Error 16049.622 1719 9.337b
a. .749 MS(Breed) + .251 MS(Error)
b. MS(Error)
Estimated Marginal Means-TLR4 C
Dependent Variable:age
TLR4C Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.662 .096 5.473 5.851
1 5.537 .147 5.250 5.825
Univariate Analysis of Variance-TLR4 D
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 17190.807 1 17190.807 102.619 .000
Error 902.776 5.389 167.521a
Breed Hypothesis 2374.243 5 474.849 50.889 .000
Error 16040.186 1719 9.331b
TLR4D Hypothesis 14.114 1 14.114 1.513 .219
Error 16040.186 1719 9.331b
a. .340 MS(Breed) + .660 MS(Error)
b. MS(Error)
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Estimated Marginal Means-TLR4 D
Dependent Variable:age
TLR4D Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.651 .083 5.487 5.814
1 5.352 .236 4.890 5.814
Appendix H: Statistical analyses for association of fecundity and variation
in IGF1R, FOXO3, CAST and TLR4-breed correction model
Univariate Analysis of Variance-IGF1R A
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 170.153 1 170.153 116.834 .000
Error 6.929 4.758 1.456a
Breed Hypothesis 58.792 4 14.698 110.365 .000
Error 86.166 647 .133b
IGF1RA Hypothesis .000 1 .000 .002 .967
Error 86.166 647 .133b
a. .091 MS(Breed) + .909 MS(Error)
b. MS(Error)
Estimated Marginal Means-IGF1R A
Dependent Variable:fecundity
IGF1RA Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.725 .095 1.538 1.911
1 1.721 .016 1.690 1.751
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Univariate Analysis of Variance-IGF1R B
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 725.872 1 725.872 126.176 .000
Error 23.678 4.116 5.753a
Breed Hypothesis 58.570 4 14.643 110.004 .000
Error 86.122 647 .133b
IGF1RB Hypothesis .044 1 .044 .331 .565
Error 86.122 647 .133b
a. .387 MS(Breed) + .613 MS(Error)
b. MS(Error)
Estimated Marginal Means-IGF1R B
Dependent Variable:fecundity
IGF1RB Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.717 .016 1.685 1.750
1 1.744 .044 1.658 1.830
Univariate Analysis of Variance-IGF1R C
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 942.899 1 942.899 127.605 .000
Error 30.096 4.073 7.389a
Breed Hypothesis 58.660 4 14.665 110.519 .000
Error 85.852 647 .133b
IGF1RC Hypothesis .313 1 .313 2.362 .125
Error 85.852 647 .133b
a. .499 MS(Breed) + .501 MS(Error)
b. MS(Error)
Estimated Marginal Means-IGF1R C
Dependent Variable:fecundity
IGF1RC Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.711 .017 1.678 1.744
1 1.773 .037 1.700 1.846
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Univariate Analysis of Variance-FOXO3 A
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 931.140 1 931.140 159.764 .000
Error 29.830 5.118 5.828a
Breed Hypothesis 57.031 5 11.406 83.343 .000
Error 85.401 624 .137b
FOXO3A Hypothesis .131 1 .131 .960 .328
Error 85.401 624 .137b
a. .505 MS(Breed) + .495 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 A
Dependent Variable:fecundity
FOXO3A Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.801 .034 1.733 1.869
1 1.837 .022 1.794 1.880
Univariate Analysis of Variance-FOXO3 B
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1061.110 1 1061.110 164.155 .000
Error 32.927 5.094 6.464a
Breed Hypothesis 56.944 5 11.389 83.269 .000
Error 85.345 624 .137b
FOXO3B Hypothesis .187 1 .187 1.364 .243
Error 85.345 624 .137b
a. .562 MS(Breed) + .438 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 B
Dependent Variable:fecundity
FOXO3B Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.842 .023 1.797 1.887
1 1.802 .030 1.743 1.861
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Univariate Analysis of Variance-FOXO3 C
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 101.395 1 101.395 137.595 .000
Error 5.433 7.373 .737a
Breed Hypothesis 60.715 5 12.143 88.616 .000
Error 85.506 624 .137b
FOXO3C Hypothesis .026 1 .026 .188 .664
Error 85.506 624 .137b
a. .050 MS(Breed) + .950 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 C
Dependent Variable:fecundity
FOXO3C Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.828 .020 1.789 1.867
1 1.886 .133 1.624 2.147
Univariate Analysis of Variance-FOXO3 D
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 947.523 1 947.523 171.432 .000
Error 28.321 5.124 5.527a
Breed Hypothesis 53.701 5 10.740 78.456 .000
Error 85.422 624 .137b
FOXO3D Hypothesis .110 1 .110 .800 .371
Error 85.422 624 .137b
a. .508 MS(Breed) + .492 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 D
Dependent Variable:fecundity
FOXO3D Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.836 .022 1.794 1.879
1 1.804 .034 1.738 1.870
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Univariate Analysis of Variance-FOXO3 E
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 262.657 1 262.657 154.232 .000
Error 9.843 5.780 1.703a
Breed Hypothesis 60.476 5 12.095 88.277 .000
Error 85.497 624 .137b
FOXO3E Hypothesis .035 1 .035 .252 .616
Error 85.497 624 .137b
a. .131 MS(Breed) + .869 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 E
Dependent Variable:fecundity
FOXO3E Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.827 .020 1.788 1.867
1 1.867 .080 1.711 2.023
Univariate Analysis of Variance-FOXO3 F
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 106.427 1 106.427 143.658 .000
Error 5.446 7.351 .741a
Breed Hypothesis 60.723 5 12.145 88.756 .000
Error 85.383 624 .137b
FOXO3F Hypothesis .149 1 .149 1.088 .297
Error 85.383 624 .137b
a. .050 MS(Breed) + .950 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 F
Dependent Variable:fecundity
FOXO3F Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.827 .020 1.788 1.866
1 1.966 .133 1.704 2.227
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Univariate Analysis of Variance-FOXO3 G
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 133.883 1 133.883 145.759 .000
Error 6.199 6.749 .919a
Breed Hypothesis 61.015 5 12.203 89.164 .000
Error 85.401 624 .137b
FOXO3G Hypothesis .131 1 .131 .958 .328
Error 85.401 624 .137b
a. .065 MS(Breed) + .935 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 G
Dependent Variable:fecundity
FOXO3G Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.824 .021 1.783 1.864
1 1.945 .120 1.708 2.181
Univariate Analysis of Variance-CAST A
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1513.570 1 1513.570 130.471 .000
Error 46.591 4.016 11.601a
Breed Hypothesis 56.141 4 14.035 105.106 .000
Error 87.064 652 .134b
CASTA Hypothesis .000 1 .000 .002 .962
Error 87.064 652 .134b
a. .825 MS(Breed) + .175 MS(Error)
b. MS(Error)
Estimated Marginal Means-CAST A
Dependent Variable:fecundity
CASTA Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.720 .026 1.670 1.770
1 1.721 .019 1.685 1.758
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Univariate Analysis of Variance-CAST B
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1326.540 1 1326.540 129.606 .000
Error 41.241 4.029 10.235a
Breed Hypothesis 56.676 4 14.169 106.279 .000
Error 86.924 652 .133b
CASTB Hypothesis .141 1 .141 1.055 .305
Error 86.924 652 .133b
a. .720 MS(Breed) + .280 MS(Error)
b. MS(Error)
Estimated Marginal Means-CAST B
Dependent Variable: fecundity
CASTB Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.747 .030 1.688 1.806
1 1.711 .018 1.675 1.747
Univariate Analysis of Variance-CAST C
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 713.382 1 713.382 129.587 .000
Error 22.711 4.125 5.505a
Breed Hypothesis 59.316 4 14.829 111.498 .000
Error 86.715 652 .133b
CASTC Hypothesis .350 1 .350 2.628 .105
Error 86.715 652 .133b
a. .366 MS(Breed) + .634 MS(Error)
b. MS(Error)
Estimated Marginal Means-CAST C
Dependent Variable:fecundity
CASTC Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.713 .016 1.682 1.745
1 1.788 .044 1.701 1.874
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Univariate Analysis of Variance-CAST D
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 51.423 1 51.423 104.379 .000
Error 3.634 7.377 .493a
Breed Hypothesis 59.580 4 14.895 111.759 .000
Error 86.897 652 .133b
CASTD Hypothesis .167 1 .167 1.255 .263
Error 86.897 652 .133b
a. .024 MS(Breed) + .976 MS(Error)
b. MS(Error)
Estimated Marginal Means-CAST D
Dependent Variable:fecundity
CASTD Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.720 .015 1.689 1.750
1 1.927 .185 1.564 2.290
Univariate Analysis of Variance-TLR4 A
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1531.703 1 1531.703 153.146 .000
Error 40.148 4.014 10.002a
Breed Hypothesis 46.015 4 11.504 86.175 .000
Error 87.038 652 .133b
TLR4A Hypothesis .026 1 .026 .198 .656
Error 87.038 652 .133b
a. .868 MS(Breed) + .132 MS(Error)
b. MS(Error)
Estimated Marginal Means-TLR4 A
Dependent Variable:fecundity
TLR4A Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.730 .026 1.679 1.782
1 1.716 .019 1.677 1.754
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Univariate Analysis of Variance-TLR4 B
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1639.524 1 1639.524 139.996 .000
Error 46.936 4.008 11.711a
Breed Hypothesis 51.179 4 12.795 95.957 .000
Error 86.936 652 .133b
TLR4B Hypothesis .128 1 .128 .963 .327
Error 86.936 652 .133b
a. .914 MS(Breed) + .086 MS(Error)
b. MS(Error)
Estimated Marginal Means-TLR4 B
Dependent Variable:fecundity
TLR4B Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.703 .024 1.657 1.750
1 1.735 .021 1.694 1.776
Univariate Analysis of Variance-TLR4 C
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1113.716 1 1113.716 119.564 .000
Error 37.637 4.041 9.315a
Breed Hypothesis 57.533 4 14.383 109.075 .000
Error 85.976 652 .132b
TLR4C Hypothesis 1.088 1 1.088 8.251 .004
Error 85.976 652 .132b
a. .644 MS(Breed) + .356 MS(Error)
b. MS(Error)
Estimated Marginal Means-TLR4 C
Dependent Variable:fecundity
TLR4C Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.745 .017 1.710 1.779
1 1.638 .033 1.574 1.702
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Univariate Analysis of Variance-TLR4 D
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 747.046 1 747.046 126.608 .000
Error 24.267 4.113 5.900a
Breed Hypothesis 59.853 4 14.963 112.211 .000
Error 86.943 652 .133b
TLR4D Hypothesis .121 1 .121 .908 .341
Error 86.943 652 .133b
a. .389 MS(Breed) + .611 MS(Error)
b. MS(Error)
Estimated Marginal Means-TLR4 D
Dependent Variable:fecundity
TLR4D Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.716 .016 1.684 1.748
1 1.759 .043 1.675 1.842
Appendix I: Statistical analyses for association of longevity and variation in
IGF1R, FOXO3, CAST and TLR4-flock correction model
Univariate Analysis of Variance-IGF1R A
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 4240.766 1 4240.766 246.660 .000
Error 2129.202 123.843 17.193a
IGF1RA Hypothesis .533 1 .533 .059 .808
Error 15150.481 1681 9.013b
farm2 Hypothesis 3233.054 35 92.373 10.249 .000
Error 15150.481 1681 9.013b
a. .098 MS(farm2) + .902 MS(Error)
b. MS(Error)
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Estimated Marginal Means-IGF1R A
Dependent Variable:age
IGF1RA Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 4.981 .456 4.086 5.875
1 5.093 .077 4.942 5.244
Univariate Analysis of Variance-IGF1R B
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 15231.924 1 15231.924 400.538 .000
Error 1861.040 48.938 38.029a
farm2 Hypothesis 3236.373 35 92.468 10.259 .000
Error 15150.853 1681 9.013b
IGF1RB Hypothesis .161 1 .161 .018 .894
Error 15150.853 1681 9.013b
a. .348 MS(farm2) + .652 MS(Error)
b. MS(Error)
Estimated Marginal Means-IGF1R B
Dependent Variable:age
IGF1RB Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.093 .081 4.935 5.251
1 5.060 .234 4.602 5.518
Univariate Analysis of Variance-IGF1R C
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 20533.721 1 20533.721 477.097 .000
Error 1935.179 44.963 43.039a
farm2 Hypothesis 3052.158 35 87.205 9.705 .000
Error 15105.241 1681 8.986b
IGF1RC Hypothesis 45.773 1 45.773 5.094 .024
Error 15105.241 1681 8.986b
a. .435 MS(farm2) + .565 MS(Error)
b. MS(Error)
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Estimated Marginal Means-IGF1R C
Dependent Variable:age
IGF1RC Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.022 .082 4.862 5.183
1 5.518 .204 5.117 5.919
Univariate Analysis of Variance-FOXO3 A
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 29154.447 1 29154.447 459.398 .000
Error 2635.789 41.533 63.462a
FOXO3A Hypothesis 2.895 1 2.895 .336 .562
Error 14554.640 1692 8.602b
farm2 Hypothesis 3396.817 38 89.390 10.392 .000
Error 14554.640 1692 8.602b
a. .679 MS(farm2) + .321 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 A
Dependent Variable:age
FOXO3A Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.067 .156 4.762 5.372
1 4.959 .089 4.785 5.133
Univariate Analysis of Variance-FOXO3 B
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 35662.995 1 35662.995 470.613 .000
Error 2979.585 39.319 75.780a
farm2 Hypothesis 3327.103 38 87.555 10.185 .000
Error 14545.660 1692 8.597b
FOXO3B Hypothesis 11.875 1 11.875 1.381 .240
Error 14545.660 1692 8.597b
a. .851 MS(farm2) + .149 MS(Error)
b. MS(Error)
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Estimated Marginal Means-FOXO3 B
Dependent Variable:age
FOXO3B Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.063 .098 4.871 5.255
1 4.862 .130 4.607 5.117
Univariate Analysis of Variance-FOXO3 C
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 2307.142 1 2307.142 179.430 .000
Error 3415.849 265.656 12.858a
farm2 Hypothesis 3400.896 38 89.497 10.402 .000
Error 14557.134 1692 8.604b
FOXO3C Hypothesis .401 1 .401 .047 .829
Error 14557.134 1692 8.604b
a. .053 MS(farm2) + .947 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 C
Dependent Variable:age
FOXO3C Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 4.986 .074 4.840 5.132
1 5.119 .611 3.920 6.318
Univariate Analysis of Variance-FOXO3 D
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 29994.489 1 29994.489 458.047 .000
Error 2674.439 40.841 65.483a
farm2 Hypothesis 3289.611 38 86.569 10.089 .000
Error 14518.811 1692 8.581b
FOXO3D Hypothesis 38.724 1 38.724 4.513 .034
Error 14518.811 1692 8.581b
a. .730 MS(farm2) + .270 MS(Error)
b. MS(Error)
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Estimated Marginal Means-FOXO3 D
Dependent Variable:age
FOXO3D Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.102 .091 4.923 5.281
1 4.714 .149 4.422 5.005
Univariate Analysis of Variance-FOXO3 E
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 5635.803 1 5635.803 285.960 .000
Error 1914.089 97.121 19.708a
farm2 Hypothesis 3424.930 38 90.130 10.477 .000
Error 14555.940 1692 8.603b
FOXO3E Hypothesis 1.595 1 1.595 .185 .667
Error 14555.940 1692 8.603b
a. .136 MS(farm2) + .864 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 E
Dependent Variable:age
FOXO3E Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 4.995 .076 4.846 5.143
1 4.828 .378 4.088 5.569
Univariate Analysis of Variance-FOXO3 F
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1599.509 1 1599.509 144.147 .000
Error 5641.158 508.378 11.096a
farm2 Hypothesis 3428.082 38 90.213 10.496 .000
Error 14542.581 1692 8.595b
FOXO3F Hypothesis 14.954 1 14.954 1.740 .187
Error 14542.581 1692 8.595b
a. .031 MS(farm2) + .969 MS(Error)
b. MS(Error)
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Estimated Marginal Means-FOXO3 F
Dependent Variable:age
FOXO3F Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 4.978 .074 4.832 5.123
1 6.046 .806 4.466 7.626
Univariate Analysis of Variance-FOXO3 G
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 2143.488 1 2143.488 177.621 .000
Error 4111.062 340.665 12.068a
farm2 Hypothesis 3443.545 38 90.620 10.544 .000
Error 14542.042 1692 8.595b
FOXO3G Hypothesis 15.493 1 15.493 1.803 .180
Error 14542.042 1692 8.595b
a. .042 MS(farm2) + .958 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 G
Dependent Variable:age
FOXO3G Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 4.978 .074 4.832 5.124
1 5.901 .684 4.559 7.242
Univariate Analysis of Variance-CAST A
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 38583.636 1 38583.636 472.975 .000
Error 2936.629 35.998 81.577a
farm2 Hypothesis 3222.198 35 92.063 10.203 .000
Error 15239.921 1689 9.023b
CASTA Hypothesis .253 1 .253 .028 .867
Error 15239.921 1689 9.023b
a. .874 MS(farm2) + .126 MS(Error)
b. MS(Error)
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Estimated Marginal Means-CAST A
Dependent Variable:age
CASTA Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.085 .125 4.839 5.330
1 5.112 .100 4.917 5.307
Univariate Analysis of Variance-CAST B
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 30364.011 1 30364.011 457.527 .000
Error 2538.002 38.243 66.366a
farm2 Hypothesis 3262.545 35 93.216 10.331 .000
Error 15239.098 1689 9.023b
CASTB Hypothesis 1.075 1 1.075 .119 .730
Error 15239.098 1689 9.023b
a. .681 MS(farm2) + .319 MS(Error)
b. MS(Error)
Estimated Marginal Means-CAST B
Dependent Variable:age
CASTB Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.149 .159 4.838 5.460
1 5.084 .091 4.906 5.262
Univariate Analysis of Variance-CAST C
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 19330.738 1 19330.738 457.373 .000
Error 1926.898 45.591 42.265a
farm2 Hypothesis 3095.498 35 88.443 9.811 .000
Error 15225.558 1689 9.015b
CASTC Hypothesis 14.616 1 14.616 1.621 .203
Error 15225.558 1689 9.015b
a. .419 MS(farm2) + .581 MS(Error)
b. MS(Error)
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Estimated Marginal Means-CAST C
Dependent Variable:age
CASTC Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.065 .081 4.906 5.224
1 5.349 .209 4.939 5.758
Univariate Analysis of Variance-CAST D
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 958.162 1 958.162 88.696 .000
Error 8023.565 742.730 10.803a
farm2 Hypothesis 3261.127 35 93.175 10.326 .000
Error 15240.091 1689 9.023b
CASTD Hypothesis .083 1 .083 .009 .924
Error 15240.091 1689 9.023b
a. .021 MS(farm2) + .979 MS(Error)
b. MS(Error)
Estimated Marginal Means-CAST D
Dependent Variable:age
CASTD Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.101 .076 4.951 5.250
1 5.197 .997 3.241 7.152
Univariate Analysis of Variance-TLR4 A
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 39474.894 1 39474.894 470.032 .000
Error 3008.560 35.823 83.983a
farm2 Hypothesis 3255.702 35 93.020 10.309 .000
Error 15240.100 1689 9.023b
TLR4A Hypothesis .073 1 .073 .008 .928
Error 15240.100 1689 9.023b
a. .892 MS(farm2) + .108 MS(Error)
b. MS(Error)
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Estimated Marginal Means-TLR4 A
Dependent Variable:age
TLR4A Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.092 .125 4.848 5.337
1 5.108 .105 4.902 5.313
Univariate Analysis of Variance-TLR4 B
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 39396.623 1 39396.623 468.488 .000
Error 3011.535 35.812 84.093a
farm2 Hypothesis 3255.928 35 93.027 10.317 .000
Error 15229.416 1689 9.017b
TLR4B Hypothesis 10.758 1 10.758 1.193 .275
Error 15229.416 1689 9.017b
a. .894 MS(farm2) + .106 MS(Error)
b. MS(Error)
Estimated Marginal Means-TLR4 B
Dependent Variable:age
TLR4B Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 4.997 .122 4.758 5.236
1 5.178 .103 4.975 5.381
Univariate Analysis of Variance-TLR4 C
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 30410.816 1 30410.816 446.529 .000
Error 2584.958 37.956 68.105a
farm2 Hypothesis 3270.576 35 93.445 10.363 .000
Error 15230.407 1689 9.017b
TLR4C Hypothesis 9.767 1 9.767 1.083 .298
Error 15230.407 1689 9.017b
a. .700 MS(farm2) + .300 MS(Error)
b. MS(Error)
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Estimated Marginal Means-TLR4 C
Dependent Variable:age
TLR4C Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.152 .090 4.975 5.329
1 4.962 .154 4.660 5.264
Univariate Analysis of Variance-TLR4 D
Dependent Variable:age
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 14931.311 1 14931.311 402.517 .000
Error 1837.263 49.529 37.095a
farm2 Hypothesis 3176.882 35 90.768 10.061 .000
Error 15237.548 1689 9.022b
TLR4D Hypothesis 2.626 1 2.626 .291 .590
Error 15237.548 1689 9.022b
a. .343 MS(farm2) + .657 MS(Error)
b. MS(Error)
Estimated Marginal Means-TLR4 D
Dependent Variable:age
tlr4d Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 5.117 .082 4.957 5.277
1 4.979 .238 4.512 5.447
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Appendix J: Statistical analyses for association of fecundity and variation
in IGF1R, FOXO3, CAST and TLR4-flock correction model
Univariate Analysis of Variance-IGF1R A
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 171.578 1 171.578 540.164 .000
Error 19.457 61.254 .318a
IGF1RA Hypothesis .004 1 .004 .043 .835
Error 62.751 620 .101b
farm2 Hypothesis 82.207 31 2.652 26.201 .000
Error 62.751 620 .101b
a. .085 MS(farm2) + .915 MS(Error)
b. MS(Error)
Estimated Marginal Means-IGF1R A
Dependent Variable:fecundity
IGF1RA Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.754 .085 1.588 1.920
1 1.772 .013 1.747 1.797
Univariate Analysis of Variance-IGF1R B
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 689.829 1 689.829 693.859 .000
Error 35.310 35.517 .994a
farm2 Hypothesis 82.219 31 2.652 26.321 .000
Error 62.474 620 .101b
IGF1RB Hypothesis .282 1 .282 2.795 .095
Error 62.474 620 .101b
a. .350 MS(farm2) + .650 MS(Error)
b. MS(Error)
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Estimated Marginal Means-IGF1R B
Dependent Variable:fecundity
IGF1RB Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.779 .014 1.753 1.806
1 1.707 .040 1.628 1.787
Univariate Analysis of Variance-IGF1R C
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 974.766 1 974.766 746.277 .000
Error 43.993 33.681 1.306a
farm2 Hypothesis 81.796 31 2.639 26.085 .000
Error 62.716 620 .101b
IGF1RC Hypothesis .039 1 .039 .386 .535
Error 62.716 620 .101b
a. .475 MS(farm2) + .525 MS(Error)
b. MS(Error)
Estimated Marginal Means-IGF1R C
Dependent Variable:fecundity
IGF1RC Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.768 .014 1.740 1.795
1 1.791 .034 1.724 1.858
Univariate Analysis of Variance-FOXO3 A
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1423.348 1 1423.348 773.041 .000
Error 59.065 32.079 1.841a
FOXO3A Hypothesis .179 1 .179 1.722 .190
Error 62.260 598 .104b
farm2 Hypothesis 80.172 31 2.586 24.840 .000
Error 62.260 598 .104b
a. .700 MS(farm2) + .300 MS(Error)
b. MS(Error)
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Estimated Marginal Means-FOXO3 A
Dependent Variable:fecundity
FOXO3A Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.831 .029 1.775 1.887
1 1.786 .016 1.753 1.818
Univariate Analysis of Variance-FOXO3 B
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1630.108 1 1630.108 775.354 .000
Error 66.433 31.599 2.102a
farm2 Hypothesis 79.869 31 2.576 24.682 .000
Error 62.421 598 .104b
FOXO3B Hypothesis .018 1 .018 .176 .675
Error 62.421 598 .104b
a. .808 MS(farm2) + .192 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 B
Dependent Variable:fecundity
FOXO3B Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.794 .017 1.760 1.827
1 1.807 .026 1.757 1.857
Univariate Analysis of Variance-FOXO3 C
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 100.259 1 100.259 443.688 .000
Error 21.640 95.764 .226a
farm2 Hypothesis 83.856 31 2.705 25.938 .000
Error 62.365 598 .104b
FOXO3C Hypothesis .075 1 .075 .716 .398
Error 62.365 598 .104b
a. .047 MS(farm2) + .953 MS(Error)
b. MS(Error)
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Estimated Marginal Means-FOXO3 C
Dependent Variable fecundity
FOXO3C Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.797 .013 1.771 1.823
1 1.898 .118 1.665 2.130
Univariate Analysis of Variance-FOXO3 D
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1501.437 1 1501.437 799.648 .000
Error 59.870 31.886 1.878a
farm2 Hypothesis 76.710 31 2.475 23.709 .000
Error 62.414 598 .104b
FOXO3D Hypothesis .026 1 .026 .245 .621
Error 62.414 598 .104b
a. .748 MS(farm2) + .252 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 D
Dependent Variable:fecundity
FOXO3D Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.803 .017 1.770 1.836
1 1.786 .027 1.733 1.840
Univariate Analysis of Variance-FOXO3 E
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 238.313 1 238.313 584.205 .000
Error 21.014 51.514 .408a
farm2 Hypothesis 83.536 31 2.695 25.809 .000
Error 62.438 598 .104b
FOXO3E Hypothesis .001 1 .001 .014 .905
Error 62.438 598 .104b
a. .117 MS(farm2) + .883 MS(Error)
b. MS(Error)
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Estimated Marginal Means-FOXO3 E
Dependent Variable:fecundity
FOXO3E Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.798 .014 1.771 1.825
1 1.807 .075 1.660 1.954
Univariate Analysis of Variance-FOXO3 F
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 101.982 1 101.982 456.534 .000
Error 21.717 97.219 .223a
farm2 Hypothesis 83.880 31 2.706 26.003 .000
Error 62.226 598 .104b
FOXO3F Hypothesis .214 1 .214 2.055 .152
Error 62.226 598 .104b
a. .046 MS(farm2) + .954 MS(Error)
b. MS(Error)
Estimated Marginal Means-FOXO3 F
Dependent Variable:fecundity
FOXO3F Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.796 .013 1.770 1.822
1 1.968 .120 1.734 2.203
Univariate Analysis of Variance-FOXO3 G
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 118.933 1 118.933 475.653 .000
Error 20.632 82.513 .250a
farm2 Hypothesis 84.071 31 2.712 26.012 .000
Error 62.345 598 .104b
FOXO3G Hypothesis .094 1 .094 .904 .342
Error 62.345 598 .104b
a. .056 MS(farm2) + .944 MS(Error)
b. MS(Error)
Appendices
212
Estimated Marginal Means-FOXO3 G
Dependent Variable:fecundity
FOXO3G Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.797 .013 1.771 1.823
1 1.900 .108 1.688 2.113
Univariate Analysis of Variance-CAST A
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1876.633 1 1876.633 793.623 .000
Error 73.834 31.224 2.365a
farm2 Hypothesis 79.716 31 2.571 25.314 .000
Error 63.489 625 .102b
CASTA Hypothesis .006 1 .006 .059 .808
Error 63.489 625 .102b
a. .916 MS(farm2) + .084 MS(Error)
b. MS(Error)
Estimated Marginal Means-CAST A
Dependent Variable:fecundity
CASTA Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.775 .021 1.733 1.817
1 1.768 .017 1.735 1.801
Univariate Analysis of Variance-CAST B
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1431.254 1 1431.254 782.442 .000
Error 58.671 32.074 1.829a
farm2 Hypothesis 80.142 31 2.585 25.462 .000
Error 63.458 625 .102b
CASTB Hypothesis .037 1 .037 .364 .546
Error 63.458 625 .102b
a. .696 MS(farm2) + .304 MS(Error)
b. MS(Error)
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Estimated Marginal Means-CAST B
Dependent Variable:fecundity
CASTB Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.786 .027 1.732 1.839
1 1.766 .015 1.736 1.796
Univariate Analysis of Variance-CAST C
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 778.239 1 778.239 740.007 .000
Error 36.941 35.126 1.052a
farm2 Hypothesis 82.712 31 2.668 26.336 .000
Error 63.319 625 .101b
CASTC Hypothesis .176 1 .176 1.733 .189
Error 63.319 625 .101b
a. .370 MS(farm2) + .630 MS(Error)
b. MS(Error)
Estimated Marginal Means-CAST C
Dependent Variable:fecundity
CASTC Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.765 .014 1.738 1.791
1 1.820 .039 1.743 1.897
Univariate Analysis of Variance-CAST D
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 50.222 1 50.222 320.553 .000
Error 31.348 200.091 .157a
farm2 Hypothesis 83.189 31 2.684 26.501 .000
Error 63.288 625 .101b
CASTD Hypothesis .207 1 .207 2.045 .153
Error 63.288 625 .101b
a. .021 MS(farm2) + .979 MS(Error)
b. MS(Error)
Appendices
214
Estimated Marginal Means-CAST D
Dependent Variable:fecundity
CASTD Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.770 .013 1.745 1.794
1 2.013 .169 1.680 2.345
Univariate Analysis of Variance-TLR4 A
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1907.485 1 1907.485 905.815 .000
Error 65.716 31.207 2.106a
farm2 Hypothesis 69.900 31 2.255 22.315 .000
Error 63.153 625 .101b
TLR4A Hypothesis .342 1 .342 3.386 .066
Error 63.153 625 .101b
a. .931 MS(farm2) + .069 MS(Error)
b. MS(Error)
Estimated Marginal Means-TLR4 A
Dependent Variable:fecundity
TLR4A Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.804 .022 1.761 1.848
1 1.748 .018 1.712 1.783
Univariate Analysis of Variance-TLR4 B
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1890.088 1 1890.088 839.138 .000
Error 70.266 31.196 2.252a
farm2 Hypothesis 74.838 31 2.414 23.845 .000
Error 63.277 625 .101b
TLR4B Hypothesis .218 1 .218 2.153 .143
Error 63.277 625 .101b
a. .930 MS(farm2) + .070 MS(Error)
b. MS(Error)
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Estimated Marginal Means-TLR4 B
Dependent Variable fecundity
TLR4B Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.745 .022 1.703 1.788
1 1.789 .018 1.754 1.823
Univariate Analysis of Variance-TLR4 C
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 1281.617 1 1281.617 760.029 .000
Error 54.626 32.395 1.686a
farm2 Hypothesis 80.254 31 2.589 25.579 .000
Error 63.255 625 .101b
TLR4C Hypothesis .240 1 .240 2.368 .124
Error 63.255 625 .101b
a. .637 MS(farm2) + .363 MS(Error)
b. MS(Error)
Estimated Marginal Means-TLR4 C
Dependent Variable:fecundity
TLR4C Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.783 .015 1.754 1.813
1 1.731 .029 1.673 1.788
Univariate Analysis of Variance-TLR4 D
Dependent Variable:fecundity
Source
Type III Sum of
Squares df Mean Square F Sig.
Intercept Hypothesis 714.333 1 714.333 711.495 .000
Error 35.659 35.517 1.004a
farm2 Hypothesis 83.301 31 2.687 26.451 .000
Error 63.495 625 .102b
TLR4D Hypothesis .000 1 .000 .002 .961
Error 63.495 625 .102b
a. .349 MS(farm2) + .651 MS(Error)
b. MS(Error)
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Estimated Marginal Means-TLR4 D
Dependent Variable:fecundity
TLR4D Mean Std. Error
95% Confidence Interval
Lower Bound Upper Bound
0 1.771 .014 1.744 1.798
1 1.773 .041 1.692 1.854
Appendix K: Statistical analyses for association of birth weight and
variation in CAST
CAST versus Birth weight - Results summary Jan 2008
Trial flock = Hugh Taylor 2006 born lambs
Birthweight:
Descriptive Statistics
N Minimum Maximum Mean
Std.
Deviation
Birth Weight 519 2.75 8.75 5.6830 .92711
Valid N
(listwise) 519
Descriptive Statistics
Dependent Variable: Birth Weight
RAM ID Mean
Std.
Deviation N
Banklea 217/00 5.9875 1.22333 20
Braebank 67/03 5.5577 .69032 26
Doughboy 45/04 5.8378 .88234 37
Glenleith 25/02 5.7273 .87358 33
Glenleith 252/04 5.7685 .90119 27
Hermiston 22/04 5.7907 1.09236 43
Lammerlaw 77/04 5.8214 .93255 21
Leeds Lodge
26/03 5.7400 1.02693 25
Longridge 626/02 5.4143 1.01631 35
Mana 83/04 5.7100 .94285 25
Mana 90/01 5.6111 .85240 36
Offord 414/01 5.6889 .79264 45
Snowlea 192/02 6.0078 .94716 32
Sudeley 102/04 5.7321 .99519 28
Tanlet 547/02 5.2778 .84163 27
Totaranui 376/02 5.6061 .90362 33
Waidale 618/04 5.3558 .68983 26
Total 5.6830 .92711 519
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Half-sib analyses
The following CAST genotypes were deduced from the progeny genotypes
Sire CAST Genotype
Banklea217/00 AB or BC
Braebank 67/03 BB
Doughboy 45/04 BB
Glenleith 25/02 BB
Glenleith 252/04 BC
Hermiston 22/04 AB
Lammerlaw 77/04 BC
Leeds Lodge 26/03 AB or BC
Longridge 626/02 BC
Mana 83/04 AB
Offord 414/01 BB
Snowlea 192/02 BB
Sudeley 102/04 BB
Tanlet 547/02 BB
Totaranui 376/02 BB
Waidale 618/04 BB
Glenleith 252/04, Hermiston 22/04, Lammerlaw 77/04, Longridge 626/02, Mana 83/04 were
analysed. No significant sire allele effect were detected. This is not surprising as in each case
at least one of the sire allele groups had n < 5
Analyses of the Pooled Data
Testing the independent effects of each of the CAST alleles. 
For each CAST allele an ANOVA was performed using the significance level of α = 0.05 to
assess the effect of allele presence, sire, and birth-rank (whether the animal was a single or
multiple) as well as the interactions of these factors on birthweight ie a full factorial model
was employed. If there were no significant interactions, these terms were removed from the
ANOVA model and only the main effects tested.
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1. CASTa
Between-Subjects Factors
N
RAM
CODE
1 16
2 22
3 36
4 30
5 24
6 41
7 17
8 24
9 31
10 20
11 30
12 40
13 32
14 24
15 24
16 30
17 21
SM m 365
s 97
CASTa 0 325
1 137
Full factorial model: No sire effect on birthweight was detected (P = 0.622). Both birth-rank
and the presence of CASTa had a significant effect on birthweight (P≤0.001 and P = 0.019,
repectively). As expected single born lambs had a heavier birthweight than there multiple
born counterparts (singles 5.496 ± 0.054kg; multiples 6.580 ± 0.106kg). Those lambs
possessing the CASTa allele were also heavier, having a mean birthweight of 6.084 ±
0.094kg, while those lambs that did not possess the CASTa allele had a mean birthweight of
5.914 ± 0.068kg. A significant interaction between birthrank and CASTa was also detected
(P = 0.008).
SM * CASTa
Dependent Variable: Birth Weight
SM CASTa Mean Std. Error 95% Confidence Interval
Lower Bound Upper Bound
m 0 5.531 .055 5.424 5.638
1 5.452 .091 5.273 5.631
s 0 6.334 .129 6.080 6.587
1 6.910 .196 6.525 7.296
To investigate this interaction further the file was split by birth-rank and each rank analysed
independently. Obviously birth-rank was removed from the ANOVA model.
Muliples: No sire effect on birthweight was detected (P = 0.360). The presence of CASTa
had no effect on birthweight (P = 0.597). An interaction between sire and CASTa was
detected (P = 0.029)
Appendices
219
RAM CODE * CASTa(a)
Dependent Variable: Birth Weight
RAM
CODE CASTa Mean
Std.
Error 95% Confidence Interval
Lower
Bound Upper Bound
1 0 5.833 .273 5.296 6.371
1 5.583 .473 4.652 6.514
2 0 5.547 .205 5.144 5.950
1 5.333 .473 4.402 6.264
3 0 5.779 .199 5.388 6.170
1 5.614 .247 5.128 6.100
4 0 5.234 .205 4.831 5.637
1 6.083 .335 5.425 6.742
5 0 5.544 .199 5.153 5.935
1 5.833 .473 4.902 6.764
6 0 5.203 .205 4.800 5.606
1 5.643 .219 5.212 6.074
7 0 5.375 .259 4.865 5.885
1 5.500 .580 4.360 6.640
8 0 5.222 .273 4.685 5.760
1 6.000 .273 5.463 6.537
9 0 5.382 .199 4.991 5.773
1 5.125 .259 4.615 5.635
10 0 6.179 .310 5.569 6.788
1 5.437 .237 4.972 5.903
11 0 5.500 .193 5.120 5.880
1 4.833 .473 3.902 5.764
12 0 5.404 .161 5.088 5.720
1 5.650 .367 4.929 6.371
13 0 5.908 .188 5.538 6.278
1 4.583 .473 3.652 5.514
14 0 5.827 .227 5.380 6.274
1 5.444 .273 4.907 5.982
15 0 5.233 .212 4.817 5.650
1 4.800 .367 4.079 5.521
16 0 5.353 .199 4.962 5.744
1 5.700 .367 4.979 6.421
17 0 5.385 .227 4.937 5.832
1 5.786 .310 5.176 6.395
a SM = m
Singles: No sire effect on birthweight was detected (P = 0.813). The presence of CASTa had
a significant effect on birthweight (P = 0.007) with those animals possessing the CASTa allele
having a mean birthweight of 6.890 ± 0.183 kg and while their counterparts not possessing the
CASTa allele had a mean birthweight of 6.328 ± 0.130 kg. A 2-way interaction between sire
and CASTa was not detected (P = 0.340)
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2. CASTb
Between-Subjects Factors
16
22
36
30
24
41
17
24
31
20
30
40
32
24
24
30
21
365
97
19
443
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
RAM
CODE
m
s
SM
0
1
CASTb
N
Full factorial model: As expected (given the CASTa results) no sire effect on birthweight was
detected (P = 0.574) whereas a significant effect of birth-rank on birthweight was observed (P
≤ 0.001). No effect of the presence of CASTb on birthweight was detected (P = 0.143).
There were no significant interactions.
Customised model: When the interaction terms were removed from the ANOVA model and
only the main effects were tested no sire effect on birthweight was detected (P = 0.456), a
significant effect of birth-rank on birthweight was observed (P ≤ 0.001) and there was a
strong tendency for those animals that possessed the CASTb allele to have a heavier
birthweight than those that did not (P = 0.055; mean birthweight CASTb present 6.036 ±
0.0.051 kg, absent 5.638 ± 0.204kg).
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3. CASTc
Between-Subjects Factors
Full factorial model: As expected (given the CASTa results) no sire effect on birthweight was
detected (P = 0.586) whereas a significant effect of birth-rank on birthweight was observed (P
≤ 0.001). A significant effect of the presence of CASTc on birthweight was detected (P ≤
0.001)with those animals possessing the CASTc allele having a mean birthweight of 5.529 ±
0.122 kg while those that did not possess the CASTc allele had a heavier mean birthweight of
6.138 ± 0.069kg . There were no significant interactions.
Customised model: When the interaction terms were removed from the ANOVA model and
only the main effects were tested, no sire effect on birthweight was detected (P = 0.410),
whereas a significant effect of birth-rank (P ≤ 0.001) and the presence of the CASTc allele (P
= 0.002) on birthweight were detected. Those animals possessing the CASTc allele had a
mean birthweight of 5.745 ± 0.102 kg while those that did not possess the CASTc allele had a
heavier mean birthweight of 6.079 ± 0.053kg. NOTE: the means quoted are estimated
marginal means and therefore change with the ANOVA model used.
Testing the effect of CAST genotype: 
 
An ANOVA was performed using the significance level of α = 0.05 to assess the effect of
CAST genotype, sire, and birth-rank (whether the animal was a single or multiple) as well as
the interactions of these factors on birthweight ie a full factorial model was employed. If there
were no significant interactions, these terms were removed from the ANOVA model and only
the main effects tested.
Before undertaking this analysis the rarer genotypes were removed from the data set.
N
RAM
CODE
1 16
2 22
3 36
4 30
5 24
6 41
7 17
8 24
9 31
10 20
11 30
12 40
13 32
14 24
15 24
16 30
17 21
SM m 365
s 97
CASTc 0 385
1 77
Appendices
222
Frequenc
y Percent
Valid
Percent
Cumulative
Percent
Valid AA 3 .6 .6 .6
AB 121 23.2 26.1 26.7
AC 13 2.5 2.8 29.5
BB 263 50.5 56.7 86.2
BC 61 11.7 13.1 99.4
CC 3 .6 .6 100.0
Total 464 89.1 100.0
Missing . 57 10.9
Total 521 100.0
 
Using the data from those lambs that had the genotypes AB, BB or BC:
Between-Subjects Factors
N
RAM
CODE
1 14
2 22
3 36
4 30
5 22
6 37
7 13
8 24
9 27
10 17
11 30
12 40
13 32
14 24
15 24
16 30
17 21
SM m 349
s 94
CASTlamb AB 121
BB 261
BC 61
Full factorial model: No sire effect on birthweight was detected (P = 0.367) whereas a
significant effect of birth-rank on birthweight was observed (P ≤ 0.001). A significant effect
of CAST genotype on birthweight was also detected (P ≤ 0.004). There were no significant
interactions.
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Estimates
Dependent Variable: Birth Weight
6.161a .100 5.963 6.358
6.017a .076 5.867 6.167
5.591a .130 5.336 5.846
CASTlamb
AB
BB
BC
Mean Std. Error Lower Bound Upper Bound
95% Conf idence Interval
Based on modif ied populat ion marginal mean.a.
Pairwise Comparisons
Dependent Variable: Birth Weight
.144b,c .126 .255 -.104 .391
.570*,b,c .164 .001 .247 .892
-.144b,c .126 .255 -.391 .104
.426*,b,c .150 .005 .130 .722
-.570*,b,c .164 .001 -.892 -.247
-.426*,b,c .150 .005 -.722 -.130
(J) CASTlamb
BB
BC
AB
BC
AB
BB
(I) CASTlamb
AB
BB
BC
Mean
Dif f erence
(I-J) Std. Error Sig.a Lower Bound Upper Bound
95% Conf idence Interv al for
Dif f erencea
Based on estimated marginal means
The mean dif f erence is signif icant at the .05 lev el.*.
Adjustment f or multiple comparisons: Least Signif icant Dif f erence (equivalent to no adjustments).a.
An est imate of the modif ied population marginal mean (I).b.
An est imate of the modif ied population marginal mean (J).c.
The above tables show a significant difference between the mean birthweight of those animals
with the AB or BB genotypes when compared to those with the BC genotype (LSD, P = 0.001
and P = 0.005, respectively).
Customised model: When the interaction terms were removed from the ANOVA model and
only the main effects were tested, no sire effect on birthweight was detected (P = 0.430),
whereas a significant effect of birth-rank (P ≤ 0.001) and CAST genotype (P = 0.019) on
birthweight were detected.
Estimates
Dependent Variable: Birth Weight
6.169 .084 6.005 6.333
6.039 .062 5.917 6.160
5.785 .112 5.565 6.005
CASTlamb
AB
BB
BC
Mean Std. Error Lower Bound Upper Bound
95% Confidence Interval
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Pairwise Comparisons
Dependent Variable: Birth Weight
.130 .095 .170 -.056 .316
.384* .136 .005 .117 .650
-.130 .095 .170 -.316 .056
.254* .121 .037 .015 .492
-.384* .136 .005 -.650 -.117
-.254* .121 .037 -.492 -.015
(J) CASTlamb
BB
BC
AB
BC
AB
BB
(I) CASTlamb
AB
BB
BC
Mean
Dif f erence
(I-J) Std. Error Sig.a Lower Bound Upper Bound
95% Conf idence Interv al for
Dif f erencea
Based on estimated marginal means
The mean dif f erence is signif icant at the .05 lev el.*.
Adjustment f or multiple comparisons: Least Signif icant Dif f erence (equivalent to no adjustments).a.
The above tables show a significant difference between the mean birthweight of those animals
with the AB or BB genotypes when compared to that of those with the BC genotype (LSD, P
= 0.005 and P = 0.037, respectively). The mean birthweight of those animals with the BC
CAST genotype were lighter. The mean birthweight for those animals with AB CAST
genotypes was not significantly different to those with BB genotypes (LSD, P = 0.170)
Using the data from those lambs that had the genotypes AB, AC, BB or BC:
Between-Subjects Factors
N
RAM
CODE
1 16
2 22
3 36
4 30
5 23
6 39
7 16
8 24
9 30
10 19
11 30
12 40
13 32
14 24
15 24
16 30
17 21
SM m 361
s 95
CASTlamb AB 121
AC 13
BB 261
BC 61
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Full factorial model: No sire effect on birthweight was detected (P = 0.330) whereas a
significant effect of birth-rank on birthweight was observed (P ≤ 0.001). A significant effect
of CAST genotype on birthweight was also detected (P ≤ 0.001) along with a 2-way
interaction between birth-rank and CAST genotype (P = 0.048). There were no other
significant interactions.
Estimates
Dependent Variable: Birth Weight
6.161a .101 5.962 6.359
5.244a .247 4.759 5.729
6.017a .077 5.866 6.168
5.591a .131 5.334 5.848
CASTlamb
AB
AC
BB
BC
Mean Std. Error Lower Bound Upper Bound
95% Conf idence Interval
Based on modif ied populat ion marginal mean.a.
Pairwise Comparisons
Dependent Variable: Birth Weight
.917*,b,c .267 .001 .392 1.441
.144b,c .127 .259 -.106 .393
.570*,b,c .165 .001 .245 .895
-.917*,b,c .267 .001 -1.441 -.392
-.773*,b,c .258 .003 -1.281 -.265
-.347b,c .279 .215 -.896 .202
-.144b,c .127 .259 -.393 .106
.773*,b,c .258 .003 .265 1.281
.426*,b,c .152 .005 .128 .724
-.570*,b,c .165 .001 -.895 -.245
.347b,c .279 .215 -.202 .896
-.426*,b,c .152 .005 -.724 -.128
(J) CASTlamb
AC
BB
BC
AB
BB
BC
AB
AC
BC
AB
AC
BB
(I) CASTlamb
AB
AC
BB
BC
Mean
Dif f erence
(I-J) Std. Error Sig.a Lower Bound Upper Bound
95% Conf idence Interv al for
Dif f erencea
Based on estimated marginal means
The mean dif f erence is signif icant at the .05 lev el.*.
Adjustment f or multiple comparisons: Least Signif icant Dif f erence (equivalent to no adjustments).a.
An est imate of the modif ied population marginal mean (I).b.
An est imate of the modif ied population marginal mean (J).c.
The above tables show that the mean birthweight for those animals with the CAST AB
genotype is significantly different from those with the AC (LSD, P = 0.001) or BC (LSD, P
= 0.001) genotypes, with the latter genotypes having lighter mean birthweights. Likewise the
the CAST BB genotype is significantly different from those with the AC (LSD, P = 0.003)or
BC (LSD, P = 0.005) genotypes, with the latter genotypes having lighter mean birthweights.
The mean birthweight for those animals with AB CAST genotypes was not significantly
different to that of those with BB genotypes (LSD, P = 0.259)
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ABSTRACT: Longevity in livestock is a valuable trait. 
When productive animals live longer, fewer replacement 
animals need to be raised. However, selection for 
longevity is not commonly the focus of breeding 
programs as direct selection for long-lived breeding stock 
is virtually impossible until late in the reproductive life of 
the animal. Additionally the underlying genetic factors 
or genes associated with longevity are either not known, 
or not well understood. In humans, there is evidence 
that IGF 1 receptor (IGF1R) is involved in longevity. 
Polymorphism in the IGF1R gene has been associated 
with longevity in a number of species. Recently, 3 alleles 
of ovine IGF1R were identifi ed, but no analysis of the 
effect of IGF1R variation on sheep longevity has been 
reported. In this study, associations between ovine IGF1R
variation, longevity and fertility were investigated. 
Polymerase chain reaction-single strand conformational 
polymorphism (PCR-SSCP) was used to type IGF1R
variation in 1,716 New Zealand sheep belonging to 6 
breeds and 36 fl ocks. Ovine IGF1R C was associated with 
age when adjusting for fl ock (present 5.5 ± 0.2 yr, absent 
5.0 ± 0.1 yr, P = 0.02). A general linear mixed effects 
model suggested an association (P = 0.06) between 
age and genotype, when correcting for fl ock. Pairwise 
comparison (least signifi cant difference) of specifi c 
genotypes revealed the difference to be between AA (5.0 
± 0.1 yr) and AC (5.6 ± 0.2 yr, P = 0.02). A weak negative 
Pearson correlation between fertility and longevity traits 
was observed (r = -0.25, P < 0.01). The fi nding of an 
association between variation in IGF1R and lifespan in 
sheep may be useful in prolonging the lifespan of sheep.
Key words: fertility, insulin-like growth factor 1, longevity, 
polymerase chain reaction-single strand conformational polymorphism, sheep
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Characterization of Genetic Variation in the Forkhead
Box Class O3 Gene (FOXO3) in Sheep
Seung O.K. Byun, Huitong Zhou, and Jon G.H. Hickford
FOXO3 is a member of the Forkhead box class O (FOXO) transcription factor family that modulates the tran-
scription of target genes in a variety of cellular functions in lower animals to mammals. It has been implicated in
the attenuation of insulin-signaling pathways, including having a potential role in lifespan control in rodents and
invertebrates. Recent studies also provide some evidence for an association between ageing, human longevity,
and variation in the FOXO3 gene. To date there has been no study on variation in ovine FOXO3 or its relation-
ship to longevity in sheep. In this study, we investigated the variation in exon 2 of ovine FOXO3. This exon
encompasses the DNA-binding domain, which is the key regulator of transcription activity in the target genes.
To enable investigation of the entire exon 2 of the gene, four overlapping fragments were amplified and analyzed
by polymerase chain reaction–single-strand conformational polymorphism and DNA sequencing. Seven haplo-
types with 10 nucleotide substitutions were identified across the 1422-bp exon 2 fragment. One of these substi-
tutions was predicted to produce an amino acid change (p.M201V). The variation identified in ovine FOXO3 may
have an impact on both the structure and function of ovine FOXO3 and, consequently, affect the longevity of
sheep.
Introduction
FOXO1 (FKHR), FOXO3 (FKHRL1), FOXO4 (AFX), andFOXO6 all belong to transcription factors of the Forkhead
box O (FOXO) class, which are characterized by having a
conserved DNA-binding domain termed the Forkhead box
(FOX) (Carlsson and Mahlapuu, 2002). FOXO3 activates the
transcription of many genes, including insulin and other
growth-related genes (Daitoku and Fukamizu, 2007). In the
helminth model organism Caenorhabditis elegans and other
species, there is evidence that FOXO3 is a major target of
insulin-like signaling and that it is therefore important in the
regulation of development, metabolism, and longevity
(Murphy, 2006).
Structurally, FOXO3 is a 71-kDa protein containing an
evolutionally conserved winged-helix Forkhead (FH) box
domain. This comprises the DNA-binding domain (that
binds the genes that are under transcriptional control) and
three additional conserved regions, called the CR1, CR2, and
CR3 domains. The FH domain is composed of three major a-
helices (H1 3), two large unstructured wings (W1, W2), and
three b-strands (S1 3) (Wang et al., 2008). It is well estab-
lished that the FH domain contains a 110-amino acid motif
that functions as a specific DNA-binding site (Carlsson and
Mahlapuu, 2002) and it has also been demonstrated that
intramolecular association between the CR3 domain and the
FH domain further contributes to interaction with DNA
(Wang et al., 2008). This suggests that the CR3 domain also
participates in DNA-binding activity.
Recent studies have revealed that the polymorphism in the
human FOXO3 gene is associated with longevity (Willcox
et al., 2008; Flachsbart et al., 2009). However, there is a lack of
studies on the variation in this gene in other animal species
and whether this variation is associated with longevity. In
this study, we screened the entire exon 2 region of ovine
FOXO3 to identify whether genetic variation exists in this
critical region of the gene. This exon encodes part of the FH,
CR2, and CR3 domains, including the DNA-binding sites of
this gene and where DNA sequences are highly conserved
across species. If variation exists in this region of the ovine
FOXO3 gene, then it might be useful for subsequent genetic
studies into longevity in sheep.
Materials and Methods
Sheep and DNA source
In total, 120 New Zealand Romney cross-bred sheep
were investigated. Blood samples were collected from
these animals onto FTA cards (Whatman BioScience, Mid-
dlesex, United Kingdom), and genomic DNA was purified
using a two-step washing procedure as described by
Zhou et al. (2006). Briefly, a 1.2-mm blood disc was incubated
with 200 mL of 20mM NaOH solution for 30min, and after
removal of the NaOH solution, the disc was washed in
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200 mL of 1 TE buffer (10mM Tris-HCl and 0.1mM EDTA,
pH 8.0).
Polymerase chain reaction primers and amplification
Four sets of polymerase chain reaction (PCR) primers
(Table 1) were designed based on the bovine FOXO3 se-
quences (GenBank accession no. XM 615634) to putatively
amplify the entire second exon of the ovine FOXO3 gene.
These were synthesized by Proligo (Boulder, CO).
Amplification was performed in a 20mL reaction mixture
containing the washed genomic DNA on one 1.2-mm punch
of FTA paper, 0.25mM of each primer, 150mM dNTPs
(Eppendorf, Hamburg, Germany), 1.5mM of MgCl2, 0.5U of
Taq DNA polymerase (Qiagen, Hilden, Germany), and 1
reaction buffer. Amplification was carried out in an iCycler
(Bio-Rad Laboratories, Hercules, CA) and consisted of de-
naturation at 948C for 2min, followed by 35 cycles of 948C
for 30 s, the optimized annealing temperature for any given
primer pair (Table 1) for 30 s, and 728C for 30 s, with a final
extension step at 728C for 5min. Amplicons were visualized
by electrophoresis in 1% agarose (Quantum Scientific,
Queensland, Australia) gels, using 1 TBE buffer (89mM
Tris, 89mM boric acid, and 2mM Na2EDTA) containing
200 ng/mL of ethidium bromide.
Single-strand conformational polymorphism (SSCP)
analysis
A 0.7 mL aliquot of each amplimer was mixed with 7mL of
loading dye (98% formamide, 10mM EDTA, 0.025% bro-
mophenol blue, and 0.025% xylene-cyanol), and after dena-
turation at 958C for 5min, the samples were rapidly cooled
on wet ice and then loaded on to 1618 cm, 12% acrylam-
ide:bisacrylamide (37.5:1; Bio-Rad Laboratories) gels. Elec-
trophoresis was performed using Protean II xi cells (Bio-Rad
Laboratories) at 200 V for 18 h at 258C in 0.5 TBE buffer.
Gels were silver stained according to the method of Byun
et al. (2009).
Cloning of four fragments covering
the entire exon 2 sequence
Sheep DNA samples that produced different PCR-SSCP
patterns were selected for amplification using the proof-
reading enzyme Pwo SuperYield DNA polymerase (Roche
Applied Science, Mannheim, Germany), using the condi-
tions previously described. Amplicons were ligated into
the pCR4Blunt-TOPO vector (Invitrogen, Carlsbad, CA),
and a 2 mL aliquot of the ligation mixture was used
to transform competent Escherichia coli cells (One Shot
INVaF0; Invitrogen), following the manufacturer’s in-
structions. Ten insert positive colonies for each transfor-
mation were picked and incubated overnight in Terrific
broth (Invitrogen) at 378C in a shaking rotary incubator
(225 rpm).
Clones were screened using a clonal PCR-SSCP approach
as previously described (Zhou et al., 2008), and only those
clones for which the PCR-SSCP patterns matched those of
the corresponding genomic DNA were selected for DNA
sequencing.
Table 1. Primers and Annealing Temperatures for Ovine FOXO3
Primers
(in pairs) Primer sequence (50 30)
Expected
amplicon size (bp)
Annealing temperature
for PCR (8C)
Amplicon 1-up AACTCTATCCGGCACAACC
365 62Amplicon 1-dn GCCAGGATGGGGGACAG
Amplicon 2-up AACGCCAGCACAGTCAGC
420 64Amplicon 2-dn CTTGTTCTCTTGGATGGTCT
Amplicon 3-up GACCGTCGTCTCTGAACTC
400 63Amplicon 3-dn TTGGCTGACCCGAGGCTG
Amplicon 4-up CATGGGCTTGAGCGACTC
376 63Amplicon 4-dn TCCCCTTTCCTCAGTGAGC
PCR, polymerase chain reaction.
FIG. 1. Polymerase chain
reaction single-strand confor-
mational polymorphism of
four fragments within exon 2
of ovine FOXO3. Six and three
unique single-strand confor-
mational polymorphism pat-
terns corresponding to six and
three variant sequences (01 06
and 01 03) are shown for
amplicons 1 (a) and 2 (b), re-
spectively, whereas no poly-
morphism was detected in
amplicons 3 (c) and 4 (d).
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DNA sequencing and sequence analysis
Plasmid DNA was extracted from overnight cultures
using a QIAprep Spin Miniprep Kit (Qiagen) and was
sequenced in both directions using the M 13-forward and
reverse primers. Identical sequences obtained from at least
three separate clones from sheep were subjected to further
sequence analysis. Sequence alignments, translations, and
comparisons were carried out using DNAMAN (Version
5.2.10; Lynnon BioSoft, Vaudreuil, Canada). The BLAST
algorithm was used to search the NCBI GenBank (www
.ncbi.nlm.nih.gov/) databases for homologous sequences.
Haplotype determination
Haplotypes were determined by screening to find sheep
homozygous for any one of the given amplicons and then
screening those sheep at the other amplicons to ascertain
what sequence variation existed in that region.
Results
To characterize the entire exon 2 region of ovine FOXO3,
four fragments were amplified using four separate sets of
PCR primers (Table 1). Primer sets were designed to produce
overlapping amplicons, such that a continuous sequence for
the whole of exon 2 could be assembled. The combined
fragments produced a 1422-bp sequence covering the entire
exon 2 region of ovine FOXO3.
Upon SSCP analysis, six and three distinct banding pat-
terns were detected in amplicons 1 and 2, respectively (Fig.
1). No variation was detected in amplicons 3 and 4 (Fig. 1).
Either one or two distinct banding patterns were observed
for each sheep, which defines homozygous or heterozygous
genotypes at the ovine FOXO3 locus, respectively. Novel
variants from amplicons 1 and 2 were sequenced, whereas
there was one sequence obtained from amplicons 3 and 4. All
the sequences identified shared high homology to the pub-
lished bovine FOXO3 sequence (GenBank accession no.
XM 615634), suggesting that these sequences represented
allelic variants of the ovine FOXO3 gene.
As variation in amplicons 3 and 4 of exon 2 of ovine
FOXO3 was not found, the haplotype was indirectly defined
from amplicons 1 and 2 of exon 2 of the gene. Amplicon 1
was used to find homozygous sheep in the population
(n¼ 120). Sheep homozygous in amplicon 1 upon SSCP
analysis were subjected to further genotyping of amplicon 2
to infer the haplotype over an extended region of the ovine
FOXO3 gene. Seven extended haplotypes were assembled
from the four amplicons (Table 2). The seven haplotype se-
quences detected were named 1 to 7 and deposited into the
NCBI GenBank with accession numbers GQ995521 to
GQ995527. Sequence analysis revealed 10 nucleotide substi-
tutions in exon 2 (Table 3).
Discussion
In the overall gene structure of FOXO3, the entire coding
region of the gene is located within exon 1 and exon 2.
However, exon 2 encompasses the functional DNA-binding
domain of the transcription factor, and therefore, we inves-
tigated the genetic variation in this exon. It encodes part of
the FH domain, which consists of the DNA-binding site of
H3, a long unstructured loop W1, the C-terminal wing W2,
and N-terminus of the FH domain. It also encodes conserved
domains CR2 and CR3. Recent nuclear magnetic resonance
and biochemical studies have demonstrated that the FH and
CR domains play a central role in regulating DNA interac-
tion (Tsai et al., 2007). Hence, genetic variation in this region
of the gene may influence FOXO3 activity and potentially
impact both the function of this gene and the genes with
which it interacts.
In this study, 10 nucleotide substitutions were identified
in the 1422-bp exon 2 fragment assembled (Table 3). One
of the substitutions, an A to G substitution at nucleotide
position 601, leads to an amino acid change of M to V at
Table 2. The Seven Different Haplotypes Derived from
Amplicons 1 and 2 of Ovine FOXO3
Haplotype
Amplicon 1 (365 bp)
Amplicon 2 (420 bp)
Frequency
(%)a
1 01 01 49.0
2 02 01 30.0
3 02 03 2.0
4 03 02 14.0
5 04 01 1.0
6 05 01 3.0
7 06 01 1.0
aRounded frequencies in 120 New Zealand cross bred sheep.
Table 3. Sequence Variation in Exon 2 of the Ovine FOXO3 Gene
SNP Positiona Haplotype 1 Haplotype 2 Haplotype 3 Haplotype 4 Haplotype 5 Haplotype 6 Haplotype 7 Amino acid substitution
G/A 93 G G G G A A A
C/T 99 C C C C C C T
T/C 135 T T T C T T T
C/T 207 C T T C C T C
A/G 216 A A A G A A A
C/T 258 C C C C C T C
C/T 327 C C C C C T C
C/A 489 C C A C C C C
T/C 519 T T T C T T T
A/G 601 A A A G A A A M/V
aNucleotide position is related to the first nucleotide of exon 2 of bovine FOXO3 reference sequence (GenBank accession no. XM 615634).
SNP, single nucleotide polymorphism.
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position 201 (p.M201V). Substitution at this position has
not been found in cattle or any other species to date, even
though the FOXO3 protein contains DNA-binding domains
that are highly conserved across species (Carlsson and
Mahlapuu, 2002). This nonsynonymous substitution in ovine
FOXO3 may be important in determining the activity of the
DNA binding-site and, therefore, affect the function of
FOXO3.
The rest of substitutions detected in this study are syn-
onymous single-nucleotide polymorphisms and, therefore,
potentially functionally neutral (Sharp et al., 1995). However,
recently, there has been mounting evidence against this line
of thought. For example, some reports suggest that synon-
ymous substitutions affect mRNA secondary structure and
stability, and hence, they may have functional effects
(Parmley et al., 2006; Qu et al., 2006). The apparently silent
polymorphism detected here could therefore also be func-
tionally important.
Mammalian FOXO3 is one of the homologs of daf-16 in
C. elegans. It is an evolutionarily conserved key regulator of
the insulin-like signaling pathway and influences metabo-
lism and lifespan in a variety of species (Murphy, 2006). It
has been suggested that there may be a connection between
insulin-like growth factor 1 receptor activity (Bonafe` et al.,
2003; Suh et al., 2008) and FOXO3 in regulating lifespan.
Recent studies provide evidence that variation in FOXO3
is associated with human longevity (Willcox et al., 2008;
Flachsbart et al., 2009), and therefore, the genetic variation
found in exon 2 of ovine FOXO3 described in this study may
be important in regards to longevity in sheep.
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A B S T R A C T
Toll like receptor 4 (TLR4) recognizes lipopolysaccharide (LPS) from Gram negative
bacteria, as well as a number of other ligands. Genetic variation in the TLR gene has been
associated with altered immune responses to pathogens and results in variation in disease
susceptibility. The objective of this work was to develop a simple and rapid genotyping
system for ovine TLR4 and of a sensitivity that would allow detection of allelic variation in
this gene. While variation in exon 3 of the ovine TLR4 gene has been described previously,
we describe here an improved genotyping method. This method could not only reveal the
four alleles that have been reported previously, but also revealed a further three new
alleles of this gene in a population of 1670 New Zealand sheep. This improved genotyping
method will be useful in understanding innate immune responses in individual sheep and
could also be a useful tool for large scale immune studies in sheep production systems.
 2008 Elsevier B.V. All rights reserved.
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Silver staining of nucleic acid has been used for various biological analyses, including polymerase chain
reaction single strand conformation polymorphism (PCR SSCP) analysis. A variety of methods have been
described, but these methods are not that effective for staining more than a few PCR SSCP gels, especially
rapidly and with high sensitivity, because they include a number of time consuming or hazardous man
ual steps that are often time dependent. Here we report a silver staining method that can efficiently stain
up to 14 gels at one time and with a detection limit of approximately 10 pg of DNA/mm2, which is com
parable to other methods.
 2008 Elsevier Inc. All rights reserved.
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